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ABSTRACT 
Follicular dem1al cells possess properties that regulate induction of follicle 
fonnation, hair growth, and follicle end bulb regeneration after amputation. While 
the molecular basis for these developmental interactions are being uncovered, it is 
evident that innervation, pigmentation and vascularisation of the follicle, together 
with its role as a stem cell repository, make interpretations of molecular function 
within the follicle, complex. This thesis examined aspects of vibrissa follicle 
development using immunohistochemistry, and demonstrated that segregation of the 
follicle dermis and epithelial differentiation were defined by lamin-A antibody. 
Versican, a proteoglycan recently implicated in dermal papilla induction, was absent 
from early dennal condensations, but its expression correlated with follicle 
innervation during development and the adult hair growth cycle. When lower follicle 
regeneration was studied with in situ hybridisation and immunohistochemistry, 
versican showed two distinct expression domains. These were the dem1al 
components of the end bulb and the follicle neck. BrdU labelling of cell division 
showed regeneration ofthe epithelial component to be consistent with stem cell 
location. Paucity of dem1al cell proliferation left the precise origin of the new dermal 
papilla unresolved, but a-smooth muscle actin expression showed that dermal sheath 
cells moved through the glassy membrane. Sonic hedgehog expression indicated that 
epithelial-mesenchymal interactions, evident in follicle development, were mirrored 
in regeneration. 
A eo-culture model investigated the capacity of follicular dermal cells to 
induce embryonic stem (ES) cell differentiation. Unexpectedly, follicle cells were 
seen to maintain ES cells in an undifferentiated condition. Differentiation assays 
demonstrated that ES cells remained pluripotent after eo-culture. Interleukin-6 family 
cytokines, known to maintain ES cell pluripotency, were detected by RT-PCR in 
cultured cells and vibrissa follicles. Thus, since the follicle dem1is produces these 
cytokines, they may be acting to inhibit the differentiation of follicular epithelial 
stem cells and/or maintain multipotent stem cell populations in the follicle. 
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For many years the hair follicle has been the subject of extensive research 
with the physiological process of cyclic hair growth coming under close scrutiny 
(Chase, 1954; Hardy, 1992; Fuchs, 2001). More recently, it has become apparent 
that the hair follicle provides an effective means of studying a number of aspects of 
biology: the epithelial-mesenchymal interactions that are an integral part of hair 
follicle cycling provide an opportunity to investigate developmental interactions in 
an accessible system; the immune privilege demonstrated by hair follicles is an 
intriguing aspect for the immunologist; pigmentation of the hair fibre presents an 
opportunity to study melanogenesis; the regulatory mechanisms that initiate hair 
growth and the cessation of growth are potentially important in tumour biology; the 
complex innervation, particularly of the rodent vibrissa follicle, provides a model for 
studies on the detailed regulation of sensory innervation; and, over the last decade, 
research into hair follicle stem cells has identified the hair follicle as a source of 
multipotent cells, demonstrating plasticity in vivo and in vitro. 
1.1. DEVELOPMENT OF THE HAIR FOLLICLE 
1.1.1. Hair follicle morphogenesis 
The hair follicle develops as a result of complex interactions between the 
epithelium and mesenchyme. Other skin appendages, including teeth and feathers, 
develop in a similar manner, sharing both morphological characteristics and signalling 
mechanisms, particularly in the earliest stages of development (Davidson & Hardy, 
1952; Hardy, 1992; van Genderen et al., 1994; Thesleff et al., 1995; Kratochwil et al., 
1996; Dassule & McMahon, 1998). A diagram ofthe developmental stages ofthe 
mouse vibrissa follicle (Figure 1.1) shows how the epidem1is first thickens, then 
invaginates in response to signals from the underlying dermis. The basic process is the 
same for all hair follicles but slight differences occur in timing and rate of development 
2 
between different types of follicles. Stmctural differences between species are also 
evident, but the underlying principles of epidermal-mesenchymal signalling are 
believed to be universal in hair follicle development (Davidson & Hardy, 1952; Chase 
1954). 
3 
Figure 1.1. The developmental stages of the rodent vibrissa follicle. 
Stage 0- thickening of the epidermis results in the epidermal placode forming. 
Stage 1 - epidermis begins to invade the underlying dermis. 
Stage 2 - the epidermal plug is now surrounded by the densely packed dermal cells that 
wil become the dermal papilla and sheath. 
Stage 3 - the presumptive dermal papilla is surrounded by the invaginating epidermal 
downgrowth. 
Stage 4- the characteristic bulbous shape of the follicle starts to appear as does the 
keratinized inner root sheath. 
Stage 5- Cells at the surface of the epidermis begin to differentiate in preparation for 
formation of the hair canal. 
Stage 6 - Apoptosis occurs at the presumptive hair canal, the developing sebaceous 
gland is visible and keratinized hair fibre is present. 
Stage 7 - The hair canal opens. 
Stage 8 - Keratinized hair fibre emerges from the follicle. 
Adapted from Davidson & Hardy (1952). 
4 
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1.1.2. Pattern formation 
The precise nature of the epidermal-mesenchymal interactions that are involved in 
appendage formation has long been a subject of great interest, as such interactions are a 
fundamental part of the development of many organs including lung, liver, mammary 
gland, intestine and teeth (Thes leff et al. , 1995; Chuong, 1998). Many of the cell 
signalling molecules involved are also implicated in patteming (Oro & Scott, 1998). 
That is they are thought to be responsible for regulating the arrangement of stmctures, 
in additi on to influencing the morphogenesis of individual structures. 
The most fundamen tal patteming processes include establishment of body axis 
and left-tight asymmetry, but there are many more refined processes which are just as 
strictly regulated. For example, the vibrissa fo lli cles develop in a particular sequence; 
pelage follicles initially develop in tri ads of primary follicles , around which secondary 
follicles develop at a later stage; and in chick skin, feather development spreads from 
the midline to the flanking regions of the tract, with feather buds developing in 
hexagonal arrays (Dhouailly, 1977; Sengel et al., 1980). In association with these 
appendages there are secondary structures such as vasculature and innervation that also 
require strict regulation of their development for successful function . 
Such elaborate patteming in an organ (the skin) that is so accessible provides an 
excellent model for studying patterning during development (Sengel et al. , 1980; 
Chuong & Widelitz, 1998). The molecular control ofpattern fonnation is a complex 
process in which threshold levels, gradi ents and sequestering of molecules all play their 
part, but it is generall y based on simple principles such as lateral inhibition and self-
promoting feedback loops (for recent reviews see Freeman, 2000; Meinhardt & Gierer, 
2000; Gm·don & Bourillot, 200 1). 
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1.1.3. Dermal condensation 
Elaborate tissue recombination experiments have established that the pattern of 
appendage development in an epidermis is determined by the underlying dermis 
(Sengel et al., 1980). The earliest indication of appendage formation is a thickening of 
the epidermis and the fom1ation of a dem1al condensation from the mesenchymal cells 
immediately beneath the basement membrane (Davidson & Hardy, 1952). This 
aggregation in the de1mis is crucial in morphogenesis of teeth, feathers and hair, but the 
means by which it is achieved are still unclear (Thesleff et al., 1995). Cell adhesion, 
migration and morphogenesis are all likely to be contributing factors. 
The physical process of aggregation is one point for discussion, but perhaps a 
more fundamental process is the segregation of these cells from those of the 
surrounding mesenchyme. The aggregative properties displayed in hair follicle 
development are maintained in adulthood and are evident in cultured dermal papilla 
cells both in vitro and, when implanted ectopically, in vivo (Jahoda & Oliver, 1984a; 
Messenger, 1984). This retention of embryonic properties makes the segregation of 
follicular dermal cells from mesenchymal cells all the more intriguing, as this 
differentiation results in a cell population that displays some remarkable properties 
throughout adulthood. 
Identifying the signalling molecules expressed by these cells is an important task 
in hair biology as the dermal condensation is responsible for the message to the 
epidermis inducing follicle formation. One molecule, whose expression in developing 
skin is exclusive to the cells of the dermal condensation, is Noggin and in noggin-/-
mice, follicle morphogenesis is significantly delayed (Botchkarev et al., 1999a). It has 
been demonstrated in other systems that Noggin induces developmental processes by 
antagonising the inhibitory influence of BMP signalling (Zimmermann et al., 1996). 
Botchkarev et al. (1999a) determined that by inhibition ofBMP-4 signalling, Noggin 
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effectively upregulates LEF1, a transcription factor crucial to hair follicle 
morphogenesis (van Genderen et al., 1994; Zhou et al., 1995; Kratochwil et al., 1996), 
and, independent of BMP-4, Noggin also inhibits the expression ofp75, a neurotrophin 
receptor that has been implicated in follicle morphogenesis (Botchkarev et al., 1999). 
Whilst Noggin is not essential to induction of hair follicle development, its expression 
clearly has an inductive effect. 
The cells of the early dermal condensation will contribute to the dermal 
components of the follicle (dermal papilla and dermal sheath), but the small number of 
cells in the early condensation is clearly not sufficient to form these tissues without 
additional cells becoming involved. Studies have shown that little or no proliferation 
occurs in these dermal condensations (Wessels & Roessner, 1965) but it is unclear by 
what means further cells are recruited into these tissues or from where these cells 
originate. Investigations into the molecular profile of aggregating dermal cells, in 
comparison to the non-follicular dermal cells, are important to further our 
understanding of some of their characteristics in adulthood as well as development. 
1.1.4. Key signalling molecules involved in hair follicle development 
The expression patterns of various growth factors, extracellular matrix (ECM) 
molecules and transcription factors have been shown to change during follicle 
organogenesis (Table 1.1) (for review see Oro & Scott, 1998; Fuchs, 2001; Callahan & 
Oro, 2001 ). Whilst many molecules have been identified as being differentially 
expressed during hair follicle development, this is not necessarily sufficient evidence to 
conclude that such molecules are directly involved in hair follicle morphogenesis. The 
isoforms ofTGF-13 are a good example as they have all been found to change 
expression during follicle development, with significant differences between the 
distribution ofTGF-(31, TGF-(32 and TGF-(33 (Heine et al., 1987; Lyons, Pelton & 
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Hogan, 1990; Pelton et al., 1991). However, a combined genetic and functional 
approach by Foitzik et al. (1999) indicated that whilst TGF-P2 was necessary for hair 
follicle development, TGF-P1 and TGF-P3 did not appear to be critical in follicle 
morphogenesis. This demonstrates how differential expression during development is 
not sufficient to imply a functional role. The development of other systems associated 
with follicles (innervation, vasculature, melanogenesis) should always be borne in mind 
when attributing function to a molecule based on expression patterns alone. 
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Table 1.1. Molecules which are implicated in hair follicle development by 
differential expression. 
Molecule 
ECM molecules 
Tenascin 
Fibulin-1 & -2 
Perlecan 
Cell adhesion molecules 
NCAM 
E-Cadherin 
P-Cadherin 
Growth (actors & receptors 
PDGF-A 
TGF-[3R 11 
TGF-a 
BMP2 &BMP4 
EGFR 
HGF 
Met (HGFR) 
Cell signalling molecules 
Notch 
Sonic Hedgehog 
[3-catenin 
Retinoic acid receptor-a & -y 
Transcription (actors 
LEF-1 
Msx1 & Msx 2 
Alx-4 
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Reference 
Jiang & Chuong, 1992 
Kaplan & Holbrook, 1994 
Zhang et al., 1996 
Kaplan & Holbrook, 1994 
Scarisbrook & Jones, 1993 
Kaplan & Holbrook, 1994 
Hirai et al., 1989 
Kaplan & Holbrook, 1994 
Hirai et al., 1989 
Karlsson et al., 1999 
Paus et al., 1997 
Luetteke et al., 1993 
Mann et al., 1993 
Lyons et al., 1990 
Bitgood & McMahon, 1995 
Wilson et al., 1999 
Green & Couchman, 1984 
Hansen et al., 1997 
Lindner et al., 2000 
Lindner et al., 2000 
Kopan & Weintraub, 1993 
Favier et al., 2000 
Bitgood & McMahon, 1995 
lseki et al., 1996 
Huelsken et al., 2001 
Viallet & Dhouailly, 1994 
van Genderen et al., 1994 
Zhou et al., 1995 
Kratochwil et al., 1996 
DasGupta & Fuchs, 1999 
Stelnicki et al., 1997 
Hudson et al., 1998 
Transgenic animals have been used to identify signalling molecules involved 
in hair follicle organogenesis, an example being the noggin -1- mice used by Botchkarev 
et al. (1999a) in the studies described earlier (see 1.1.3). Often a role in hair follicle 
development corresponds to functions at other sites of epithelial-mesenchymal 
interactions (van Genderen et al., 1994, Hudson et al., 1998). The most widely studied 
molecules include those of the Wnt/[3-catenin/LEF-1 pathway (outlined in Figure 1.2), 
BMPs and sonic hedgehog (Shh) (Millar et al., 1999, van Genderen et al., 1994, Gat et 
al., 1998, Chiang et al., 1999, St-Jacques et al., 1998, Wang et al., 2000). A significant 
number of growth factors, including platelet-derived growth factor, TGF-a and -13, FGF 
and EGF (du Cros, 1993; Luetteke et al., 1993; Danilenko et al., 1996; Karlsson et al., 
1999; Betsholtz et al., 2001 ), have also been shown to exert an effect on hair follicle 
development by functional studies. A list of molecules that function in hair follicle 
morphogenesis is presented in Table 1.2. 
11 
Figure 1.2. Wnt canonical pathway. 
(A) In the absence ofWnt signalling glycogen synthase kinase (GSK3) degrades 
intracellular 13-catenin. 
(B) Binding of Wnt to the receptor frizzled, signals dishevelled (Dvl) to inhibit GSK3 
from destabilizing 13-catenin. This results in an accumulation of 13-catenin which is then 
transported into the nucleus to bind with TCF/LEF complexes and so regulate the target 
genes ofWnt. The membrane bound protein Notch is also capable of binding Wnt, as are 
cell surface glycosaminoglycans (GAG) and these are thought to act as co-receptors. 
Cerberus antagonizes Wnt signaling by binding the protein to a site which overlaps its 
antagonistic binding site for BMP. Such competition could result in Cerberus 
functioning to regulate the levels ofWnt and BMP in relation to each other. 
Adapted from Dale (1998). 
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Table 1.2. Molecules which have been demonstrated to influence hair follicle 
morphogenesis by functional studies. 
Molecule and method Influence on follicle Reference 
Truncated ~-catenin 
under Kl4 promoter 
Interfollicular epidermal cells induced Gat et al., 1998 
de novo follicle formation 
~-catenin -mutant gene ~-catenin -ve skin has no hair follicles Huelsken et al., 2001 
under K14 promoter 
cannot encode protein 
~1 integrin 
Sonic hedgehog-/-
mice 
Shh - transient 
expressiOn 
TGF-a -1- mice 
TGF-~2 -1- mice 
TGF-~2 treatment of 
wildtype skin explants 
FGF subcutaneous 
injection 
EGF subcutaneous 
injection 
PDGF-A -1- mice 
Crucial for follicle development to 
occur 
Follicle development limited to hair 
germ formation, any further epithelial 
downgrowth resulted in epidermal 
cyst-like structures 
Premature onset of anagen 
Disorientated, misaligned follicles 
with curly whiskers and wavy hair 
Delayed HF morphogenesis and a 
50% reduction in follicle number 
Induction of HF development 
Inhibition of follicle development and 
thickening of connective tissue layer 
beneath pamiculus camosus -
restricted to area around injection site 
Inhibition of follicle growth and 
reduced skin thickness - affected 
whole body 
Disorganization of follicles and 
mishapen bulbs, reduced number of 
a-sma positive dermal sheath cells 
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Brakebusch et al., 2000 
Raghavan et al., 2000 
St-Jacques et al., 1998 
Chiang et al., 1999 
Wang et al., 2000 
Sato et al., 1999 
Luetteke et al., 1993 
Mann et al., 1993 
Foitzik et al., 1999 
F oi tzik et al., 1999 
du Cros, 1993 
du Cros, 1993 
Karlsson et al., 1999 
Signalling molecules are often described in association with a particular 
intracellular pathway. However, cellular morphogenesis occurs as a result of a 
multitude of signals and the relationship between signalling pathways, both 
extracellularly and intracellularly, is important in understanding developmental signals. 
Feedback loops are often established by connections between pathways and provide an 
important mechanism by which developmental processes can be strictly regulated 
(reviewed by Freeman, 2000). In the developing hair follicle, Wnt5a is a downstream 
target of Shh (Reddy et al., 2001 ), j3-catenin acts upstream of Shh and bmp (Huelsken et 
al., 2001), and BMP signalling is mediated by the transcription factor LEF1 
(Kratochwil et al., 1996). Thus the signalling ofWnt, BMPs and Shh is linked in a 
fairly complex fashion (Figure 1.3). Unravelling the signalling mechanisms of hair 
follicle development is a complex but important topic of hair follicle research. 
15 
Figure 1.3. Relationships between Wnt, Shh and BMP signalling. 
Cerberus potentially balances Wnt and BMP signalling by extracellular 
antagonism. Shh regulates Wnt gene expression. LEF -1 acts downstream of 13-
catenin (which is downstream of Shh and Wnt) and BMP. 
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1.2. THE ADULT HAIR GROWTH CYCLE 
1.2.1. Anatomy and remodelling of hair follicles during the adult hair growth cycle 
Unlike most organs, the hair follicle undergoes extensive remodelling throughout 
adulthood. All follicles cycle at regular intervals with the length of the cycle ranging 
from weeks to years depending on the species and type ofhair follicle in question. 
During each cycle the dermal papilla signals the epithelial cells of the surrounding 
matrix to proliferate and differentiate resulting in hair growth (anagen). When growth 
stops the follicle regresses (catagen) before entering a rest period (telogen) after which 
anagen restarts and the cycle is repeated. The process of shedding the fibre after the 
follicle has regressed is sometimes referred to as exogen (Paus & Cotsarelis, 1999). 
The basic cycle of anagen-catagen-telogen-anagen is common to all types of hair 
follicle but there are significant differences in the anatomy, and consequently the cyclic 
remodelling process, of different types of hair follicle. An example of this is the rat 
vibrissa follicle (see Figure 1.4) when compared to the rat pelage follicle (Young & 
Oliver, 1976). The most obvious anatomical difference is in size, but perhaps the most 
significant cyclic difference is in the telogen phase of the cycle (Figure 1.5). The pelage 
dermal papilla regresses with the column of epidermal cells up to the level of the bulge, 
so reducing the length of the follicle to less than a third of its anagen length. In contrast, 
there is very little regression of the vibrissa follicle papilla. The epithelial matrix 
regresses and the bulb of the follicle shrinks in size but the papilla remains in the same 
place. These morphological differences have raised significant questions regarding the 
initiation of the next anagen phase. 
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Figure 1.4. Diagrammatic representation of an anagen vibrissa follicle. 
Key structures of the follicle-sinus complex are shown excluding blood supply, 
innervation and external muscle attachments. DP- dermal papilla, DS- dermal sheath, 
GM - glassy membrane, IRS - inner root sheath, ORS - outer root sheath, C - capsule, 
SG - sebaceous gland, CF - club fibre, GF - growing fibre, RW - ringwulst. 
Adapted from Oliver, 1966a. 
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Figure 1.5. Comparison between vibrissa and pelage follicle growth cycles. 
A) In the vibrissa follicle the shape of the dermal papilla (DP) and the position 
of the growing (GF) and club fibres (CF) are the key indicators of cycle 
stage. 
B) The pelage follicle undergoes more dramatic changes during the growth 
cycle with the regression of the dermal papilla to the level of the bulge 
( catagen-telogen). Initiation of anagen results in regeneration of this 
temporary part of the follicle, a fibre is produced and the. cycle repeats 
itself. 
ORS - outer root sheath, IRS - inner root sheath, SG - sebaceous gland, 
CC - collagen capsule, HS - hair shaft, APM - arrector pili muscle. 
Adapted from Paus et al. , 1997. 
Anagen Catagen 
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The epithelial-mesenchymal interactions have always been regarded as the 
key interactions for regulating the adult cycle as well as follicle morphogenesis. 
Cotsarelis et al (1990) proposed that a population of slow-cycling cells in the bulge 
of the pelage follicle outer root sheath were putative stem cells. It was hypothesised 
that regression of the follicle end bulb during telogen provided the means by which 
dermal papilla cells gained contact with these follicular stem cells to initiate the next 
anagen phase. However, this did not provide a suitable explanation of how this was 
achieved in the vibrissa follicle where the dermal papilla remains at a significant 
distance from the bulge. This has since been resolved by some elegant experiments 
demonstrating a migration of stem cells through the outer root sheath into the 
vibrissa follicle end bulb (Oshima et al., 200 I). 
The vibrissa follicle (Figure 1.5) is a specialised hair follicle characterised by a 
blood-filled sinus surrounding the follicle itself and forming what is referred to as a 
follicle-sinus complex (Rice et al., 1986). The follicle-sinus complex is highly 
innervated commensurate with the vibrissa follicle's specialised role as a 
mechanoreceptor. Despite these differences the vibrissa follicle remains a valid model 
for hair biology research, as properties initially attributed to vibrissa follicle cells, such 
as the capacity to induce hair follicle formation, have since been identified in pelage 
follicles (Jahoda et al., 1984; Reynolds & Jahoda, 1992). 
1.2.2. Molecular basis of the adult cycle 
The anatomical changes that occur through the hair follicle cycle are well 
documented, but still relatively little is known about the signals involved in triggering 
the switch from one stage of the process to the next. In the search for this information, 
many studies have observed that specific molecules undergo cyclic changes within 
certain parts of the hair follicle, and subsequently proposed that these molecules are 
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involved with the regulation of the cycle. An extensive review ofmolecules associated 
with hair follicle cycling was carried out by Stenn, Prouty & Seiberg (1994) and this 
has recently been followed up by Stenn & Paus (2001). 
Functional studies, either in vivo or in vitro, have provided information about a 
number of molecules which influence the adult hair growth cycle (Table 1.3). Clinical 
treatments can also provide clues to the mechanisms that regulate hair growth. The 
unexpected side-effects of cyclosporin A, a treatment for autoimmune conditions, 
includes hirsuitism and this has been attributed to promotion offollicular epithelial cell 
proliferation (Takahashi & Kamimura, 2001 ). 
Despite the significant amount of research into the control of the hair growth 
cycle, there is still limited evidence as to which molecules are fundamental to hair 
growth and which are functional in systems linked to the follicle, such as innervation or 
melanogenesis. In a recent descriptive study, Ito & Kizawa (2001) found the cell-
growth-associated, calcium-binding proteins SlOOA4 and A6, to be expressed in such a 
manner through the pelage follicle growth cycle, they proposed that these genes are 
associated with migration and proliferation offollicular stem cells. Whilst there is 
nothing to say this is not the case, and such work can only help to unravel the complex 
processes within the follicle, the evidence appears to be purely circumstantial. Findings 
such as these should be regarded as interesting observations to be followed up with 
more functional analysis, relating not only to the hair growth cycle but also to the other 
processes involved such as innervation and vascularization of this dynamic organ. 
During the hair growth cycle, epithelial-mesenchymal interactions regulate the 
morphological changes occurring in the follicle (Hardy, 1992) with much of the 
developmental process being recapitulated. The hair follicle is therefore an excellent 
model for studying such interactions. 
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Table 1.3. Molecules affecting the adult hair growth cycle as shown by functional 
studies. 
Molecule Expression/function Reference 
Shh Induction of anagen Sato et al., 1999 
Wang et al., 2000 
J3-catenin Induction of anagen Huelsken et al., 2001 
Wnt3 Hair shaft differentiation Millar et el., 1999 
Dvl2 Hair shaft formation Millar et al., 1999 
BMPs Matrix proliferation and hair shaft Blessing et al., 1993 
differentiation Kulessa et al., 2000 
Fgf5 Transition from anagen to catagen Hebert et al., 1994 
EGF receptor Transition from anagen to catagen Hansen et al., 1997 
J31-integrin Matrix proliferation Brakebusch et al., 2000 
Raghavan et al., 2000 
KGF receptor Blocked signalling delays hair W em er et al., 1994 
re growth 
Protein kinase A Inhibition of matrix proliferation in Harmon & Nevins, 
vitro 1997 
IL-1a Inhibition of matrix proliferation in Ham1on & Nevins, 
vitro 1993 
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1.3. METHODOLOGY IN HAIR BIOLOGY RESEARCH 
The methods employed to study hair follicle biology have developed as both 
technology and knowledge of the subject have progressed. Early histological studies led 
to an anatomical understanding of hair follicle development and adult cycling and 
provided the basis for many subsequent expression and functional studies (Davidson & 
Hardy, 1952; Chase, 1954; Wessels & Roessner, 1965; Young & Oliver, 1976). The 
availability of antibodies specific to growth factors and their receptors, extracellular 
matrix components, and cell signalling proteins has enabled the expression of many 
molecules to be identified within the follicle (Green & Couchman, 1984; Couchman & 
Gibson, 1985; Jahoda et al., 1992b; du Cros et al., 1995; Paus et al., 1997). Relatively 
simple molecular techniques, such as RT-PCR (Lindner et al., 2000), have been 
followed by in situ hybridisation (van Genderen et al., 1994; Gat et al., 1998; DasGupta 
& Fuchs, 1999) and RNase-protection assays for detection of gene transcripts in situ. 
Such biological techniques are applicable to any experimental system, but the 
significance of the data can only be as good as the model system employed. Table 1.4 
highlights the advantages and disadvantages of some of the experimental systems that 
are used in hair biology research. 
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Table 1.4. Experimental models used to investigate various aspects of hair biology. 
Applications, advantages and disadvantages are highlighted (disadvantages in italics), 
and some example studies that have used such models are listed. 
Model system Comments References 
Rodent skin Postnatal hair growth synchronized Blessing et al., 1993 
Depilation induces synchronized growth Botchkarev et al., 1999b 
Simple and inexpensive Lindner et al., 2000 
Factors can be investigated by topical 
application 
Comparative Specialised hair follicles (eg. vibrissa) Mosconi & Rice, 1993 
studies Deer stags show seasonal changes in Thorn ton et al., 1996 
response to androgens (mane follicles) 
Transgenic mice Genetics of mice well known van Genderen et al., 1994 
Effects throughout organism St-Jacques et al., 1998 
Genetic redundancy can mask effects Y amanishi, 1998 
Knockout may be embryonical/y lethal Karlsson et al., 1999 
Natural mutants Altered hair growth, keratinization, Hebert et al., 1994 
orientation or pigmentation Nehls et al., 1994 
Establish genetic basis of human forms Ahmad et al., 1998 
( eg. hairless) 
Unknown genetic background 
Transgenes Restricts expression to basal cells of Botchkarev et al., 1998 
underK14 epidermis and outer root sheath cells Millar et al., 1999 
promoter Can manipulate genes of which knockouts Charpentier et al., 2000 
prove embryonically lethal Huelsken et al., 2001 
Cell culture Distinct populations grown in isolation or Messenger, 1984 
in combination with other cell types Jahoda & Oliver, 1984a 
Strict regulation of exogenous factors Calver et al., 1993 
Cells can change characteristics (eg. a- Takahashi & Kamimura, 
sma in DP cells) 2001 
Organ culture Maintains in vivo relationship between Philpott et al., 1989, 1992 
follicular cell populations Hirai et al., 1992 
Strict regulation of growth conditions Tobin et al., 1993 
cyclic effects of exogenous factors Harmon & Nevins, 1997 
Limited period of growth 
Tissue Spatial, temporal and species specificity Dhouailly, 1977 
recombinations Exogenous factors can be applied Sengel et al., 1980 
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1.3.1. The rodent vibrissa follicle 
The rodent vibrissa follicle (Figure 1.4) is particularly suited to experimental 
manipulation and study due to its size and accessibility, making isolation, histological 
studies, surgical manipulation, stage identification (by fibre length), and organ culture 
all relatively straightforward. The ability to microdissect the vibrissa follicle has also 
enabled the production of cON A libraries from different components of the end-bulb, 
leading to the development of subtractive libraries (Whitehouse et al., 2001 - in press). 
The rat vibrissa follicle was the first to be used for the isolation of dermal papilla 
cells for cell culture purposes, and subsequently, dermal sheath and gem1inative 
epithelial cells have also been cultured from these large follicles (Jahoda & Oliver, 
1981; Reynolds & Jahoda, 1991, 1996). Just as tissue recombination experiments 
revealed the inductive properties of embryonic dermis, recombinations of adult 
epidermis and vibrissa dermal papillae resulted in follicle formation indicating the 
inductive properties of the dermal papilla (Oliver, 1970). The advantage of the vibrissa 
follicle in such experiments is the phenotypically recognisable fibre that results from 
these induced follicles (Jahoda et al., 1993). This a) enables identification of the site of 
implant, and b) demonstrates the dermal papilla is responsible for the type of follicle 
formed, as was indicated by earlier work using embryonic tissue recombinations 
(Dhouailly, 1977; Sengel et al., 1980). These inductive properties were first identified 
using vibrissa follicle dermal tissue, but have subsequently been demonstrated in 
dermal papillae from human follicles (Reynolds et al., 1995), thus supporting the use of 
the vibrissa follicle as a valid model for hair biology research. 
The vibrissa follicle has also been used as an experimental model for innervation 
due to the complex arrangement of fibres and the spatial arrangement of 'barrels' in the 
cortex corresponding to that of the vibrissa follicles in the mystacial pad (Woolsey & 
Van der Loos, 1970; Woolsey et al., 1975; Van Exan & Hardy, 1980; Munger & Rice, 
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1986; Rice et al., 1986; Arvidsson & Rice, 1991; Waite & Jacquin, 1992; Mosconi et 
al., 1993; Rice, 1993; Rice et al., 1993; Fundin et al., 1999). The proliferative capacity 
of the epithelial component of the follicle has also led to the vibrissa follicle being used 
as the paradigm for epithelial stem cell studies (Rochat et al., 1994; Oshima et al., 
2001). 
The wide variety of disciplines that have employed the vibrissa follicle as a model 
have led to a considerable body of literature on the subject. However, there are still 
fundamental questions that remain to be answered regarding the nature of the dermal-
epithelial interactions that regulate the follicle cycle, the relationship between dermal 
papilla and dermal sheath cells, and the stem cell population within the follicle. 
1.4 STEM CELLS 
1.4.1. What are stem cells? 
The term stem cells refers to a population of cells that have, amongst other 
characteristics, the potential for unlimited self-renewal, and the ability to give rise to 
large numbers of differentiated cells of a number of lineages (Miller, Lavker & Sun, 
1997). There are progenitor cells in most tissue types that can multiply to replace cells 
when necessary, blood and epidermis being good examples. The stem cells of 
mammalian epidermis have been extensively researched due to the accessibility of the 
tissue for both in vivo and in vitro studies (Watt, 2001; Fuchs & Segre, 2000). Whilst 
studies of stem cells of adult tissues is an important area of research, both in relation to 
therapeutic possibilities and as a means of understanding the differentiation processes 
within a particular lineage, the oppmtunity to investigate very early differentiation is 
provided by embryonic stem cells. These are the ultimate stem cells as they can 
differentiate along any lineage and produce all the cells of an organism, including cells 
of the gem1 line. 
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1.4.2. Embryonic stem cells 
Embryonic stem (ES) cells were first isolated and cultured by Evans & Kaufi:nan 
(1981) and Martin (1981) who obtained them (by slightly different methods) from the 
inner cell mass of pre-implantation blastocysts. The key characteristic of these cells is 
the ability to differentiate along any cell lineage, including that of the germ cells, a 
property known as totipotency. The totipotency of ES cells was demonstrated by 
injection into blastocysts which were then implanted into pseudo-pregnant, surrogate 
mothers so generating chimaeric mice (Bradley et al., 1984). These experiments 
highlighted the potential for generating transgenic mice from cultured ES cells which 
had been genetically manipulated. The first examples of animals generated from ES 
cells carrying a specific mutation were two lines of mice lacking the enzyme 
hypoxanthine phosporibosyl transferase (hprt), one generated by selecting for 
spontaneous mutants (Hooper et al., 1987) and one selecting from retrovirally infected 
ES cells for rare insertional mutants (Kuehn et al., 1987). Since these early experiments 
many more mutations have been studied, using gene targeting combined with ES cell 
technology (Koller & Smithies, 1992). 
The generation of transgenic animals using ES cell technology is a great aid to 
research into specific genes, regarding their function in the development and function of 
an organ or system. However, studies of ES cells in vitro can also provide a wealth of 
information for the developmental biologist regarding cellular characteristics (review 
Rathjen & Rathjen, 2001). For example, how the ES cells interact with each other as 
well as other cell types (as they would in the developing blastocyst), what extracellular 
matrix they produce, if any, and what influences specific growth factors and cytokines 
may have on these totipotent cells. With regard to this last point the routine use of 
exogenous leukemia inhibitory factor (LIF) to maintain ES cell cultures results from 
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studies which isolated differentiating inhibitory activity (DIA), later identified as LIF, 
from culture media conditioned by buffalo rat liver cells (Smith & Rathjen, 1991). The 
action of LIF on ES cells in vitro appears to replicate its role in embryogenesis as LIF is 
expressed by extra-embryonic tissues, whilst the cells of the inner cell mass express LIF 
receptors in the pre-implantation blastocyst (Rathjen et al., 1990b; Nichols et al., 1996). 
Such investigations are key to fundamental questions in developmental biology, whilst 
the production oftransgenic lines and chimaeric mice aim to answer more specific 
questions. 
In recent years the potential of ES cell-derived populations of specific cell 
lineages for use in transplants has gained a great deal of attention both in the scientific 
community and in the world's media. The ethical issues involved in human ES cell 
research have been extensively debated whilst studies on murine ES cells have made 
huge steps towards developing the techniques required for such therapeutic approaches. 
Transplantation techniques to replace the damaged cells in Parkinson's disease have 
been developed using foetal neurons, so paving the way for similar treatment with stem 
cell-derived neurons (Bjorklund & Lindvall, 2000). Meanwhile ES cell-derived glial 
cells have efficiently myelinated axons in the central nervous system (CNS) of myelin-
deficient mice, demonstrating that such cells can function in vivo (Brustle et al., 1999; 
Liu et al., 2000). ES cell research holds great potential for such therapies, but there will 
always be an ethical issue with human ES cell research and therapy. 
1.4.3. Adult stem cells 
Stem cells are present in a wide range of adult tissues enabling these tissues to 
undergo a certain amount of self-healing/regeneration. Recently, adult stem cells have 
been exposed as more multipotent than was initially thought. For many years it was 
believed that the CNS had a decidedly limited regenerative capacity. It was then noted 
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that particular neuronal populations in the adult brain were replaced efficiently and 
neural stem cells have since been identified (for review see Kuhn & Svendsen, 1999). It 
has recently been shown that ependymal cells from the ventricular walls of the brain are 
not only neural stem cells, capable of producing neurons, astrocytes and 
oligodendrocytes (Johansson et al., 1999), but also have the capacity to undergo 
haematopoietic differentiation when injected into sublethally irradiated mice (Bjomson 
et al., 1999). Intriguingly, transplanted bone marrow cells have been shown to infiltrate 
the central nervous system and differentiate into cells which possess neuronal 
characteristics (Mezey et al., 2000). This is in contrast to the long-held belief that any 
neural cells lost due to toxins, disease or injury could not be replaced. Experiments such 
as those mentioned suggest that such cells may be replaced, albeit at a slow rate, by 
cells originating from outside of the CNS. It has also been proposed that this may be the 
route by which diseases spread from the haematopoietic system into the CNS (Mezey et 
al., 2000). 
Another example of adult stem cells are those cells isolated from murine skeletal 
muscle which Jackson et al. (1999) demonstrated to have haematopoietic potential. 
Gussoni et al. (1999) took this a step further by demonstrating the reverse to be true 
with haematopoietic cells contributing to muscle fibres. This work also demonstrated 
the potential of the haematopoietic system as a delivery mechanism for stem cell 
therapy when targeting multiple sites around the body. 
There is also the possiblity that cells are not simply remaining as stem cells until 
they are required to differentiate, but that they remain plastic after a certain amount of 
differentiation. That is they are not terminally differentiated but have the capacity to be 
reprogrammed. As more and more studies find that adult somatic cells, previously 
thought to be irreversibly committed to a particular lineage, possess a degree of 
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multipotency, the possibilities seem endless. This point was highlighted by a recent 
article asking "Can anything make anything?" (Morrison, 2001 ). 
Recently the ever-increasing numbers of multipotent or "reprogrammable" cells 
found in adult tissues has led to suggestions that these cells may in fact become more 
plastic during the latter stages of development. Stem cells are typically found in a 
'niche' distinct from the surrounding cell population. This isolation results in influence 
from only the immediate neighbours of these cells and so there is a limited number of 
signals affecting the stem cells. During development as cells are migrating, 
differentiating, proliferating and undergoing morphogenesis, all cells are exposed to a 
wide variety of signals. The suggestion is that during this time the future 'adult stem 
cells' are more differentiated than the same cells in adulthood to protect them from 
these influences. Once in the niche they are no longer at risk of encountering these 
signals and can revert to a state in which they are ready to fulfil their role as a stem cell. 
This plasticity is not evident in vivo as the cells are only required to provide cells of the 
lineage appropriate to their location. Only by manipulating these cells in vitro has the 
degree ofmultipotency become evident (review, Clarke & Frisen, 2001). 
Research into adult stem cells has huge potential therapeutic benefits and despite 
many problems that need to be overcome before such treatment will become routine, 
the prospect of clinical use of adult stem cells is a very appealing one. Whilst ES cells 
have considerable potential, the ethical issues involved in obtaining human ES cells and 
deriving treatments from them are hugely complex and to many people would be totally 
unacceptable. Somatic nuclear transfer (Campbell et al., 1996; Wilmut et al., 1997) 
would still have some ethical arguments associated with it as an oocyte would be 
required. The ethics of using adult stem cells would be far simpler if methods can be 
developed to remove the adult stem cells from the patient's body and either implant 
them into the therapy site or culture them to change their properties to the required 
30 
lineage prior to implantation. This would also have the added bonus that rejection of the 
graft would not be an issue as the cells would have originated from the recipient of the 
treatment. Locating multipotent cells in adult tissues which are easily accessible, and 
developing techniques to manipulate these cells along several lineages are research 
targets that could provide huge benefit for sufferers of many clinical disorders. 
1.4.4. Epidermal stem cells 
The skin is perhaps the most obviously self-renewing tissue of the human body 
with the uppermost layers of cells being constantly sloughed off. All cells of the 
epidermis derive from stem cells within the basal layer. These proliferate, producing 
cells which migrate through the layers of the stratified epidermis, and will ultimately 
repopulate the upper layers as they are shed. The cells change characteristics, or 
differentiate, as they progress through the layers to the outer surface of the skin 
(reviewed by Potten, 1981; Turks ten & Troy, 1998). 
The most widely accepted model for epidermal proliferation is for the stem cell 
daughter cells to be either stem cells themselves (self-renewal) or epidermal progenitor 
cells. These progenitors are transit-amplifying (TA) cells which have a limited 
proliferative capacity, but will undergo several rounds of division before committing to 
a specific fate and undergoing terminal differentiation. By this means, a single stem cell 
can give rise to numerous terminally differentiated cells from just one cell cycle (Figure 
1.6). Hence, the stem cells are slow-cycling cells whilst TA cells are frequently 
dividing, a distinction that is often used to characterise cells in adult tissues (Watt, 
2001). 
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Figure 1.6. One stem cell cycle results in multiple terminally differentiated cells. 
Stem cell (SC) division results in self-renewal and a transient amplifying (TA) 
daughter cell. The TA cell undergoes a limited number of rounds of division 
before the progeny become terminally differentiated (TD) cells. 
Adapted from Watt, 2001. 
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1.4.4.1. Location of epidermal stem cells 
The morphology of the epidermis is highly diverse, differing in mechanical and 
biochemical propetties, depending on the body site. Similarly the location of the stem 
cells is varied (reviews - Miller et al., 1997; Jones, 1997). For example, palm epidermis 
has clusters of stem cells in the rete ridges, whilst in the ear skin, stem cells are spread 
throughout the tissue with a single stem cell located at the centre of a group ofT A cells 
in the basal layer of the thin epidermis. This second arrangement is described by the 
epidermal proliferative unit (EPU) theory which was first proposed by Potten (Potten, 
1974; Potten & Alien, 1975; Alien & Potten, 1976). In the EPU model (presented in 
diagramatic form in Figure 1. 7) the skin is divided into hexagonal columns based 
around a single stem cell in the basal layer. The stem cell of the EPU gives rise to 
between 8 and 10 TA cells. These proliferate in the surrounding basal layer before 
moving into the suprabasallayers as non-dividing, committed cells that progress 
through the upper layers of the epidermis, undergoing terminal differentiation in the 
process. Further evidence to support this model has come from a number of studies 
(Morris et al., 1985; Kam et al., 1986; Pellegrini et al., 2001; Ghazizadeh & Taichman, 
2001; reviewed by Potten, 1981; Miller et al., 1997; Slack, 2000). 
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Figure 1.7. The epidermal proliferative unit. 
According to this model of epidermal proliferation, a central stem cell is surrounded 
by 8 - 10 mitotic basal cells. A post-mitotic cell will move (indicated by small 
arrow) into the suprabasallayer and undergo differentiation, becoming enucleated 
during the process. Ultimately the cell will become a squame which will be lost 
from the skin after it has reached the surface. 
Adapted from Allen & Potten, 1976. 
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There is considerable variation in skin structure between species, as well as areas 
of the body. Whilst the EPU model is widely accepted for the thin stratified epidermis 
of dorsal mouse skin, the majority of human epidermis shows no evidence of EPUs 
based on a single stem cell (Jones, 1997). Instead, the epidermal stem cells appear to be 
in clusters in anatomically defined sites, reminiscent of the corneal stem cell 
compartment. For example, the epidermis of both human and monkey palm is quite 
thick, and characterised by alternating deep and shallow rete ridges which contain stem 
cells and transit amplifying cells respectively (Lavker & Sun, 1982, 1983; Miller et al., 
1997). In contrast, the epidermal stem cells in human scalp skin are at the tips of the 
dermal papillae (Jones et al., 1995) (Figure 1.8). Although the anatomical arrangement 
of epidern1al stem cell and TA cell compartments varies, the model of stem cell division 
producing TA cells which give rise to numerous terminally differentiated cells 
(summarised in Figure. 1.6) is valid for all epidermis. 
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Figure 1.8. The location of epidermal stem cells differs between palm and scalp 
epidermis. 
The stem cells of scalp epidermis (red) are located at the tips of the dermal 
papillae (DP), whilst the stem cells of palm epidermis (blue) are at the base 
of the rete ridges (RR). 
epidermis 
dermis RR 
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1.4.4.2. Molecular characteristics of epidermal stem cells 
Models such as the EPU provide anatomical definitions of epidermal stem cells 
whilst the molecular characteristics of these cells are slowly being revealed. A high 
level of cell surface ~ 1-integrin expression correlates with rapid adhesion to type IV 
collagen, and has been described as a marker for keratinocyte stem cells in vitro and in 
vivo (Jones & Watt, 1993; Jones et al., 1995; Zhu & Watt, 1999). The expression of this 
integrin is thought to maintain cells in the stem cell compartment (Zhu et al., 1999). 
Whole mount staining of human epidermis determined that islands of cells with higher 
levels of~ 1-integrin expression than those around them, did not include proliferating 
cells (Jensen et al., 1999). A recent study by Pellegrini et al. (2001) identified epidermal 
stem cells with an antibody to the transcription factor p63. Strong expression was 
detected in individual cells along the basal layer of epidetmis whilst the adjacent TA 
cells showed some expression, but this was significantly weaker. Building up a 
molecular profile for epidermal stem cells is likely to bring the greatest success in 
identifying pure stem cell populations, as individual markers will frequently include 
other cell populations such as TA cells. This fact was highlighted by a recent 
differential display study in which no molecules showed more than a two-fold 
difference in expression between stem cell- and transit amplifying cell-enriched 
populations (O'Shaughnessy et al., 2000). 
1.4.5. Hair follicle stem cells 
Stem cells of epithelial tissues, particularly epidermis, are amongst those that 
have been the most widely investigated (Fuchs & Segre, 2000). The two populations of 
the hair follicle, dermal and epidermal, have both been shown to possess regenerative 
and inductive capabilites (Oliver, 1966a, 1966b; Jahoda et al., 1984, 1992a, 1993; 
Reynolds & Jahoda, 1992, 1996; Reynolds et al., 1995) that enable the follicle to 
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recover from accidental loss of a hair fibre or a more severe insult such as a skin 
wound. The influence of follicular dermal cells on epithelial cell populations has been 
widely studied (Oliver, 1967, 1970; Ibrahim & Wright, 1982; Jahoda et al., 1984; 
Jahoda & Reynolds, 1993; Matsuzaki et al., 1996; Robinson et al., 2001). 
Extensive studies on outer root sheath cells have led to proposals that this tissue 
harbours the stem cells of the follicular epidermis (Cotsarelis et al., 1990, Rochat et al., 
1994; Oshima et al., 2001) and studies have also identified the contribution ofthe outer 
root sheath to interfollicular epidermis (Lenoir et al., 1988; Limat et al., 1991; Taylor et 
al., 2000). The multipotent germinative epithelial cells were only isolated from follicles 
fairly recently and therefore less experimental data is available on their characteristics 
both in vivo and in vitro (Reynolds & Jahoda, 1991, 1996). However, all these studies 
combined indicate that the anatomically distinct dermal and epidermal populations of 
the hair follicle contain cells that possess extensive proliferative potential, 
multipotency, inductive and regenerative properties, and in the case of GE cells have an 
undifferentiated cytoplasm. 
All of the features described above are characteristic of stem cells and whilst there 
is still a great deal of work to be done, the idea that the hair follicle might provide a 
source of adult stem cells that may be exploited for therapeutic use is gaining evidence 
all the time (Reynolds & Jahoda, 1994; Jahoda & Reynolds, 2001). An additional 
feature of hair follicle cells that would be beneficial in clinical use is their apparent 
immune privilege which allows transplantation between immunologically incompatible 
individuals with no evidence of graft rejection (Reynolds et al., 1999). While the 
epithelial stem cells of the hair follicle are subject to intense study, there has been less 
interest in the possibility of a dermal stem cell population. 
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1.5. FOLLICULAR DERMAL CELL CHARAC'fERI!STICS 
The capacity to induce follicle formation is retained in low passage dermal papilla 
cells which display aggregative properties, crucial to follicle induction, in vitro and 
when implanted in vivo (Jahoda et al., 1984; Jahoda & Oliver, 1984a). This behaviour 
originates from the embryonic dermal condensation as discussed previously. Both 
dermal sheath and de1mal papilla cells arise from the dermal condensation. This 
common origin is believed to account for the two cell types sharing characteristics and 
being able to compensate for each other in some instances. 
Cultured follicular dermal cells can be distinguished from skin fibroblasts in vitro 
by their aggregative behaviour (although this is less evident in dermal sheath cells) and 
expression of a-smooth muscle actin (Jahoda et al. 1984a, Reynolds et al., 1993). In the 
same way that tissue recombinations have demonstrated properties specific to dermis 
and epidermis, cultures of various cell combinations have revealed some interesting 
relationships between different follicular cell populations. In particular, combinations of 
detmal and epidermal cells have demonstrated the trophic support provided by dermal 
papilla cells to be greater than that from skin fibroblasts (Reynolds et al., 1991 ). The 
germinative epidermal cells, that are located around the basal stalk of the dermal papilla 
in the follicle end bulb, display organotypic behaviour in vitro in the presence of dermal 
papilla cells. Discrete groups of germinative epidermal cells are separated from the 
surrounding dem1al cells by a basement membrane (Reynolds & Jahoda, 1991). This is 
particular to dermal papilla cells as gem1inative epidermal cells showed no evidence of 
forming similar structures when exposed to skin fibroblasts. The ability to influence 
epidermal cell populations is therefore possessed by embryonic and adult follicular 
dermal cells and these can be demonstrated in vitro, by altering epidermal cell growth 
or behaviour, and in vivo, by inducing follicle formation. 
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As well as possessing inductive properties, the regenerative capacity of follicular 
dermal tissue is considerable. Amputation of the lower third of the vib1issa follicle, 
including the end bulb, results in the regeneration of a fully functional end bulb (Oliver, 
1966a, 1966b ). In these circumstances, the lower dermal sheath is believed to interact 
with the outer root sheath cells at the site of the amputation and subsequently a dermal 
papilla forms (Oliver, 1966b, Jahoda et al., 1992a). In follicle regeneration the dem1al 
sheath apparently gives rise to dermal papilla cells, whilst in follicles induced by 
implantation of dermal papilla, these cells give rise to the dermal sheath of the resulting 
follicle. This interchangeable role not only reflects the common origin of dermal papilla 
and dermal sheath cells, but also demonstrates a degree of plasticity in these dermal 
cells that is intriguing. Whilst the hair follicle displays characteristics that suggest there 
is a multipotent epithelial cell population present and investigations into these 
progenitor cells have been extensive, the potential of the dermal component has largely 
been ignored. 
1.6. OBJECTIVES 
The work presented in the following chapters aims to investigate interactions 
between various cell populations relating to follicle development, cycling and 
regeneration. 
1) I compared the expression of versican with follicle innervation to investigate a 
possible role for this extracellular matrix molecule, in the developing and adult follicle, 
other than regulation of follicle growth. The recruitment of mesenchymal cells into the 
dermal component of the developing follicle was observed using a marker ofmitotically 
quiescent cells. 
2) In vibrissa follicle regeneration, cellular proliferation and a-smooth muscle actin 
expression were investigated in an attempt to identify the source of the dermal papilla 
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cells in the regenerated end bulb. The process of epithelial regeneration, partly revealed 
by cell proliferation, was also studied by detecting Sonic hedgehog expression. I 
compared patterns of Sonic hedgehog and versican expression in regeneration to 
previously reported developmental expression patterns to determine whether aspects of 
development are reflected in follicle regeneration. 
3) I eo-cultured follicular dermal cells with embryonic stem cells to investigate if 
epithelial differentiation would be induced. This did not occur but some interesting 
observations were made which led me to further investigate the interactions between 
follicular dermal cells and embryonic stem cells in culture. Cytokine expression was 
studied in follicular cells in vitro and in vivo. I also studied the effect ofES cells on 
dermal cell expression of a-smooth muscle actin. 
The work presented provides further insight into the properties of follicular cell 
populations and how they interact with their environment in situ and embryonic stem 
cells in vitro. 
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Chapter 2: Versocan expression in relation to 
follicle innervation, and nuclear lamin A 
expression, during the development and adult 
growth cycle of rat vibrissa follicles. 
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2.1. INTRODUCTION 
2.1.1. Extracellular matrix 
2.1.1.1. The extracellular matrix in development 
Extracellular matrix (ECM) has a crucial role to play in many developmental 
processes in which it facilitates cell growth, migration, differentiation and adhesion, in 
addition to stabilising established structures. The morphogenesis of the hair follicle 
requires significant changes in the ECM, biochemical and structural, particularly at the 
epithelial-mesenchymal interface, where the ECM forms a basement membrane. In 
appendage development, the basement membrane undergoes changes to allow the 
proliferation of epithelial cells to result in invasion of the dermis. The importance of the 
ECM components in this process were first demonstrated over 30 years ago. Collagen 
was shown to be a crucial factor in epithelial morphogenesis in a number of structures, 
whilst the differential turnover of glycosaminoglycans in regions of the basal lamina, 
correlated with the occurrence ofmorphogenetic change (Wessels & Cohen, 1968; 
Grobstein & Cohen, 1965; Bemfield & Banerjee, 1982; reviewed by Thesleff et al., 
1995). Whilst ECM influences many developmental processes, it is important to keep in 
mind that integrity and composition of the ECM is directed by cells. 
2.1.1.2. The extracellular matrix of the dermal papilla 
Cell-cell interactions are clearly an important factor in the development and 
cycling of the hair follicle, but cell-matrix interactions may prove to be just as critical. 
The extracellular matrix provides structural support to the cells of a tissue but is also a 
key player in a number of regulatory mechanisms, mediated by the binding of cell 
surface molecules and signalling molecules to its components. For example, ECM 
proteoglycans have been shown to affect patteming and development by regulation of 
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Wnt, Hedgehog and BMP signalling (Dale, 1998; Capdevila & Belmonte, 1999; 
Selleck, 2000). The number of dermal papilla (DP) cells is believed to remain the same 
throughout the adult growth cycle, with no evidence for significant proliferation at any 
stage (Pierard & de la Brassinne, 1975; Young, 1980). However, the DP is known to be 
the major regulator of hair growth, and although these cells are mitotically inactive, 
they are very active in other areas, particularly in the synthesis ofECM. The amount of 
ECM in the DP fluctuates with the hair growth cycle and this is reflected in the 
changing volume of the DP, whilst the number of cells remains fairly constant (Young, 
1980; Messenger, 1991). 
Various components of the ECM have been described in relation to hair follicle 
biology. Collagen, fibronectin and laminin are present in the basement membrane 
between the dermal and epidermal components of the follicle, and in the ECM of the 
DP at various stages of the growth cycle (Couchman & Gibson, 1985; Couchman, 
1986; Messenger et al., 1991; Jahoda et al., 1992b). Proteoglycans make up a 
significant portion of the ECM and consist of a polypeptide backbone with glycosylated 
side chains. The nature of these side-chains distinguishes between heparan sulfate and 
chondroitin sulfate proteoglycans, both of which are found in the hair follicle ECM, 
along with smaller proteoglycans, the syndecans and decorin (Couchman & du Cros, 
1995; Couchman, 1986 & 1993). Chondroitin-6-sulfate proteoglycan, with its cyclical 
expression in the lower part of the follicle, has been proposed to contribute to the 
immune privilege of the hair follicle by "screening" the bulb cells, which lack 
histocompatibility antigens, from natural cytotoxic cells (Westgate et al., 1991 ). 
Cyclical expression patterns together with extensive expression during follicle 
regeneration (Jahoda et al, 1992a) have led to proposals that components of the ECM 
might be responsible for regulating the follicle growth cycle. 
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2.1.1.3. Versican 
The proteoglycan versican undergoes a dramatic change in expression levels 
during the hair growth cycle and has been proposed to play a role in its regulation (du 
Cros et al., 1995). Versican is a large extracellular matrix molecule from the family of 
aggregating chondroitin sulphate proteoglycans that includes aggrecan, neurocan and 
brevican (review, Schwartz et al., 1999). Neurocan and brevican are specific to the 
nervous system (Rauch et al., 1992; Yamada et al., 1994), whilst aggrecan and versican 
are expressed both in the nervous system and a number of other tissues (Bode-
Lesniewska et al., 1996; Li et al., 1996; Schwartz, 1999). 
The structure of versican (Figure 2.1) is characteristic of the aggrecan family with 
globular domains at either end of the glycosaminoglycan (GAG) attachment domain. At 
theN terminus, a hyaluronic acid-binding site is present, whilst at the C tenninus there 
is a complex multiple binding site, including epidermal growth factor (EGF)-like and 
lectin-like motifs (Zimmermann & Ruoslahti, 1989). These domains allow versican to 
bind and interact with many other ECM components. 
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Figure 2.1. Schematic diagram of the structure of versican. 
Versican consists of a core polypeptide backbone with multiple chondroitin 
sulfate chains attached to the central portion. At theN terminus the globular 
domains comprise the hyaluronic acid-binding domain (HABD) whilst at 
the C terminus, a complex multiple binding domain (CMBD) includes 
EGF -like, lectin-like and complement regulatory protein-like domains. 
Adapted from Zimmerman & Ruoslahti, 1989. 
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In expression studies in adult murine skin, versican was found to be strongly 
expressed in the hair follicle DP during anagen, but lost from the papillae of non-
growing (telogen) follicles (du Cros et al, 1995). Due to this cyclic expression in the DP 
it was proposed that versican may play an inductive role or support the regulatory 
process of the follicle growth cycle. More recently, molecular techniques have been 
used to directly investigate the inductive properties of versican (Kishimoto et al., 1999). 
A transgenic mouse was made expressing green fluorescent protein (GFP) driven by the 
versican promoter. After versican-expressing DP cells, combined with keratinocytes, 
were implanted onto the skin of nude mice, they successfully induced hair follicle 
fom1ation. However after the cells were passaged once, the fluorescent subpopulation 
of cells was lost, along with their inductive capacity. From this the authors concluded 
that versican may contribute to the induction of hair follicle formation. 
2.1.2. Inhibition of neural growth 
Proteoglycans play a wide range of roles as mediators of cell-cell and cell-matrix 
interactions and as structural components of the ECM (Perrimon & Bemfield, 200 1; 
Rapraeger, 2001). They have also been shown to influence patteming of neural crest 
cell migration and axon outgrowth (reviewed by Margolis & Margolis, 1997, Perris & 
Perissinotto, 2000 and Yamaguchi, 2001). Snow et al. (1991) demonstrated that the 
chondroitin sulfate chains of a pat1icular proteoglycan were responsible for altering the 
course of axon growth in vitro, and proposed that this molecule may play an inhibitory 
role in the development of retinal ganglion cell axons. The inhibitory properties of the 
chondroitin sulfate proteoglycan, phosphacan, on neurite outgrowth in vitro, were not 
attributable to the chondroitin sulfate side chains but to the core protein (Milev et al., 
1994). In the aggrecan family, neurocan and brevican have both been shown to be 
potent inhibitors of neurite outgrowth in vitro and are proposed to regulate neuronal 
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outgrowth in vivo (Friedlander et al., 1994; Margolis & Margolis, 1997 (review); 
Yamada et al., 1997). Whilst neurocan's core protein is responsible for this effect (Li et 
al., 2000), the chondroitin sulphate chains ofbrevican are the key to this role (Yamada 
et al., 1997). This is a good example of how, even within the same family of 
proteoglycans, there are significant differences in the manner by which they induce a 
similar effect. 
In the development ofboth the chick (Landolt et al., 1995) and the mouse 
(Henderson et al., 1997) versican has been shown to influence neural crest cell 
migration. V ersican has been thought to form part of the barrier to neural crest cell 
migration and axon outgrowth, so restricting their pathways (Landolt et al., 1995; 
Henderson et al., 1997). As versican has a more widespread distribution than neurocan 
and brevican, it is possible that such effects will influence the peripheral as well as the 
central nervous system. 
2.1.3. Vibrissa follicle innervation 
The vibrissa follicle is a well-innervated mechanoreceptor (Figure 2.2) 
whose adult innervation has been well-documented (Arvidsson & Rice, 1991; 
Mosconi & Rice, 1993; Rice, 1993; Rice et al., 1986, 1993; Waite & Jacquin, 
1992) whilst developmentally, the link between patteming of whisker follicles on 
the face and cortical barrels in the brain has also been the subject of in depth 
research (Woolsey and Van der Loos, 1970; Woolsey et al, 1975; Munger & Rice, 
I 986, for reviews see Micheva & Beaulieu, I 997; Schlaggar & O'Leary, I 993). As 
such, it provides a good model for studies on development of peripheral 
innervation. 
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Figure 2.2. Innervation of the rodent vibrissa follicle. 
The lower two thirds of the follicle are supplied by the deep vibrissa! nerve (DVN) 
whilst superficial vibrissa! nerves (SVN) converge at the neck of the follicle to 
innervate the inner conical body (I CB) and the epidermal tissues distal to this. Many 
different types of nerve endings are present in the follicle, both in the epidennal 
and dermal components. 
Drawing after Oliver (1966a) and Rice et al. (1993). 
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Each vibrissa follicle is supplied by a single deep vibrissa! nerve (DVN) and 
several superficial vib1issal nerves (SVN). These nerves are derived from the 
infraorbital branch of the trigeminal nerve which runs through the lower dermis of the 
mystacial pad. Van Exan & Hardy (1980) have described the early stages of murine 
vibrissa follicle innervation, and Fundin et al. (1999) studied the glial cell line-derived 
neurotrophic factor (GDNF) family of molecules in relation to the molecular control of 
murine vibrissa follicle innervation and nerve ending distribution. However, very little 
has been published about other molecular influences during the transition from the 
placode stage of follicle development, with a nerve plexus beneath it, to a highly 
innervated and evolved structure featuring many different types of nerve endings. 
Pelage follicles are also well innervated, but to a lesser degree than vibrissa 
follicles. A series ofpapers (Botchkarev et al., 1997, 1999b; Peters et al., 2001) have 
described the changes in pelage follicle innervation dming the follicle cycle, regarding 
the number of fibres associated with particular parts of the follicle as well as the type of 
fibres involved. Botchkarev et al. (1997) found that in rodent skin the number of nerve 
fibres innervating pelage follicles changed with the hair cycle, particularly around the 
isthmus of the follicle. This region corresponds to the inner conical body of the vibrissa 
follicle. These authors suggest that the cycle-linked variation of neural cell adhesion 
molecule (N-CAM) and growth-associated protein (GAP) 43 expression in pelage 
follicles may be related to change in innervation rather than hair growth mechanisms. In 
the original versican expression study on adult murine skin, du Cros et al. (1995) 
observed that versican was present at the neck of the murine pelage follicle in telogen, 
but absent from this region in anagen. Given that the changes in versican expression at 
the neck of the follicle are in synchrony with changes in the nerve supply, this suggests 
a possible link between versican and follicle innervation. No work has been published 
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on any cyclic changes in vibrissa innervation, despite detailed studies establishing the 
extensive and complex innervation of the follicle-sinus complex (Rice et al., 1993). 
2.1.4. Nuclear lamins 
Nuclear lamins are type V intem1ediate filament proteins which form the network 
that is the nuclear lamina, a structure lining the inner aspect of the inner nuclear 
membrane. The nuclear lamina interacts with many integral proteins of the nuclear 
envelope, as well as chromatin (reviewed by Gruenbaum et al., 2000) and is involved in 
a number of important processes: targeting nuclear membrane vesicles to chromatin 
after mitosis; regulating nuclear size and shape; and contributing to organisation of 
replication domains (reviewed by Vaughan et al., 2000; Moir et al., 2000). 
These functions are a necessary feature of all cell types and hence lamins are 
present in all cells, but the subtypes of these filaments vary according to the cell type 
and the stage of the cell cycle. Lamins A and Care alternatively spliced products of the 
same gene and are expressed in differentiated cells and proliferating cells respectively 
(Rober et al.,l989; Vaughan et al., 2000; Venables et al, 2001). Mutations in the lamin 
A gene cause some types ofEmery-Dreifuss muscular dystrophy (EDMD), a muscle-
wasting disease (Bonne et al., 1999). Mice with a knockout in the laminA gene develop 
an EDMD phenotype and also suffer from loss of fat cells, a characteristic of a familial 
lipodystrophy which has been traced to a missense mutation in the human lamin A/C 
gene (Cao & Hegele, 2000; Sullivan et al., 1999). The reasons why fat and muscle cells 
appear to be more affected by altered Iamin A/C function are not fully understood 
although various theories have been proposed, all of which are yet to be substantiated 
(reviewed by Gruenbaum et al., 2000). Clinical studies have also revealed lamins to be 
a target of autoantibodies in a wide variety of auto immune diseases, paticularly those 
associated with the liver (Gruenbaum et al., 2000). The components of the nuclear 
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lamina are evidently important in a number of processes and extensive work will be 
required to appreciate the full complexity of their interactions and regulation within the 
nucleus. 
One important function of the lam in A protein is the structural and mechanical 
integrity of the nucleus. Studies have shown that iflamin A expression is disrupted, the 
nuclear structure is distorted and there is ectopic expression of emerin, a lamin-
associated protein usually found within the nuclear membrane (Spann et al., 1997; 
Sullivan et al., 1999). Other intermediate filaments have been shown to function in 
mechanical stabilisation of cells and it is thought, from these studies and lamin A gene 
knockout mice (EDMD mice), that lamins A and C make a significant contribution to 
the structural integrity of the nucleus (reviewed by Moir et al., 2000). The differential 
expression of the splice variants between non-dividing and proliferating cells may be a 
means of maintaining or regulating this integtity whilst the major changes of cell 
division are occurring. 
Jol-4 is a monoclonal antibody that is specific to laminA and reacts with the 
nuclear envelope of quiescent (non-proliferating) cells (Dyer et al., 1997). Previous 
work has demonstrated that the cells of the developing hair follicle dermal condensation 
are essentially non-dividing and these cells apparently remain in this quiescent state 
through to DP formation (Wessels & Roessner, 1965). The Jol4 antibody was therefore 
used to observe the formation of the dem1al condensation and subsequent establishment 
of the dermal components (dermal papilla and dermal sheath) of the vibrissa follicle. 
2.1.5. Aims 
Versican expression within the hair follicle is intriguing because it has been 
associated with induction of follicle formation and regulation of the hair growth cycle, 
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as well as regulating development of the nervous system. Using the vibrissa follicle as a 
model, the aim of this study was to establish the distribution of versican during follicle 
development, and investigate whether a relationship existed between versican 
expression and development of the complex vibrissa} innervation. The population of 
non-dividing cells was also investigated as a means of identifying follicular de1mal cells 
from the surrounding mesenchyme. 
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2.2. MATERIALS AND METHODS 
2.2.1. Animals 
PVG rats of either sex (3-7 months) were killed and the vibrissa follicles isolated 
under a microscope (Nikon SMZ-1 0) using the method described by Robinson et al. 
(1997). An L-shaped incision was made postero-ventral to the mystacial pad and the 
flap of skin folded back. The connective tissue sunounding the vibrissa follicles was 
removed with fine forceps. The exposed follicles were cut transversely at the neck, 
placed in minimal essential medium (MEM) and sorted according to their hair cycle 
stage (Williams et al., 1994) prior to embedding. Snouts were dissected from 
decapitated embryonic (E14 to E18) and newborn (PO) Wistar rats and the lower jaws 
were removed and discarded. Dorsal skin was dissected from E 18 rat embryos. 
Specimens were embedded in TissueTek O.C.T. compound (Agar Aids), snap 
frozen in liquid nitrogen and stored at -80°C prior to being sectioned for 
immunohistochemistry. Table 2.1 shows the number of specimens sectioned and 
stained. 
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Table 2.1. Total numbers of specimens stained for versican, neurofilament and 
lamin A expression (including those that were double-labelled). 
Tissue sample Versican Neurofilament LaminA 
Embryonic snout 19 11 8 
Newborn snout 2 2 0 
Anagen vibrissa follicle 3 3 3 
Catagen vibrissa follicle 2 3 2 
Telogen vibrissa follicle 4 3 1 
Embryonic skin 2 0 1 
Cultured DP/DS 5 0 0 
2.2.2. Immunohistochemistry 
Frozen sections (7J.lm) of vibrissa follicles, embryonic and newborn rat snouts, 
and E18 dorsal skin were cut (on a Leica CM3050 S cryostat), thaw-mounted on poly-
lysine coated slides and air-dried for 1 to 3 hours before being processed for 
immunohistochemistry. For comparison between versican and neurofilament 
expression, sections were mounted on alternate slides. 
For basic immunohistochemistry, sections were washed three times in PBS before 
application of the primary antibody (Table 2.2) diluted in filter-sterilised PBS. The 
slides were then incubated for 1 hour at room temperature, or overnight at 4°C before 
removing the primary antibody with four 5-minute washes in PBS. Secondary antibody 
(Table 2.3), diluted in filter-sterilised PBS, with Evans blue counterstain (30J.lg/ml) in 
some cases, was then applied and incubated for 30 minutes at room temperature in the 
dark before four 5-minute washes with PBS. Sections treated with a biotinylated 
secondary antibody had streptavidin-fluorescein isothiocyanate (FITC) (1:80, Gibco) 
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applied and incubated as for the secondary before the final four 5-minute washes with 
PBS. All sections were mounted under coverslips in mowiol 4-88 (Calbiochem). 
Negative controls were performed by omitting the primary antibody and/or secondary 
antibody and incubating the sections in PBS instead. 
For more direct comparison between versican and neurofilament expression, 
some sections were double-immunolabelled by the following method. The slides were 
air-dried as above then washed three times in PBS before applying the primary 
antibodies ( 12C5 and NF200) mixed and diluted in filter-sterilised PBS. The slides 
were incubated overnight at 4°C then the primary antibodies were removed with four 5-
minute washes in PBS. Secondary antibodies were applied and incubated in a dark 
humidity chamber for 45 minutes at room temperature. The secondary antibodies were 
washed off as for the primary antibodies. Sections treated with a biotinylated secondary 
antibody were incubated in streptavidin FITC (1 :80, Gibco) as for the secondary before 
the final four 5-minute washes with PBS. The stained sections were mounted in mowiol 
4-88 (Calbiochem) under coverslips. 
A Nikon Optiphot UFX-II microscope, equipped with epifluorescence and the 
appropriate filter sets for FITC and tetramethylrhodamine isothiocyanate (TRITC) 
fluorescence, was used for initial observation and analysis. Images were taken on 35mm 
film with a Nikon FX-35A camera. Further analysis was carried out and images 
recorded using a confocallaser-scanning microscope (MicroRadiance scanning system, 
BioRad). All images were processed using Adobe Photoshop 3.0 software. 
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Table 2.2. Details of primary antibodies used for immunohistochemistry. 
Antigen Host Antibody Dilution Source Reference 
Factor 
vers1can mouse 12C5 (monoclonal) I :5 DSHB Asher et al., 1991 
neurofilament 68 mouse NF68 (monoclonal) 1:100 Sigma 
neurofilament 200 rabbit NF200 (polyclonal) I :lOO Sigma 
LaminA mouse Jol4 (monoclonal) 1:10 Serotec Dyer et al., 1997 
Table 2.3. Details of secondary antibodies used for immunohistochemistry. 
Antigen Host Conjugate Dilution Factor Source 
mouse IgG rabbit FITC I :30 DAKO 
mouse lgG goat AlexaFluor546 1:100 Molecular Probes 
mouse lgG goat biotin I :80 Gibco 
mouse lgG goat AlexaFluor488 1:100 Molecular Probes 
rabbit IgG goat A lexaFI uor546 1:100 Molecular Probes 
rabbit IgG goat TRITC I :lOO KPL 
2.2.3. Histology 
8~-tm wax sections were stained with Weigert's hematoxylin, Curtis's ponceau S 
and Alcian blue. Photos were taken on Axiovert 135 microscope using Fuji Provia 400 
film or a Spot RT digital camera (Diagnostic lnstmments Inc.). 
All images were processed using Adobe Photoshop 3.0 software. 
2.2.4. Cell culture 
Rat dermal papilla and dermal sheath cells were isolated and cultured as described 
in section 4.2.1. 
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2.3. RESULTS 
2.3.1. Versican expression during the development of vibrissa follicles 
The overall pattern of versican staining in the mystacial pad changed as the 
vibrissa follicles developed. A diagrammatic summary of the major changes is shown in 
Figure 2.3. Low magnification microscopy showed that at the earliest stages of follicle 
development (E14/15, stages 1-3) versican staining was present throughout the majmity 
of the facial dermis, but it became progressively restricted so that by E16 (stage 4/5) 
versican was seen as a strip of strong immunoreactivity immediately below the 
epidermis. 
Formation of a dermal condensation below the epithelial placode is one of the 
earliest cellular events in hair follicle development (Fig. 2.3, stage 1 and Fig. 2.4 A). 
Consistently at this stage of vibrissa follicle development, the condensed mesenchyme 
had significantly lower levels ofversican expression than the neighbouring dermis, 
which revealed strongly positive immunolabelling (Fig. 2.4 B,C). 
In the next stage of hair follicle development, the epithelium grows down into the 
dermis to form a bud (Fig. 2.3, stage 2, Fig. 2.4 D). During this process the lack of 
versican staining was maintained in the dermis adjacent to the epidermal tissue. 
However as the epithelial downgrowth became flattened at the plug stage (Fig. 2.3 stage 
3), versican expression increased in a group of dermal cells at the base of this structure 
whilst the dermis to the side of the downgrowth remained weakly labelled relative to 
the interfollicular dermis (Fig. 2.4 E). 
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Figure 2.3. Schema of versican immunoreactivity through the developmental 
stages of the rat vibrissa follicle. 
Intensity of shading reflects the intensity of staining seen. 
1 4/5 
2 
6+ 
3 
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lFngure 2A. Versican expression from stage 1 to stage 4/5 of rat vib1issa follicle 
development. 
Sections of embryonic (A-E, El5; F, El6) snout stained with Weigert's haematoxylin, 
Curtis' ponceau Sand Alcian blue (A, D) or immunostained for versican (B, C, E-F). 
The nerve (anow) approaches the follicle from the posterior aspect (A) and divides 
below the developing hair peg sending branches (arrows) around the sides of the 
mesenchymal condensation (D). Comparable stages show the mesenchymal 
condensation to be very weakly stained for versican relative to the surrounding dermis 
(B,C). Dem1is around the epidermal downgrowth maintains this weak staining as cells at 
the base of the hair peg start to develop versican immunoreactivity (E). At a later stage 
the presumptive papilla and de1mal sheath show strong versican labelling (F). 
Scale bar= 50~-tm. 
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As the epithelial component of the follicle continues to grow into the detmis, it 
invaginates to surround the dermal cells at the base, which then constitute the 
presumptive detmal papilla. Versican labelling in this group of dermal cells developed 
from an initial low level (Fig. 2.4 E) to a strong presence in the developing papilla (Fig. 
2.4 F). At E16, the dermal components of the follicle became more defined and the 
lower dennal sheath also displayed strong versican immunoreactivity. As the base of the 
hair follicle extended down into the weakly labelled lower dermis, the positively stained 
elements at the follicle base became increasingly sharply delineated (Fig. 2.3, stage 4/5). 
This restricted expression pattern was maintained through E 18 and into newborn 
samples. Versican staining in the upper dermis changed from a layer of moderate 
staining at El6, to strong staining in the dermis at the neck of the vibrissa follicles with 
moderate expression in the interfollicular sub-epithelial dermis at El8 (Fig. 2.3, stage 
6+ ). In newborn snout, pelage follicles were occasionally observed between the vibrissa 
follicles, highlighted by the strong versican expression in the dermal papilla. 
Normal histology gave limited inforn1ation regarding the innervation of the 
developing follicles but it was observed that the nerves were located on the periphery of 
the dermal condensation (Fig. 2.3 A,D). Comparable samples showed the dermal 
condensation to be very weakly stained for versican (Fig. 2.3 B,C). These observations 
prompted further investigation into the relationship between versican expression and 
follicle innervation. 
2.3.2. V ersican distribution compared with the innervation of developing vibrissa 
follicles 
Examination of adjacent sections at stage 1 of follicle development revealed that 
nerves approached the follicle primordia from the posterior aspect and branched in the 
dermis beneath the epidermal placode (Fig. 2.5 A,E). By stage 2 fibres had diverged 
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and were cupping the dermal condensation below the developing follicle bud (Fig. 2.5 
B,F). This was clearly not a simple case of the approaching nerve dividing in two, 
instead its fibres spread to create a basket-like network that encased the developing 
follicle. This branching occuned within the follicular dermis, which displayed the 
weakest versican staining, but interestingly nerves skirted around the edge of this region 
rather than entering the dermal condensation itself (Fig. 2. 5 B,F). 
As the follicle elongated and versican staining became evident in the presumptive 
papilla (stage 3), nerve fibres were seen running up either side of the follicle alongside 
the epithelial downgrowth just above the level of the developing papilla (Fig. 2.5 
C,G,D,H). The fact that they were located in the dermis with the weakest versican 
staining was most clearly demonstrated using double immunolabelling (Fig. 2.5 I). 
Occasionally when a follicle had been cut off-centre a network of fibres could be seen 
spreading over the length of the follicle (Fig. 2.5 G,H) which gives a clearer picture of 
the three dimensional network of fibres present. It should be noted that the red 
fluorescence seen in the epithelial tissue (Fig. 2.5, I, J) is non-specific autofluorescence 
which was also seen in negative controls in which the primary antibody was omitted. 
The strong labelling of the nerves was however specific as it was not seen in negative 
controls. 
At lower magnification using double immunolabelling, the infraorbital 
branch of the trigeminal ganglion that innervates vibrissa follicles, could be seen 
running through the cheek pad sending out smaller branches to individual 
developing follicles (Fig. 2.5 J). The pathway of this large nerve bundle ran 
through the lower detmis of the mystacial pad, which displayed very weak versican 
labelling. 
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!Figanre 2.5. V ersican and neurofilament expression patterns in developing vibrissa 
follicles. 
Adjacent sections (A,E, El4; B-D, F-H, all EIS) stained for versican (A-D) or 
neurofilament (E-H) show the correlation between weak versican expression and axonal 
pathways from the earliest stage of follicle development (A, E) through to stage 4 (D, 
H). Occasionally when a follicle is cut off-centre a network of fibres is seen spreading 
over the middle portion of the follicle (G, H) giving a clearer picture of the three-
dimensional network of fibres present. Note that fibres do not associate with the follicle 
at the level of the end bulb where the dermal sheath and dem1al papilla show versican 
immunoreactivity. Double immunolabelling (I, J , E 15) clearly demonstrates the nerves 
(red fluorescence) following paths free ofversican (green fluorescence) 
immunoreactivity. 
Scale bar: A= 100!-tm, B- J = 50!-tm. 
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Sections of E 18 and newborn rat snout (Fig. 2.6) showed rows of vibrissa follicles 
at stage 6+ with the collagen capsule developing around the follicle. When stained for 
neurofilament, fibres were seen running up the sides of follicles starting above the end-
bulb. Fibres immediately caudal to the follicle were regularly observed to be slightly 
lower than those on the rostra] aspect, consistent with the observation that the deep 
vibrissa! nerve approached the follicle from the posterior aspect (Fig. 2.6 A-C). The 
restricted areas of strong versican labelling correlated inversely with the pattern of 
innervation. Thus, nerves were absent from the detmal papilla and lower dermal sheath. 
In the mesenchyme below the follicles, absence of versican staining appeared to 
conespond with the path oflarge nerves (Fig. 2.6 A-C). This reciprocity was 
highlighted in the follicle neck, where the level at which the main nerve stopped 
appeared to correspond precisely with the point at which strong versican labelling 
started (Fig. 2.6 D,E). This was confitmed by double labelling at a slightly earlier stage 
(E 18) where the clear border between the two stains was evident (Fig. 2.6 F). As before 
the specific staining of the nerves was accompanied by red auto fluorescence in the 
epithelial tissue (Fig. 2.6 C,F). Some green autofluorescence was also evident in 
epithelial tissue (Fig. 2.6 D,E). Small nerve fibres were present around the neck of the 
developed follicle within the area showing strong versican expression (Fig. 2.6 E). This 
was in contrast to the nerves in the lower part of the follicle, which were only observed 
in areas with weak versican staining. 
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Figllllre 2.6. Versican and neurofilament expression patterns in stage 6+ follicles. 
Newborn (A, B, D, E) and E 18 (C, F) rat vibrissa follicles stained for versican (A, D) or 
neurofilament (B, E) or double immunolabelled (C, F). A strong inverse correlation 
between the expression of versican and the presence of nerve fibres is most clearly 
demonstrated at the point where neurofilament staining stops at the border of versican 
expression (A- C). Each follicle is innervated by a deep vibrissa! nerve (arrowhead) 
whose fibres wrap around the follicle appearing more distal to the follicle bulb of the 
rostra! aspect than the caudal aspect of the follicle (indicated by lines). Also visible are 
skin nerves (arrow) that nm between the vibrissa! follicles and branch to fonn the 
superficial vibrissa! nerves (Rice et al., 1986). 
Scale bar: A, B = 50~tm, C- F = 100~m. 
67 
68 
In summary, at key points in development, staining of adjacent sections with 
versican and NF68 antibodies, combined with double immunolabelling, demonstrated a 
notable absence ofversican expression from the path of developing vibrissa} 
innervation. This relationship was maintained from the early stage of detmal 
condensation to stage 4/5, during which time considerable morphogenesis had occurred 
and the pattern ofversican and neurofilament expression had changed accordingly. 
2.3.3. Versican expression and innervation at the follicle neck during the adult 
vibrissa follicle cycle 
Neurofilament immunostaining of 20).tm sections of an anagen follicle gave a 
good overall picture of the major components of the vibrissa follicle innervation with 
confocal microscopy (Fig. 2. 7). Some non-specific staining was evident in the epithelial 
matrix. The deep vibrissa} nerve (DVN) was clearly visible entering the collagen 
capsule and extending branches into the dem1al sheath (Fig. 2.7 A,C). At the level of 
the ring sinus, nerve endings were observed penetrating the glassy membrane (boxed 
area- Fig. 2.7 C). Superficial vibrissa} nerves (SVN) were also observed approaching 
the follicle distal to the level at which fibres of the DVN extend. The SVN extended 
fibres which encircled the follicle, this orientation is clearly seen in an oblique section 
(Fig. 2.7 C) and at high magnification (Fig. 2.7 B,D). Labelling was largely absent from 
the lower third of the follicle, below the nerve entry point, although in one anagen 
follicle very small nerves were visible entering the dermal papilla at its base (Fig. 2. 7 
E). 
lmmunostaining of follicles at different stages of the hair growth cycle with 
neurofilament antibody demonstrated a fairly consistent innervation. All the major 
innervation in the upper two thirds of the follicle remained constant, and the circular 
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arrangement of smaller nerves surrounding the neck of the follicle was also consistent 
at all stages of the hair cycle (arrowheads, Fig. 2.8 A-C). 
Versican immunostaining showed that versican was abundant in the neck ofthe 
adult follicle in anagen, telogen and catagen (Fig. 2.8 D-F). Versican staining encircled 
the epithelial shaft just below the sebaceous gland and was also present in the dermal 
tissue around the deep vibrissa] nerve within the collagen capsule (not shown). 
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lFfigmre 2.7. Neurofilament staining of the adult rat vibrissa follicle. 
Innervation by supericial vibrissa! nerves (SVN) is evident above the dotted line whilst 
innervation below this is from the deep vibrissa} nerve (DVN) (A). At higher 
magnification (B) SVN descend towards the circumferentially ananged fibres of the 
inner conical body. An oblique section of the follicle demonstrates the difference in 
orientation of the nerve fibres between the DVN whose fibres tend to run along the 
length of the follicle whilst those of the SVN are perpendicular to the follicle at the neck 
(C,D). Some nerve endings at the level of the ring sinus penetrate the glassy membrane 
(boxed area in C). Small axons are seen in the basal stalk of the dennal papilla (E). 
Scale bar: A, C = lOO~tm, B, D, E = 20~tm. 
71 
72 
Figure 2.8. Versican and neurofilament staining through the adult vibrissa follicle cycle. 
Anagen (A, 0, G), catagen (B, E, H) and telogen (C, F, I) follicles stained for 
neurofilament (A- C) and versican (D- I). Red fluorescence (0-I) is due to the Evans 
blue counterstain. Small calibre nerve fibres around the follicle neck (arrowheads) are 
present throughout the cycle (A- C) as is the high level of versican immunoreactivity 
(0- F). Versican is abundant in the anagen dermal papilla (G), starts to diminish in 
catagen (H) and is severely reduced in telogen (I). 
Scale bar= lOOJ.!m. 
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In the bulb of anagen follicles there was strong versican labelling in the dermal 
papilla and lower detmal sheath (Fig. 2.8 G). This started to disappear from the papilla 
in catagen, progressing from the fallen apex to the base of the papilla, but remained 
quite strong in the sheath (Fig. 2.8 H). During telogen versican staining was 
dramatically reduced in the papilla but increased in the dermal sheath (Fig. 2.8 I). As 
the follicle switched back to anagen, versican expression increased from the base of the 
papilla upwards and the cycle was repeated. 
2.3.4. Versican is expressed in the extracellular matrix of dermal papilla and 
dermal sheath cells in vitro 
Versican staining of cultured dermal sheath and dermal papilla cells showed that 
the extracellular matrix produced by both types of cells contained versican (Fig. 2. 9). 
The strength of versican immunoreactivity increased with cell density so in the same 
cultures there were areas which were relatively free ofversican (Fig. 2.9 A,B) and areas 
where the proteoglycan was abundant (Fig. 2.9 C,D). The cells themselves were very 
weakly stained irrespective of passage number. This is in agreement with the 
observations of Zimmermann et al. (1994) who found that only a small proportion of 
versican was retained in skin fibroblast cells whilst a significant amount was secreted 
into the culture medium. However, in their cultures the versican expression levels 
decreased with confluency whilst any mitotic cells displayed a bright signal. The 
difference in findings could be attributed to the fact that papilla and sheath cells do not 
reach confluency as such but continue proliferating, forming clumps and layers on top 
of one another. Such aggregates are associated with a localised increase in ECM and 
this is again reflected in the versican immunoreactivity (Fig. 2.9 E,F) which highlights 
such patches. The expression ofversican in the ECM of dermal papilla and sheath 
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cultures suppm1s the in vivo findings and shows this proteoglycan is an important 
component of the dem1al tissue of the hair follicle. 
2.3.5. Jol-4 immunostaining pattern in vibrissa follicles 
In the early stages of vibrissa follicle development Jol-4 immunoreactivity was 
evident in the early dermal condensation below the thickening epidem1al placode of the 
stage 1 vibrissa follicle (Fig. 2.10 A). In the surrounding mesenchyme a few cells were 
also positive but the number of positively-stained cells decreased as the distance from 
the dermal condensation increased. As the epidetmis became invaginated, the 
surrounding dermal cells maintained strong Jol-4 immunoreactivity and became more 
condensed (Fig. 2.10 B,C). At stage 3 when the epidetmal downgrowth flattened at the 
base, the presumptive papilla cells were Jol-4 immunoreactive, as was a layer of dermal 
cells two to three cells thick, around the epidermal downgrowth which would 
presumably fom1 the dermal sheath in the developed follicle (Fig. 2.10 D,E). 
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Figure 2.9. Versican expression in dermal papilla and detmal sheath cell cultures. 
Versican is expressed in the ECM of dermal sheath (A, C, E) and dermal papilla (B, D, 
F) cultures. Levels of expression change with cell density as does the level of ECM so 
low density culture (A, B) shows a low level ofversican immunoreactivity whilst high 
density areas (C, D) have a much higher level of immunoreactivity. In both sheath and 
papilla cultures this fluctuation of expression in concert with cell density is emphasised 
by the raised expression levels in patches of aggregating cells (E, F). 
Scale bar= 50).!m. 
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lF'igUllre 2.10. Jol4 immunoreactivity in the early stages ofvibtissa follicle development. 
Sections of embryonic (E 15) rat snout immunostained with Jol4 antibody show that from 
the earliest stage of follicle development the cells of the dermal condensation are 
immunoreactive (A-C). 1l1is staining is consistent as the epidem1is thickens (B) and 
develops into the hair peg at which stage Jol4 staining is evident in the dermal cells 
adjacent to the epidennal downgrowth as well as beneath the leading edge (C). At stage 
3 of follicle development Jol4 staining is evident in the presumptive papilla and sheath 
as well as in the central column of the epidermal downgrowth (D,E). 
Scale bar= 50~-tm. 
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E 18 rat back skin was also immunostained with the Jol-4 antibody. The frequency 
of Jol-4 positive cells appeared to be greater in the dermis than in mystacial pad dermis 
but dermal condensations were still evident and the pattern of staining in pelage 
follicles reflected that seen in vibrissa follicles (Fig. 2.11 A-C). There was also a 
significant number of suprabasal epidermal cells that were Jol-4 immunoreactive. 
Jol-4 immunoreactivity was maintained by the vibrissa follicle dermal cells right 
through to adulthood and appeared to be consistent throughout the follicle cycle (Fig. 
2.11 D-G). In anagen, strong staining was observed in dermal papilla and dennal sheath 
cells (particularly in the lower third of the follicle), and in the epithelial cells of the 
outer root sheath. There was also a layer of inner root sheath that displayed Jol-4 
immunoreactivity, seen in newborn and adult follicles (Fig. 2.11 C,D). In catagen, 
detmal papilla, detmal sheath and outer root sheath staining was maintained and the 
gern1inative epithelial cells, and a layer of outer root sheath cells around the lower end 
bulb (Fig. 2.11 G) developed Jol-4 immunoreactivity. 
Throughout development, Jol-4 immunoreactivity distinguished the densely 
packed dermal cells of the follicle from the dern1al fibroblasts of the surrounding 
tissue, so providing a useful tool for early identification of dermal cells of the 
follicle. The Jol-4 staining pattern was almost the exact reverse of that ofversican 
in follicular dermal tissue from the earliest stage of follicle development. As 
development progressed versican expression was upregulated in the Jol-4 stained 
dermal papilla and sheath, changing the relationship between the two staining 
patterns. 
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Figure 2.11. Jol4 immunoreactivity in pelage follicle development and the developed 
vibrissa follicle. 
E 18 pelage follicles at various stages of development (A-C) display similar Jol4 
labelling to corresponding stages of vibrissa follicle development. Certain layers of the 
stage 6+ follicle (outermost layer ofORS and a layer ofiRS) are highlighted by Jol4 
immunoreactivity as well as the dermal papilla and dem1al sheath (D). Red fluorescence 
is due to the Evans blue counterstain (D). The same structures remain highlighted by 
Jol4 labelling during anagen (E) and catagen (F,G) in the adult follicle. In catagen the 
germinative epithelial cells display a higher level of staining than the epithelial matrix 
(G). 
Scale bar: A-C = 20J.lm, D-G = lOOJ.lm. 
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2.4. DISCUSSION 
2.4.1. Summary 
From the work described here I have made three ptincipal observations: (A) 
versican has a distinct expression pattern through the process of follicle development as 
well as during the growth cycle of the adult follicle, which exhibits two independent 
areas of expression; (B) significant changes in versican expression coincide with 
changes in the expression of neurofilament, suggesting a relationship between the 
extracellular matrix proteoglycan and the path of axons, both during development and 
the adult follicle cycle; and (C) both versican expression and Jol-4 immunoreactivity 
highlight the early dermal condensation, indicating the withdrawal of these aggregated 
cells from the cell cycle and a change in their extracellular matrix, supporting previous 
proposals that the fate of dermal cells of the hair follicle is detetmined from a very early 
stage in development. 
2.4.2. Versican in follicle development 
Versican was first described in association with hair follicles by du Cros et al. 
( 1995) who observed that expression of this proteoglycan changed with the hair growth 
cycle in two regions of the follicle- the dem1al papilla and at the neck of the follicle. 
Inttiguingly versican has been proposed to play a key role in the induction of follicles 
by transplanted dermal papilla cells. Kishimoto et al. (1999) demonstrated that adult 
detmal papilla cells that lost versican expression in culture, also lost their inductive 
propet1ies when put into a hair follicle induction assay. In contrast to our work, these 
authors report strong versican expression in the initial dermal condensation using a 
versican promoter driven lacZ gene. The discrepancy may reflect the different methods 
used to detect versican expression at the gene or protein level, but it should be noted 
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that their focus is the pelage follicle, whilst the results presented here are focused on the 
vibrissa follicle. Kishimoto et al. (1999) state that at E13.5 (the age when they observe 
the earliest dermal cell expression of the lacZ gene in pelage follicles) the condensed 
mesenchyme of vibrissa follicles also expressed lacZ. The data to support this statement 
is not presented but as vibrissa follicles develop at an earlier embryonic age than pelage 
follicles it is likely that the vibrissa follicles in question are at a significantly later 
developmental stage. If this is the case and the lacZ gene expression occurred as 
follicles entered stage 3 (Fig. 2.3) this would correspond to our findings in rat vibrissa 
follicles. Assuming this to be true, pelage and vibrissa follicles appear to differ in their 
versican expression during the earliest stages of development. (There is a precedent for 
such an argument as Wang et al. (2000) observed that Sonic hedgehog signalling was 
crucial for development of body hair beyond the hair peg stage, whilst the vibrissa 
follicles were unaffected by interference in the Shh signaling pathway.) Whilst pelage 
follicles were evident in some of our sections of newborn snout, they were invariably at 
stage 6+ and noticeable due to the strong versican expression in the dem1al papilla. 
A more detailed and concentrated comparison between pelage and vibrissa 
follicle development regarding versican expression would be required to clarify this 
issue. Any difference in versican expression, between pelage and vibrissa follicles, 
should be considered in the light of their functional and anatomical differences, 
including different degrees of complexity in follicular innervation. 
2.4.3. Regulation of innervation by versican 
Like other aggregating chondroitin sulphate proteoglycans, versican has 
previously been implicated in directing neuronal outgrowth, but only in relation to 
neural crest cell migration and axon growth in the central nervous system. Splotch mice 
have mutations in the transcription factor Pax3, and exhibit significant neural crest cell 
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migration defects, despite the neural crest cells being intrinsically capable of migration. 
Henderson et al. (1997) found versican was over-expressed in neural crest migration 
pathways of the splotch mouse and proposed that this was due to the mutated Pax3 gene 
being unable to down-regulate versican in these areas. Bovine versican has also been 
demonstrated to have inhibitory effects on axon growth in vitro (Schmalfeldt et al., 
2000). 
The investigation ofversican distribution within and around the developing 
vibrissa follicle, revealed a distinct and progressively well-defined pattern of 
expression. Between stage 1 and stage 6+ of follicle development, versican expression 
changed from being very weak in the mesenchymal aggregation and the dermis 
surrounding the hair peg, to strongly positive in the dermal papilla and lower dermal 
sheath. In general, early on in development, its absence in the dermis immediately 
sunounding the developing vibrissa follicle conesponded with the presence of axons. It 
is also clear that the localised reduction ofversican staining was not simply due to the 
axons (which do not express versican) covering particular areas, as nerve fibres 
occupied only part of the weakly labelled tissue. 
Nerves do not appear to cross boundaries between strong and weak versican 
domains. The transition from a basket of nerve fibres encasing the entire stage 3 follicle 
to a tube of fibres nmning from just above the papilla up to the neck of the follicle is an 
interesting morphological change, the mechanics ofwhich are not clear. If nerves are 
avoiding penetrating, or crossing over, areas of high versican expression, it is possible 
that the downwards movement of the presumptive papilla, which at the stage in 
question is beginning to express versican, results in the basket of fibres allowing the 
follicle to grow down through the network. The observations described here suggest 
that versican influences the complex peripheral innervation of the rat vibrissa follicle 
relatively late on in development. 
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2.4.4. Does versican act alone? 
The idea that nerves may be channelled into areas with little or no versican, does 
not, on its own, account for all my observations. In particular, I observed that at the start 
of follicle development, nerves remained at the outer edge of a zone of dermis that had 
weak versican expression, but did not penetrate the actual dermal condensation at the 
centre of this zone. Other molecules expressed in the condensation may, therefore, act 
to prevent nerve fibres straying into this area. Coupled with relatively high versican 
expression outside of the condensation, this would provide a very specific growth path 
for innervation. The relative absence ofversican inside the condensation does correlate 
well with cell activities that accompany the formation of this structure. Previous studies 
have shown that versican inhibits cell adhesion and has a positive role in cell 
proliferation (Yamagata et al., 1989, Zimmermann et al., 1994, Yang et al., 1999). 
Therefore its absence from the dermis immediately beneath the epidermal placode is 
consistent with increased cell adhesion (Kaplan & Holbrook, 1994) and absence of 
proliferation (Wessels & Roessner, 1965), both ofwhich are characteristic ofthe dermal 
condensation. 
Vibrissa follicle innervation is complex with many different types of nerve 
endings present in the different components of the follicle-sinus complex. A recent 
study has observed that the expression patterns of GDNF family ligands and receptors 
cone late with the development of specific sensory nerve endings in vibrissa follicles 
(Fundin et. al., 1999). This work highlights GFRa2 as having an expression pattern 
directly opposite to that ofversican in the early stages offollicle development. For 
example, GFRa2 mRNA expression is seen in the mesenchymal condensation in stage 
1, and in stage 2 it is visible around the sides of the epidermal downgrowth. Clearly the 
fine detail of follicle innervation is dependent on multiple molecular cues. As the 
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innervation of the vibrissa follicle is well-documented it could be a useful tool for 
fmiher investigations into molecular controls of innervation in a similar manner to the 
work ofFundin et al. (1999). 
2.4.5. Innervation at the neck of the vibrissa follicle is constant through the adult 
follicle cycle 
Recent work has shown that peripheral innervation in skin is not constant. 
Intriguingly, it changes with the pelage hair follicle cycle, pmiicularly the network of 
fibres around the portion of the follicle distal to the point of insertion of the arrector pili 
muscle, that changes in both number and type of fibres (Botchkarev et al., 1997; Peters 
et al., 2001). Previously du Cros et al. (1995) observed changes in versican expression 
in the corresponding region of the follicle neck, and when these two studies are 
compared the changes in versican expression and innervation correlate well. When 
versican is present at the neck ofpelage follicles during telogen, the number of nerve 
fibres is reduced, whereas during anagen this versican expression is lost whilst nerve 
fibres are increased in number. 
A significant difference between rodent vibrissa and pelage follicles is that 
vibrissa follicles retain their non-growing club hair while the next one grows, hence a 
fibre is always present. Pelage follicles lose their hair part way through the telogen 
phase of the hair cycle. As specialised mechanoreceptors, vibrissa follicles provide 
constant sensory input, therefore it is not surprising I observed constant innervation in 
the inner conical body, the region of the vibrissa follicle corresponding to that in which 
versican and innervation are cyclic in pelage follicles. Innervation in this pati of the 
follicle arises from a number of superficial vibrissa! nerves rather than the deep 
vibrissa! nerve, which innervates the majority of the follicle (Mosconi et al., 1993; Rice 
et al., 1993). In their detailed study on vibrissa follicle innervation Rice et al. (1993) 
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made no specific observations regarding the cycle stage of the follicles, but due to the 
number of samples used it would be expected that these authors would also have 
mentioned any significant changes in follicle innervation. 
The relatively constant innervation at the neck of the follicle is accompanied by 
consistently strong versican expression in the surrounding dermal tissue. Whilst the 
versican expression in the lower third of the follicle is similar between pelage and 
vibrissa follicles it is the expression around the neck that differs, as does the 
innervation. The relationship between innervation and versican is therefore maintained 
beyond birth. 
2.4.6. Summary of adult vibrissa follicle innervation 
Over the last 15 years detailed studies have been carried out on the neuroanatomy 
of the vibrissa follicle providing an excellent reference for those whose work depends 
on an understanding of the complexity of this organ's innervation (Figure 2.2). Six 
areas of the follicle are innervated: 1) the epidermal rete ridge collar, 2) the inner 
conical body, 3) the dermal sheath at the level of the ring sinus, 4) the outer root sheath 
at the level of the ring sinus, 5) the dermal sheath at the level of the cavemous sinus, 
and 6) the dermal papilla. All vibrissal innervation is derived from the infraorbital 
branch of the trigeminal nerve that gives rise to nerves that run through the dermis of 
the mystacial pad, dorsal to the rows of vibrissae that they supply. These are the row 
nerves, branches from which form the deep vibrissa! nerves (DVN), of which there is 
one per follicle, and superficial vibrissa! nerves (SVN), which are more numerous with 
several SVN supplying the distal portion of each vibrissa follicle (Rice et al., 1986). 
The range of types of nerve fibres and nerve te1minals has led to many proposals 
of function for the extensive neural network in the follicle. Nociception and 
proprioception seem to be the main roles attributed to the nerves (Arvidsson & Rice, 
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1991; Mosconi et al., 1993; Rice et al, 1986). This work has also emphasised the 
anatomical and physiological difference between the SVN and DVN networks. One 
example of this is the proposal by Rice et al. (1986) that the fibres innervating the inner 
conical body detect movements of the follicle-sinus complex with respect to the 
mystacial pad, whilst innervation from the DVN detects movements of the vibrissa with 
respect to the follicle-sinus complex. In later work, Rice (1993) used a lectin to identify 
a subpopulation of neurons within the vibrissa follicle. It highlighted the axons that are 
circumferentially arranged in the inner conical body and only a small number ofDVN 
fibres in the cavernous sinus were labelled by this method, so providing further 
evidence that the superior and deep innervation of the vibrissa! follicle are two separate 
networks within a complex structure. 
2.4. 7. V ersican expression associated with fine nerve fibres 
The area of strong versican expression at the follicle neck included the path of 
fine nerve fibres from the SVN which were observed consistently throughout the 
follicle cycle. The association of axons with strong versican expression is contradictory 
to the pattern seen in development where axons appeared with weak versican 
expression. However, this is in line with recent ideas suggesting that versican regulates 
innervation in a far more complex manner than was first thought. Initially versican was 
believed to simply have an inhibitory effect on neural crest cell migration and axon 
outgrowth (Landolt et al., 1995; Henderson et al., 1997), but there is recent evidence 
that in the mature central nervous system, versican acts as a stabilizing factor to limit 
neuronal plasticity (Niederost et al., 1999; Schmalfeldt et al., 2000). Versican' s constant 
presence at the neck of the established (stage 6+) follicle may well be ensuring the 
stable innervation necessary for the follicle to successfully function as a sensory organ. 
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This leaves the question of how, developmentally, this nerve supply reached this 
region. The innervation at the follicle neck from the superficial vibrissa! nerve appears 
to develop slightly later than the deep vibrissa! nerve supply to the lower two thirds of 
the follicle. Fibres were not evident at the follicle neck until the newborn stage, despite 
a significant number of fibres being present in the subepidermal dermis in the 
interfollicular skin. Since the neck of the follicle has a ring ofversican around it, (Fig 
2.8 D - F) this must require fibres to move into an area abundant in versican. 
A recent proposal is that versican positively influences neural crest cell migration 
if the gradient of versican expression is gradually increasing but any significant 
stepwise change in concentration, whether that be an increase or decrease, will 
negatively affect their migration (Perissinotto et al., 2000; Perris & Perissinotto, 2000 
(review)). It is possible from the observations presented here that this is also the case 
with axonal growth. Axons run through areas of weak versican expression rather than 
enter adjacent dermal tissue that has considerably higher levels of the proteoglycan 
present (Figure 2.5). Axons appear to be directed along the correct path by sharp 
boundaries in versican expression. It is therefore possible that the superficial fibres 
grow toward the follicle neck with the increasing versican gradient which develops 
between E 16 and E 18. This is when the uppermost layer of dermis changes from 
uniform versican expression to moderate staining in the interfollicular area and strong 
staining immediately around the vibrissa follicles. Once the fibres have reached their 
target in the follicle the versican acts to maintain this innervation during the complex 
process of remodelling that occurs during the follicle cycle. 
The relationship betweeen versican and neural pathways does not appear to be a 
black and white permissive or non-permissive one, more a case of guidance which, in 
combination with other factors, results in a delicate system being established and 
maintained to the best effect. 
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2.4.8. A conserved function within the aggrecan family 
This work suppm1s previous studies proposing that versican influences the 
outgrowth of axons in development and in adult neuronal remodelling. The mechanism 
by which it does this has not been elucidated. As mentioned earlier, other members of 
the aggrecan family have been shown to have a similar effect on neurite outgrowth and 
therefore it seems likely that a part of the gene that is highly conserved between all of 
these molecules (aggrecan, versican, brevican and neurocan) would be responsible for 
this effect. The binding of the glycosaminoglycan, hyaluronan, to the highly conserved 
NH2 terminal region is a common characteristic of the aggrecan family, so hyaluronan 
may be the effector molecule. However, in vitro assays have demonstrated inhibition of 
neurite outgrowth by purified proteoglycans (Friedlander et al., 1994), and in one case 
hyaluronan was used in such an assay and shown to have no inhibitory effect on neurite 
outgrowth (Schmalfeldt et al., 1998). Nevertheless, it has recently been demonstrated 
that it is an NH2-tem1inal fragment of neurocan containing an Ig loop and an HA 
binding domain that is responsible for the inhibition ofN-cadherin and 131 integrin-
mediated neurite outgrowth and cell adhesion, and that breaking this fragment down 
further leads to loss of the inhibitory activity (Li et al., 2000). It therefore appears that 
the inhibitory characteristics of the aggrecan family proteoglycans on neurite 
outgrowth, are encoded in the same highly-conserved region that imparts the 
hyaluronan-binding capacity. This is consistent with the fact that the smaller 
glycoproteins hyaluronectin and GHAP also appear to have an inhibitory effect on 
neurite outgrowth (Bignami et al, 1988). 
Hyaluronectin is a hyaluronan binding glycoprotein that has been isolated from 
brain and is probably an alternatively spliced gene product that is produced by cells as 
well as resulting from proteolytic cleavage of the larger versican molecule (Zako et al., 
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1995). It has been demonstrated that hyaluronectin is produced by oligodendrocytes and 
Schwann cells in vitro (Courel et al., 1998) so the glial cells produce a glycoprotein that 
binds with hyaluronan in the ECM and at the same time appears to regulate neurite 
outgrowth. Hyaluronectin is possibly the same as GHAP but this has not been 
confirmed in the literature to date. 
The antibody used for these studies was originally designed against glial 
hyaluronate binding protein (GHAP) (Asher et al., 1991), which has now been found to 
be a product of proteolytic cleavage of versican (Zimmermann & Ruoslahti, 1989; 
Perides et al., 1995). Later work by the group showed the antibody to bind to versican 
as well as GHAP (Perides et al., 1995). 
CD44 is the hyaluronan receptor and this is involved in the degradation of 
hyaluronan, that is it binds the glycoprotein to the cell surface so it can be internalised 
and degraded. A major function ofhyaluronan appears to be maintenance of the 
extracellular space between cells, an example being the development of the cornea 
when hyaluronan loss results in condensation of the stroma of the cornea (Toole & 
Underhill, 1983). Using murine pelage skin, Underhill (1993) studied CD44 and 
hyaluronan distribution during development of follicles and observed an inverse 
correlation, with CD44 being present in the condensed mesenchyme beneath 
developing follicles and hyaluronan being present elsewhere in the mesenchyme but 
absent from these condensed areas. Hyaluronan therefore appears to have the same 
expression pattern as that described here for versican, which is not unexpected as 
versican binds hyaluronan (LeBaron et al., 1992). However, in adult pelage skin, 
hyaluronan (at low levels) is present in the de1mal papilla in anagen, present but less so 
in catagen, but also present in telogen whilst versican is absent from the telogen papilla. 
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2.4.9. Further work to support the proposed relationship between versican and 
peripheral innervation 
The data shown here is purely descriptive with no functional evidence to suppmt 
the proposed functional role of versican in directing the innervation of the vibrissa 
follicle. Using the techniques employed here, further support for these proposals may be 
obtained by carrying out similar studies on other follicle systems which have different 
innervation patterns. The follicle-sinus complexes of different species are known to 
vary in the level of innervation particularly within the inner conical body (Rice et al., 
1986; Mosconi & Rice, 1993) and hence a different versican expression pattern may 
support the correlation described here. Also, the development of other peripheral 
sensory organs, such as taste buds, may provide information about the relationship 
between versican and neural pathways. Expression ofthe hyaluronan receptor, CD44, 
has been studied in taste buds (Witt & Kasper, 1998) suggesting hyaluronan, a high-
affinity ligand for versican, is likely to be present. 
Transgenic techniques could be employed to incorporate the versican gene under 
the control of a promoter for a gene expressed specifically by dermal condensation 
(DC) cells. From this data lamin A is a possible candidate in that it is expressed by DC 
cells but the expression of lamin A is too widespread for this to be a viable option. 
Other options might include BMP, FGF and Wnt family members but again these are 
involved in a wide range of structures through development so may not be viable for the 
development of transgenic animals. However, if a suitable promoter could be identified 
and the technique employed, it would be possible to determine whether nerve fibres 
would be able to penetrate the outer part of the early dermal condensation and so 
facilitate the passage of the DVN into the dermal sheath of the vibrissa follicle. Based 
on the proposed role of versican in cell proliferation and adhesion, it may be the case 
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that the DC would not develop into such a defined structure and ectopic versican 
expression in this region may affect the overall development of the hair follicles. 
Alternatively a mutation could be generated in the NH2 terminal of the versican 
gene to see if a) the same developmental expression occurs and b) how innervation is 
affected. This would follow up the theory that it is the hyaluronan-binding domain that 
is responsible for the effects of versican on neural outgrowth. 
Corthesy et al. ( 1999) established that partial denervation of the whisker pad 
resulted in regeneration of follicle innervation in the normal arrangement. There was no 
compensation by intact nerves from other follicles and regenerating fibres innervated 
specific follicles only. Studies on versican distribution in relation to such regenerating 
innervation would indicate whether the neuronal guidance mechanisms differ in the 
adult animal relative to those seen in development. The data presented here, along with 
that of du Cros et al. (1995) would suggest that versican is still involved in such a 
process in adulthood, but regeneration after denervation would involve a major nerve 
bundle, rather than the delicate nerve branches and endings that are involved in the 
cyclic remodelling of the hair follicle. 
2.4.1 0. Versican as an indicator/regulator of cell proliferation 
Versican is produced by dennal (skin) fibroblasts in culture but versican mRNA 
expression has been shown to be inversely proportional to the confluency of the 
cultures. Due to this and the localisation of versican in the proliferating basal epidermis 
it has been suggested to regulate cell proliferation along with the high-affinity ligand, 
hyaluronan (Zimmern1ann et al., 1994). The expression pattern ofversican in the early 
stages of development appears to support this as the very weakly stained dern1al 
condensation has been shown to consist of non-dividing cells (Wessells & Roessner, 
1965). Cultured dermal papilla and dermal sheath cells do not reach confluency as such, 
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but continue to divide in culture. V ersican forms part of the extracellular matrix of 
dermal papilla and dem1al sheath cultures with levels ofversican increasing as the cell 
density increases, as might be expected as the amount of ECM produced will increase 
with the number of cells. Zimmermann et al. (1994) observed versican expression was 
lost when keratinocytes were induced to terminally differentiate, providing another 
indication that versican expression may be associated with proliferation. 
2.4.11. Nuclear laminA expression 
Cells labelled by the Jol-4 antibody are non-dividing cells as the epitope against 
which the antibody is designed becomes masked by lamin-protein or lamin-chromatin 
interactions when the cell prepares for proliferation (Dyer et al, 1997). The term 
"quiescent" has been used to describe Jol-4-positive cells (Dyer et al., 1997) but this 
gives the impression the cells are inactive, and is therefore very misleading in the case 
of follicular dem1al cells that are actively producing ECM and growth factors 
throughout development and the adult cycle (Couchman & Gibson, 1985; Couchman, 
1986; Messenger et al., 1991; Jahoda et al., 1992b; Kaplan & Holbrook, 1994; 
Kozlowska et al., 1998). The cells will therefore be described as non-dividing rather 
than quiescent. 
Jol-4 immunoreactivity in the early dermal condensation supports observations 
made in feather as well as hair development that dermal condensation formation is not a 
result of cell proliferation but due to rearrangement of cells resulting from changes in 
cell adhesion (Wessells & Roessner, 1965; Noveen et al, 1995). In the absence of cell 
proliferation, the increase in the number of Jol-4 immunoreactive cells suggests 
recruitment from the surrounding mesenchyme continues through development. 
The distinct staining pattern of dermal cells of the hair follicle from the earliest 
stages of follicle development suggests that the fate of these cells is predetem1ined from 
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a very early embryonic age. The lack ofversican expression in the dermal condensation 
also identifies these cells, but whilst lamin A expression is a characteristic offollicular 
dem1al cells at all stages of the follicles life, versican expression is more changeable 
through the developmental process. Osada & Kobayashi (2000) found dermal cells from 
the sites of developing murine vibrissa follicles have the ability to induce ectopic 
follicle formation from El4 (stage 2), confirming that the cells start to possess 
characteristics of the mature follicle dermal cells from very early on. However, this 
inductive capacity is not yet present in these cells at the stage at which the distinctive 
versican/Jol-4 expression pattern is first seen. The distinctive lack ofversican 
expression coupled with Jol-4-immunoreactivity therefore identifies the dermal cells of 
the hair follicle from the surrounding mesenchyme in the earliest stages of follicle 
morphogenesis. 
The presence of Jol-4 immunoreactive cells in the dem1al papilla of the mature 
vibrissa follicle is no great surprise. Perhaps a more interesting observation is the 
number of quiescent cells present in the outer root sheath, particularly in the bulge area. 
Cotsarelis et al. (1990) identified a population of slow-cycling cells in this region, 
leading to proposals that the stem cells of the hair follicle reside in the follicle bulge. 
Oshima et al. (200 1) have recently proposed a model by which the stem cells of the 
vibrissa follicle originate in the bulge of the follicle and migrate through the outer root 
sheath down to the follicle bulb where they differentiate under the influence of the 
dem1al papilla. Prior to this, the bulge hypothesis appeared to be feasible in pelage 
follicles as anagen is initiated in such follicles by regression of the dermal papilla up to 
the level of the bulge bringing the necessary tissues into close proximity for the 
exchange of signals. However, in the vibrissa follicle such an extensive shortening of 
the follicle does not occur (Young & Oliver, 1976) and there appears to be no physical 
interaction between the dermal papilla and the cells of the bulge. My results 
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demonstrate that quiescent cells predominate throughout the length of the outer root 
sheath at all stages of the adult follicle cycle. This supports the proposal put forward by 
Oshima et al. (200 1) that non-dividing stem cells migrate through the outermost 
epide1mallayer to gain the position where division and differentiation can occur under 
the influence of the dem1al component of the follicle. 
2.4.12. Conclusions 
Versican and Jol-4 immunoreactivity distinguish follicular dem1al cells from the 
surrounding mesenchyme in the initial stages of vibrissa follicle development and have 
distinctive patterns of expression throughout follicle morphogenesis. During the adult 
follicle cycle, Jol-4 expression confirms the lack of proliferation in dermal papilla and 
dermal sheath, whilst demonstrating that a non-dividing population of cells is 
consistently present along the length of the outer root sheath. Versican expression in the 
adult follicle is cyclic in the dermal papilla, but consistently strong in the inner conical 
body. I propose a separate role for versican in regulation of vibrissa follicle innervation, 
that is distinct from versican's expression in the dermal papilla and its putative 
involvement in the inductive process of hair growth. 
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CHAPTER 3: The regenerat~ve response of 
epithelial and dermal cells in the amputated 
vnbrissa follicle. 
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3.1. INTRO][)UCTION 
3.1.1. Regeneration of complex structures 
The ability to regenerate complex structures that require orientation of multiple 
tissues is extremely limited in mammals. Deer display a naturally occurring 
regenerative process, the annual growth of antlers. This involves regeneration of 
cm1ilage and skin which develops into antler velvet (Li & Suttie, 2000). In response to 
injury however, there is only one known example of regeneration of a partial limb, that 
occurs in the absence of exogenous factors. Regeneration of the most distal tip of the 
murine limb is successful provided that the amputation is proximal to the nail bed 
(Borgens, 1982; Reginelli et al., 1995). However, the regenerative potential in urodele 
amphibians and teleost fish is more extensive, with the two species displaying 
successful limb regeneration and dermal fin regeneration, respectively (Brockes, 1997; 
Laforest et al., 1998). 
Both limb and fin regeneration are preceded by the development of a blastema 
immediately below the wound healing epidermis at the site of amputation. This 
structure consists of relatively undifferentiated mesenchymal cells that are derived from 
the structures at the site of amputation. The interaction of these multipotent cells with 
the overlying epidermis induces formation of the muscular, neuronal and cartilaginous 
structures required for limb or fin regeneration (Brockes, 1997; Laforest et al., 1998). 
The epidermal-mesenchymal interactions that facilitate regeneration involve some 
of the signalling molecules common to many developmental processes, including both 
limb and hair follicle development. Fibroblast growth factors (FGF) and Sonic 
hedgehog (Shh) are involved in a feedback loop in limb development (Niswander et al., 
1994) as well as being involved in hair follicle development (du Cros, 1993; St-Jacques 
et al., 1998; Chiang et al., 1999). These signalling molecules have been identified as 
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key factors in regenerative processes in fish and amphibians (Laforest et al., 1998; 
Torok et al., 1999; Poss et al., 2000). In addition, the exposure of amputated chick limb 
buds to FGF-2 or FGF-4 induces a regenerative response which includes upregulation 
of Shh expression (Taylor et al., 1994; Kostakopoulou et al., 1996). These models of 
regeneration therefore provide excellent opportunities for further investigations into 
developmental signalling mechanisms. 
3.1.2. Sonic hedgehog in hair follicle development 
Sonic hedgehog (Shh) is expressed in epidermal cells at all stages of follicle 
development, initially in a group of cells in the epidermal placode. Expression 
continues in the epidermal cells at the base of the downgrowth, and subsequently, Shh 
expression is limited to the inner root sheath in the adult follicle (Iseki et al., 1996). 
Although Shh expression is detected in the epithelial placode, prior to formation of a 
dem1al condensation (Iseki et al., 1996; Karlsson et al., 1999), the induction of follicle 
morphogenesis does not require Shh signalling, as demonstrated by the fact that hair 
gem1s form in the skin of Shh -1- mice (St-Jacques et al., 1998; Chiang et al., 1999). 
However, the expression of Shh is evidently important to follicle morphogenesis as a 
number of studies have demonstrated abnormal follicle development as a result of 
altered Shh signalling (St-Jacques et al., 1998; Chiang et al., 1999; Karlsson et al., 
1999; Wang et al., 2000). Expression ofthis gene is therefore functionally important in 
the epidermal-mesenchymal interactions that regulate hair follicle development. 
The regulation of the hair growth cycle in adulthood is also under the influence of 
Shh, as demonstrated by Wang et al. (2000) who effectively inhibited postnatal hair 
growth by blocking Shh signalling with a monoclonal antibody. Transient expression of 
Shh is capable of inducing telogen follicles to enter anagen, providing further evidence 
that this gene regulates follicle cycling as well as morphogenesis (Sato et al., 1999). 
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Whilst expression of Shh is limited to epidermal cells of the hair follicle, the signal is 
thought to act in a paracrine fashion on the mesenchymal cells. This is supported by 
functional studies in which the skin of Shh -1- mice, when grafted onto nude mice, 
failed to develop dem1al papillae. The epithelial cells formed downgrowths but with no 
associated papillae they were simply columns of cells that displayed no signs of hair 
differentiation (Chiang et al., 1999). The expression of Shh is therefore a crucial factor 
in the development of the dermal components of the hair follicle, but is not essential for 
follicle induction. 
3.1.3. Follicle induction 
The induction of follicle development results from signals from the dermis 
conveying information to the epide1mis regarding the size and location of the 
appendage that will fmm. The nature and orientation of the appendage is dependent on 
the epidermis. Each tissue therefore has a distinct role in successful appendage 
development. These properties were identified in the respective tissues by a series of 
elaborate dermis-epidermis recombination experiments (Sengel, 1976b; Dhouailly, 
1977; Sengel et al., 1980). 
Embryonic inductive properties are maintained beyond birth in follicular dermal 
cells. The inductive properties of adult follicular dermal tissue were first demonstrated 
by Oliver (1967b) who implanted vibrissa dermal papillae into the remaining upper 
segment of vibrissa follicles from which the lower half had been amputated. The 
subsequent production of a hair fibre detennined that the dermal papilla of the hair 
follicle was responsible for inducing fibre production in the vibrissa follicle. The 
resilient nature of this inductive capacity was demonstrated by combining organ culture 
techniques with dermal implantation. Fibre growth ceases at I 0-15 days of follicle 
organ culture. Robinson et al. (200 1) cultured follicles for at least 35 days before 
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isolating the dennal tissue from the end bulb and implanting it into the base of an 
amputated follicle. In all cases, fibres were produced indicating that the cessation of 
fibre growth was no reflection on the inductive capacity of the follicular dermal tissue. 
The inductive properties described demonstrate that, in association with follicular 
epithelial tissue, the dermal papilla induces hair fibre production (Oliver, 1967b; 
Kobayashi & Nishimura, 1989). It could be argued that this is an innate property of the 
epithelial tissue as well as the dermal tissue. However, Oliver (1970) implanted dem1al 
papillae in association with ear, scrotal sac and keratinizing oral epithelium and 
demonstrated that afollicular epithelia could be induced by association with detmal 
papilla to produce cells of a follicular nature. This work was one of the first indications 
of the pluripotent nature of epithelial cells. 
The capacity of the intact dermal papilla to induce follicle bulb formation and 
fibre growth was also found to be true of cultured dermal papilla cells of low passage 
number (Jahoda et al., 1984; Home et al., 1986; Lichti et al., 1995). The cells were 
implanted as a pellet in amputated follicles in the same manner that intact dermal 
papilla had been implanted, and subsequently fibres were produced. Similarly, detmal 
papilla cells were capable of inducing follicle formation in non-follicular epidermis 
(Reynolds & Jahoda, 1992) as had been seen with intact dermal papilla (Oliver, 1970). 
In another model of follicle induction, low passage cultured dermal papilla cells 
combined with epithelial cells from neonates induced follicle formation and hair growth 
on the back of a nude mouse (Lichti et al., 1995). These experiments demonstrate that 
the embryonic inductive propet1ies retained in the adult dermal papilla, are not lost in 
cultured dermal papilla cells of low passage number. 
Later studies, in which dermal papilla cells were implanted in ear wounds, 
indicated that the dermal papilla was responsible for determining the type of fibre 
produced as large vibrissa-type fibres were evident amongst the fine hairs of the ear 
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(J ahoda et al., 1993). Pelage de1mal papilla cells and human dermal papillae also 
induced follicle fmmation, suppmting the theory that inductive properties of the dem1al 
papilla are universal and are not limited to the vibrissa follicle dermal papilla (Reynolds 
& Jahoda, 1992; Reynolds et al., 1995). 
The inductive properties of dermal sheath tissue, when implanted in the upper half 
of amputated vibrissa follicles, were initally demonstrated by Home & Jahoda (1992). 
This tissue successfully formed fully functional dem1al papillae in over 60% of 
recipient follicles. The fom1ation of multiple papillae in some follicles resulting in 
multiple fibres, and a lack of distinct papillae corresponding to no fibre production, 
emphasised the crucial role of the dermal papilla in hair growth. More recently, dermal 
sheath dissected from the scalp of a male, was shown to induce follicle formation in the 
foream1 of a female recipient (Reynolds et al., 1999). The nature of the fibre produced 
was markedly different from the native hairs, providing evidence that the dermal 
component of the follicle determines the size and type of the hair follicle. 
Experiments with cultured dermal sheath cells have been less successful in 
inducing follicle formation. However, combining dermal sheath cells with germinative 
epithelial (GE) cells prior to implantation resulted in follicle formation (Reynolds & 
Jahoda, 1996). The effect was the same on high passage dermal papilla cells that had 
lost their inductive capacity. The fact that skin fibroblasts were incapable of follicle 
induction with or without the presence of GE cells demonstrated that follicular dermal 
cells were receptive to the influence of the GE cells, and it was not a universal influence 
on dem1al cells. The maintenance of the inductive capacity, and the acceptance of 
epithelial instruction to induce follicle formation supports the idea that follicular dermal 
cells retain embryonic properties in adulthood. 
When follicle formation is induced in adult epithelial tissue, the implanted dermal 
papilla is believed to give rise to the entire dermal component of the follicle, including 
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the dermal sheath (Reynolds & Jahoda, 1992). This implies a degree of multi potency in 
cells of the dermal papilla or at least a capacity to switch phenotype. Similarly, non-
follicular epithelial cells demonstrate the ability to produce cells of a follicular lineage 
as a result of induction by dermal papillae (Oliver, 1970). The transition from one cell 
type to another is a process that requires investigation as the steps involved may provide 
important infom1ation regarding the lineage of cells and their developmental 
background. The transition between dermal papilla and dermal sheath cells, which 
appears to proceed in either direction according to which tissue is inducing follicle 
fom1ation, provides an opportunity to investigate the relationship between these cell 
types which both appear to retain embryonic properties. 
3.1.4. Follicle regeneration 
Pioneering studies by Oliver in the 1960s demonstrated not only the inductive 
properties of the dermal papilla, but also the regenerative capacity of vibrissa follicles 
after a major insult. Removal of the dermal papilla or the lower third of the follicle 
resulted in the regeneration of these structures from the remaining follicular 
components, dem1al sheath being the proposed source of the regenerated dermal papilla 
(Oliver, 1966a, 1966b ). The idea that such regenerative properties were common to all 
hair follicles was supported by studies on terminal human hair follicles (Jahoda et al., 
1996). 
Amputation is an extreme insult to the hair follicle. Regeneration after less severe 
injury has also been investigated and revealed that loss of dermal papilla cells was 
rectified by recruitment of cells from the "local lower mesenchyme" (Jahoda & Oliver, 
1984c ). This again reflects the events seen in amputated follicles where the dermal 
papilla is believed to be reformed from lower dermal sheath cells (Oiiver, 1966b; 
Jahoda et al., 1992a). The fact that dermal sheath is capable of producing dermal papilla 
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tissue is evident from the inductive studies described previously (Home et al., 1986; 
Reynolds et al., 1999). 
The vibrissa follicle will only regenerate if amputation is restricted to the lower 
third of the follicle. This has been attributed to properties of the lower dermal sheath 
that may be lacking in the upper two thirds. One known difference is the expression of 
a-smooth muscle actin which is evident in the lower third of the dermal sheath but 
absent from the upper pmt of the follicle. Investigators have used this lower portion of 
the tissue for follicle induction and this is also the portion generally used for cell culture 
expetiments. Home observed a behavioural difference in vitro between the cells of the 
lower third, which displayed a degree of aggregation, and those of the upper two thirds, 
which gave no indication of aggregative behaviour. TI1is aggregative property is 
believed to be crucial in the induction and regeneration ofhair follicles (Jahoda & 
Oliver, 1984a; Jahoda & Oliver, 1984c; Home et al., 1986). 
Unlike limb or fin regeneration in amphibians and fish, there is no distinct 
blastema in the regenerating vibrissa follicle. However, the ptinciple of an 
undifferentiated mass of cells at the site of amputation that interact with epithelial cells 
to result in successful regeneration, is much the same. The source ofthe 
undifferentiated cells in the vibtissa follicle is open to question, the dermal sheath 
having been thought of as the otigin of the new dermal papilla cells (Oliver, 1966b; 
Jahoda et al., 1992a), but there is also the possibility that the mesenchymal tissue 
around the follicle conttibutes to the regenerative process as well. Detennining the 
exact origin of the newly fom1ed tissues in the regenerated end bulb is fundamental to 
understanding the mechanisms involved in follicle regeneration. 
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3.1.5. Follicular epithelial cell regeneration 
During follicle regeneration, the remodelling of the dem1al components is 
accompanied by significant changes in the remaining epithelial component, the outer 
root sheath. The epithelial cells of the hair follicle have significant regenerative 
capabilities. These are evident both in the normal growth cycle, where proliferation and 
differentiation are continually occuring to generate a new hair fibre, and in a wound 
healing situation, whether this be end bulb amputation or an insult to the interfollicular 
skin. After experimental removal of the end bulb and the hair fibre, layers of outer root 
sheath cells are left in situ. These are thought to proliferate, to produce the epithelial 
cell population which will initially plug the hole created by removal of the fibre, and 
subsequently interact with dermal components to generate a new matrix and hair fibre 
(Oliver, 1966b; Jahoda et al., 1992a). If the interfollicular epidermis is mechanically 
separated from the dermis, hair follicle epithelial cells migrate from the upper region of 
the follicle out onto the dermis and regenerate an epidermis (Krawczyk, 1971; Pang et 
al., 1978). Outer root sheath cells therefore exhibit a degree of multipotency that is 
exploited in response to injury. 
Lenoir et al. (1988) developed a method in which hair follicles were implanted 
vertically in a dermal substrate thus mimicking the in vivo conditions produced at the 
donor site of split-skin surgical grafts. From the outer root sheath cells of these follicles, 
a stratified epidetmis was successfully generated in vitro. ORS cells have also 
generated a stratified epithelium when cocultured with dermal fibroblasts, which was 
comparable to that generated by normal epidetmal keratinocytes in the same 
experimental conditions (Limat et al., 1991 ). The regenerative qualities of epithelial 
cells therefore, include considerable proliferative potential as well as multipotency that 
results in contributions to the epidermis as well as differentiated hair fibre. 
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3.1.6. Epithelial stem cells of the hair follicle 
The proliferative capacity and multipotency displayed by follicular epithelial cells 
indicates the presence of a stem cell population within this tissue. The isolation of these 
stem cells could prove extremely useful as the hair follicle is a repository for stem cells 
that can contribute to the interfollicular epidermis as well as the epithelial components 
of the pilosebaceous unit (Taylor et al., 2000). Rochat et al (1994) determined that a 
single follicular keratinocyte colony-forming (stem) cell had the proliferative capacity 
to renew the epidermis of the whole human body. Such properties mean research into 
these cells is potentially relevant to clinical applications, ranging from tumour biology 
and gene therapy to skin replacement treatments (Lenoir et al., 1988; Cotsarelis et al., 
1990; Lavker et al., 1993; Miller et al., 1993; Li & Hoffman, 1995; Jahoda & Reynolds, 
2000). In the search for follicular stem cells two potential sources have been identified: 
a subpopulation of outer root sheath cells in the bulge, (an anatomically distinct area in 
rodent pelage follicles) situated at the arrector pili muscle attachment site; and the 
ge1minative epithelial cells, a population of cells at the base of the follicle bulb. The 
research into these two putative stem cell populations is outlined below. 
3.1.6.1. Stem cells in the follicle bulge 
Cotsarelis et al. ( 1990) identified a slow-cycling population of outer root sheath 
cells in the bulge, by their capacity to retain a radio-isotopic label, and proposed that 
these cells constituted the stem cell population of the hair follicle. The bulge is at the 
level of the most proximal pm1 of the permanent upper follicle during the growth cycle, 
and the fact that it remains in situ after plucking of the hair fibre, supports the proposal 
that epithelial stem cells of the follicle reside in this section of the ORS rather than the 
temporary portion of the follicle. Having identified the location of the putative stem 
cells, Cotsarelis et al. (1990) then went on to propose a model, described as the bulge-
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activation hypothesis, whereby the stem cells in the bulge are activated to proliferate, so 
initiate anagen, when in close contact with the dermal papilla of the shortened, telogen 
follicle (Figure 3.1 ). 
Further evidence that stem cells reside in the bulge was gained from studies of 
neonatal follicles and interfollicular epidem1is. Label-retaining cells which originated in 
the follicle bulge, contributed to the neonatal interfollicular epidermis as well as to the 
components of the temporary pm1ion of the pelage follicle. The same cells were also 
observed to migrate into the adult interfollicular epidermis as part of the wound healing 
process (Taylor et al., 2000). Whilst it has long been known that outer root sheath cells 
contribute to reepithelialisation in wounded skin, this was the first demonstration that 
such cells originate from the bulge of the follicle. 
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Figure 3.1. The bulge activation hypothesis. 
The bulge (B) and structures distal to it comprise the permanent portion of the 
follicle during the pelage follicle cycle. During catagen the lower portion of the 
follicle degenerates and the dermal papilla (DP) regresses to rest below the follicle 
bulge during telogen. This close association acitvates the epithelial cells of the 
bulge resulting in the initiation of anagen. This hypothesis also proposes that 
the growing epidermal matrix activates the dermal papilla in early anagen: 
ORS - outer root sheath, IRS - inner root sheath, C - cortex, Md - medulla, 
M - matrix, S - sebaceous gland, E - epidermis, APM - arrector pili muscle. 
Cotsarelis et al., 1990. 
ANAGEN :m: CATAGEN TELOGEN 
ANAGEN nz: ANAGEN li 
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3.1.6.2. Stem cells in the follicle end bulb 
The germinative epithelial (GE) cells are those at the very base of the epithelial 
matrix, sandwiched between the dermal sheath and the dermal papilla. They 
differentiate to produce the epithelial cell layers of the hair follicle comprising the root 
sheaths and the fibre. Their ultrastructural profile is decidedly stem cell-like with a 
large nuclear-cytoplasmic ratio and with minimum organelles visible in the cytoplasm, 
reflecting a slow metabolic rate (Reynolds & Jahoda, 1991). As well as being 
multipotent, the GE cells have the capacity to confer follicle inducing properties onto 
other cell types (Reynolds & Jahoda, 1996). Evidence of the high proliferative potential 
in the GE cell population is the observation that repeated plucking of a follicle results in 
repeated re growth of a fibre. Gharzi et al. (1999) demonstrated that up to three times the 
nmmal length of fibre can be generated by such means, indicating GE cells are capable 
of proliferating indefinitely and the length of anagen is not regulated by a limited 
proliferative capacity of GE cells. These cells are protected when a fibre is removed 
prematurely (plucking) (Gharzi et al., 1999), as are the outer root sheath cells of the 
bulge. During catagen, the epithelial matrix visibly separates from the GE cells 
(personal observation, Fig. 2.11 G) indicating that GE cells remain in the epithelial 
follicular tissue during the catagen and telogen phases of the cycle. These cells 
therefore display a range of qualities that are common to stem cells: multipotency; high 
proliferative capacity; protected location; simple cytoplasm; and a high 
nuclear:cytoplasmic volume ratio. 
3.1.6.3. Are stem cells restricted to one location within hair follicles? 
There is evidence to support both locations as sites in which follicular epithelial 
stem cells reside, but there is also evidence to suggest that cells are not restricted to 
either one or the other. A distinguishing characteristic of stem cells is their colony-
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forming ability in vitro, demonstrating their high rate of proliferation and capacity for 
self-renewal. 85% of the cells with clonogenic potential in human hair follicles, which 
lack an anatomically distinct bulge, were found to be in the lower outer root sheath 
(Rochat et al., 1994). In contrast, Kobayashi et al. (1993) found 95% of the colony-
forming cells in the mid-anagen rodent vibrissa follicle were located in the section that 
contained the bulge. However, in late catagen vibrissa follicles, colony-forming cells 
were present in the intermediate section, between the bulge and the end bulb, where 
none had been observed in the mid-anagen follicle (Kobayashi et al., 1993). This was 
the first indication that cells migrate from the bulge to the end bulb as stem cells. 
Oshima et al. (2001) used the constitutive expression of the lacZ reporter gene in 
Rosa 26 mice, to investigate the migration of cells from the vibrissa follicle bulge. 
Migration of the cells through the outer root sheath into the end bulb, combined with 
the changing distribution of clonogenic cells during the growth cycle provided strong 
evidence that stem cells migrate from the follicle bulge before dividing in the end bulb 
(Oshima et al., 2001 ). Other studies have proposed epithelial stem cells exist in multiple 
compartments in the pilosebaceous unit (Comma et al., 2000; Ghazizadeh & Taichman, 
2001 ). Taking into account all the studies discussed it appears that follicular epithelial 
stem cells can be found at multiple sites in the hair follicle at any stage in the follicle 
cycle. 
End bulb amputation deprives the regenerating follicle of the germinative 
epithelial cells as a potential source of epithelial cells. Regeneration of a functional end 
bulb can be induced by implanting dem1al tissue at the base of the follicle in contact 
with the cut edge of the outer root sheath (Oliver, 1967; Home & Jahoda, 1992), or the 
upper two thirds will spontaneously regenerate an end bulb by interactions between the 
remaining tissues at the site of amputation (Oliver, 1966b; Jahoda et al., 1992a). There 
have been no indications from previous studies on follicle regeneration, that the cells of 
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the bulge are specifically activated in the regenerative process. In the early stages of 
regeneration, cell numbers increase considerably to fill the central cavity. Such a rapid 
increase in cell numbers is likely to result from stem cell proliferation, thus providing 
an opportunity for analysing the distribution of epithelial stem cells in the regenerating 
vibrisaa follicle. 
3.1.7. The role of the extracellular matrix in follicle regeneration 
Extracellular matrix is known to play an important role in the morphogenesis of 
many structures that develop as a result of epithelial-mesenchymal interactions, 
including the hair follicle. The process of follicle regeneration has also been shown to 
involve considerable changes in the extracellular matrix. Jahoda et al. (1992a) studied 
the distribution of laminin, fibronectin and collagen type IV dming follicle regeneration 
and, from morphological and biochemical changes, the initial events were described as 
a wound response. The significant difference to normal healing however, was the lack 
of scar tissue in the regenerated follicle. This was also true of follicles which had been 
wounded in the end bulb (Jahoda & Oliver, 1984c ), and amputated follicles in which 
hair fibre growth was induced by implantation of dermal papilla cells (Home et al., 
1986). Significantly the implantation of skin fibroblasts in the same experimental model 
resulted in the deposition of scar tissue at the level of amputation (Home et al., 1986). 
The specialised nature of the ECM produced by follicular dermal cells has been 
investigated in vivo and in vitro but the functional significance has only been described 
in te1ms of hair growth. Given the extensive role the ECM plays in wound healing 
(Martin, 1997), a specialised ECM could hold great potential for scar-free wound 
healing. The regenerating vib1issa follicle provides an excellent model for studying 
scar-free healing, as well as extracellular matrix remodelling in a morphogenetic 
process. 
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3.1.8. Aims 
The regenerative properties of vibrissa follicles are well established but many 
questions remain unanswered (Oliver, 1966a, 1966b; Kobayashi & Nishimura, 1989; 
Jahoda et al., 1992a). A number of methods were employed in this study to investigate 
various aspects of the regenerative process. The degree of cell proliferation was 
investigated by BrdU incorporation, and a-smooth muscle actin, a marker for follicular 
dermal sheath in vivo, was detected by immunostaining. Both these approaches were 
intended as means to identify the origin of the dermal papilla. Epithelial regeneration 
was observed and the location of putative stem cells investigated by BrdU incorporation 
and Jol-4 immunostaining. The expression of a key signalling molecule in epidermal-
mesenchymal interactions, Sonic hedgehog, was studied by in situ hybridisation to 
establish whether signalling in follicle regeneration reflected that seen in follicle 
development. Finally, versican and laminin, were immunolabelled to extend the studies 
of Jahoda et al. (1992a) on ECM remodelling during regeneration. 
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3.2. MATERIALS AND METHODS 
3.2.1. Surgical procedure for end-bulb amputation 
End bulb amputation was performed on up to 10 vibrissa follicles in one 
mystacial pad of 13 PVG rats of either sex, aged between 3 and 5 months, with the 
exception of two rats aged 12 months (used for 6d and 8d BrdU treated regenerating 
follicles). The method was essentially that ofOliver (1966a). Animals were initially 
sedated with Halothane and then anaesthetized by an intramuscular injection of 
Hypnorm (80~tl) (Janssen Animal Health), immediately followed by an intraperitoneal 
injection of75~-tl Valium (5mg/ml) (Phoenix Pharmaceuticals). The vibrissa follicles 
were then exposed by cutting an L-shaped incision around the anterior and ventral 
edges of the mystacial pad and, using fine forceps and spring scissors, cutting away the 
connective tissue to expose the end bulbs. Individual vibrissa follicles had the end bulb 
amputated and discarded before the vibrissae (club and growing fibres) were plucked 
from the follicle. The mystacial pad was then sutured back in place and the rat left to 
recover for a specific length of time before the regenerating follicles were biopsied. 
The majority of follicles were in mid-late anagen at the time of amputation. 
However, in two rats the amputated follicles were in the very early stages of anagen and 
consequently the fine growing fibres were not always successfully removed. This was 
evident when the follicles were sectioned and these follicles were excluded from the 
results data. 
3.2.2. Freezing down regenerating follicles 
Follicles were dissected out of the mystacial pad of the rat 1, 2, 4, 6, 8, 10 or 12 
days after the amputation surgery. They were either BrdU treated (see 3.2.3.1) prior to 
embedding or immediately embedded individually in TissueTek O.C.T. compound 
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(Agar Aids), snap frozen in liquid nitrogen and stored at -80°C prior to being sectioned 
for immunohistochemistry or in situ hybridisation. 
3.2.3. Assessing cell proliferation 
3.2.3.1. BrdU treating regenerating follicles 
Follicles were dissected out of the mystacial pad of the rat 1, 2, 4, 6 or 8 days 
after the amputation surgery. They were immediately placed in 1 0~-tM BrdU in pre-
warmed MEM and incubated at 37°C for 2 hours. This was followed by a 20min PBS 
wash at 37°C and the follicles were then individually embedded as described above. 
3.2.3.2. Immunological detection of BrdU incorporation 
6~-tm frozen sections were cut on a Leica CM3050 cryostat, and thaw-mounted on 
to poly-lysine coated slides. They were fixed in ethanol fixative (70ml absolute ethanol 
made up to 1 OOml with 50mM glycine, pH2) at -20°C for 20min followed by three 
washes in PBS. The sections were incubated in 10% lamb serum in PBS for 30min to 
block non-specific binding. A monoclonal antibody against BrdU was diluted ( 1: 1 0), 
and a polyclonal antibody to laminin was diluted (1 :40) in PBS for double-labelling of 
sections. The diluted primary antibody mix was applied to the sections and incubated at 
37°C for 1hr. Unbound antibody was removed with four PBS washes before application 
of the secondary antibody mix (AlexaFluor 488 anti-mouse and AlexaFluor 546 anti-
rabbit (Molecular Probes), both diluted 1:100 in PBS) in which the sections were 
incubated for 45min. Unbound antibody was removed as before and the sections were 
mounted in mowiol 4-88 (Calbiochem), containing an anti-fade agent, under glass 
covers lips. 
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Negative controls were perf01med by omitting the primary antibody and/or 
secondary antibody and incubating the sections in PBS instead. All controls gave 
negative results. 
3.2.4. Immunostaining 
6~m frozen sections were cut, as described above. Sections were washed three 
times in PBS before application of the primary antibodies diluted in filter-sterilised PBS 
(see Table 3.1 for antibodies and dilution factors). The slides were then incubated for 1 
hour at room temperature, or overnight at 4 oc and the unbound primary antibody 
removed with four washes in PBS. Secondary antibodies (AlexaFluor 488 anti-mouse 
and AlexaFluor 546 anti-rabbit (Molecular Probes), both diluted 1: 100 in PBS), were 
then applied and incubated for 30min at room temperature in the dark. Unbound 
antibody was removed with four PBS washes and sections were mounted in mowiol 
under glass coverslips. 
Negative controls were performed by omitting the primary antibody and/or 
secondary antibody and incubating the sections in PBS instead. All controls gave 
negative results. 
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Table 3.1. Details of primary antibodies, the source from which they were 
obtained, and dilution factor for immunostaining. All antibodies were monoclonal 
except NF200 & L9393. 
Antigen Host Antibody Dilution Source Reference 
Factor 
LaminA mouse Jol4 1:10 Serotec Dyer et al., 1997 
BrdU mouse anti-BrdU 1:10 Boehringer 
a-sma mouse anti- asma 1:10 Prof. Gabbiani, Skalli et al., 1986 
Geneva University 
Versican mouse 12C5 1:5 DSHB Asheretal., 1991 
neurofilament rabbit NF200 1:100 Sigma 
laminin rabbit L9393 1:40 Sigma 
Table 3.2. Numbers of regenerating follicles biopsied, at a range of time points 
after surgery, and immunostained with a panel of antibodies or hybridised with a 
Shh riboprobe. 
Marker 1d 2d 4d 6d 8d 10d 12d 
Jol4 5 2 1 2 2 5 
BrdU 4 1 2 2 1 
Versican 2 1 2 1 1 1 
a-sma 1 1 
NF200 1 
Laminin 5 1 2 2 2 5 
Shh 1 2*1 1* 2 3 
.. 
* no anagen pos1ttve control 
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3.2.5. Detection of Shh transcripts 
3.2.5.1. Sonic hedgehog construct for riboprobe synthesis 
1.6kb of human sonic hedgehog (Shh) cDNA inserted into the multi-cloning site 
(EcoRI) of pBluescript SK( +) was used as the template for synthesis of sense and 
antisense Shh riboprobes. This construct was a generous gift from Paul Hunt, Durham 
University, who received the construct from Colin Tabin, Harvard Medical School, 
Boston, U. S. A .. 
3.2.5.2. Synthesis of DIG-labelled riboprobes 
Shh plasmid DNA was isolated from 1.5mlliquid culture ofbacteria using a 
Qiagen miniprep kit according to the manufacturer's instructions. 
Plasmid DNA was linearised with BamHI for the sense probe, or with Xhol for 
the antisense probe, and an aliquot electrophoresed on a 1.2% agarose gel to confirm 
that the digestion was complete. 
Riboprobes were prepared by transcription of 0.5-1.01-lg linearised plasmid (see 
above) in a 201-ll reaction containing transcription buffer (Promega), 10mM DTT 
(Promega), 2!!1 nucleotide mix containing Digoxygenin (DIG)-labelled UTP 
(Boehringer), 0.5~tl (20U) placental Rnase inhibitor (RNaseOUT, Gibco) and 1!!1 (10-
20U) RNA polymerase (T7 for sense or T3 for antisense) (Promega). The reaction was 
incubated at 3?DC for 2 hours. 
A 1!!1 aliquot was run on a 1% agarose gel to determine the efficiency of the 
transcription. The remaining probe was treated with 2!!1 Dnase I (Rnase free) (Promega) 
and incubated at 37°C for a further 15min. 100!!1 DEPC-treated H20, l0!!14M LiCl and 
3001-ll 100% ethanol were then added and the reaction incubated at -20°C for 30min. 
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The precipitated RNA was then spun down for 10min at 14,000rpm, the supematant 
removed and the pellet washed in 75% ethanol/25% DEPC-treated H20. The pellet was 
then air-dried before being resuspended in 30f.tl DEPC-treated H20. The optical density 
at 260nm was then read on a spectrophotometer and the RNA diluted to a final 
concentration of 0.1 flg/fll before storing at -20°C. 
3.2.5.3. In situ hybridisation and washing 
Method based on that ofWilkinson (1992). 
All incubations were done at room temperature unless otherwise stated and all 
solutions were DEPC-treated (or made up with DEPC-treated dH20 in the case ofTris 
buffers). 
6f.tm cryostat sections were cut and thaw-mounted onto RNase-free Polysine 
slides (BDH). The sections were immediately fixed in 4% paraformaldehyde in PBS for 
20min. They were washed (3 x 5min) in PBT (DEPC-treated PBS with 0.1% Tween-
20) before bleaching with 6% hydrogen peroxide in PBT for 1 hour. Three x 5min PBT 
washes were followed by treatment with Proteinase K (lOf.tg/ml for 15min) then 
another 5min PBT wash before post-fixing the sections in 0.2% glutaraldehyde I 4% 
paraformaldehyde in PBS for 20min. The sections were then washed twice (5min each) 
in PBS before dehydrating them with 5min incubations in the following series of 
solutions (all made up with DEPC-treated H20): 0.83% NaCl; 25% methanol; 50% 
methanol; 75% methanol; 100% methanol. After a final 5min incubation in 100% 
methanol the slides were allowed to air-dry. 
Hybridisation buffer was made up and the riboprobes diluted to 3ng/f.tl in 
hybridisation buffer (50% formamide, 1% SDS, 5x SSC (pH 5.0), 50f.tg/ml heparin, 
50f.tg/ml yeast RNA) before applying 100f.tl of the relevant probe to each slide. 
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SuresealTM frames (Hybaid) were used to prevent subsequent evaporation of the probe. 
Slides were placed on a flat rack within a humidity chamber and incubated overnight at 
65°C. 
The SuresealTM frames were removed with a razor blade and the slides 
immediately placed in solution 1 (50% formamide, 5x SSC, 1% SDS warmed to 60°C) 
for 2 x 30min washes at 60°C. This was followed by 3 x 30min washes in solution 2 
(50% formamide, 2x SSC warmed to 60°C) at 60°C. The slides were washed twice 
(lOmin each) in TBST followed by a 30min wash in TBST with 30mM levamisole 
(Sigma). Slides were now ready for detection of the DIG-labeled probe. 
3.2.5.4. Preparation of Anti-DIG antibody 
A small amount of follicle powder (prepared as described in Appendix I) was 
added to 1ml TBST (0.29M NaCl, 5.6mM KCl, 25mM Tris Hcl (pH 7.5), 0.1% Tween-
20 in DEPC-treated H20) and incubated at 65°C for 1 hour. 50~-tllamb serum (Gibco) 
plus 20~-tl anti-DIG-alkaline phosphatase antibody (Boehringer Mannheim) were added 
to the follicle powder mix which was then agitated at 4°C for 1 hour. The follicle 
powder was then pelleted by centrifugation at 14,000rpm for 2min and the supernatant 
containing the pre-adsorbed antibody (approximately 1ml) was decanted off. 
3.2.5.5. Immunological detection of DIG-labelled probe 
1ml pre-adsorbed antibody was diluted in 99ml TBST plus lmllamb serum. The 
slides were immersed in this solution and incubated at 4°C overnight. Unbound 
antibody was removed with 3 x 20min PBT washes followed by 2 x 30min NTMT 
(lOOmM Tris Hcl (pH 9.5), 50mM MgCh, 100mM NaCl, 0.1% Tween-20) washes. A 
subsequent 30min NTMT wash included 2mM levamisole. Finally the colour substrate 
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was prepared by adding 11.25J .. d 30mg/ml nitro blue tetrazolium (NBT) plus 8.75J1l 
20mg/ml 5-bromo-4-chloro-3-indolyl phosphate (BCIP) (Sigma) to 1 ml NTMT. The 
slides were placed on a flat rack and 500J1l colour substrate added per slide. They were 
then placed in the dark, in a humidity chamber, and incubated at room temperature for 
lhr to 3 days with regular checks for colour change. The slides were sometimes 
incubated in NTMT overnight and fresh colour substrate added in the morning to enable 
better control of the development of background colour. When colour had developed to 
a sufficient level slides were washed twice in NTMT before being mounted under glass 
coverslips in gelatin glycerol (Sigma). 
A sense probe synthesised from the same plasmid was used as a negative control, 
whilst mid-anagen vibrissa follicles from rats which had not been subjected to surgery 
were used as positive controls in the majority of expe1iments .. 
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3.3. RESULTS 
3.3.1. General observations 
Follicle regeneration proceeded as described by Oliver (1966b) and Jahoda et al. 
(1992a), with no significant differences observed in the majority of samples. Variation 
in the rate of regeneration was previously noted by Jahoda et al. (1992a) who described 
the regeneration process in stages, identified by morphology, to clarify the description 
of results (Figure 3 .2). These stages will be used to categorize the results presented here 
with one additional substage. The first stage in follicle regeneration results in epithelial 
cells filling the hollow tube created by removal of the fibre at the time of amputation. In 
some follicles biopsied after 24 hours, this space had not yet been occupied and such 
follicles will therefore be referred to as being pre-stage 1 (Figure 3.2). 
Table 3.3. Numbers of follicles, at different stages of regeneration, immunolabelled 
with a panel of antibodies. 
Laminin was also labelled in follicles of all stages included in this data set. 
Jol-4 BrdU Versican a-sma 
Pre-stage 1 4 4 2 
Stage 1 4 2 2 
Stage 2 3 2 1 1 
Stage 3 4 2 2 
Stage 4 2 1 1 
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Figure 3.2. Key stages in lower follicle regeneration. 
Stage 0: immediately after end bulb amputation the fibre is removed resulting in a 
hollow cylinder of epithelial tissue within the glassy membrane. 
Pre-stage I: the cavity caused by removal of the hair fibre is still considerable and the 
glassy membrane is distorted/irregular in shape at the site of amputation. 
Stage I: the epithelial cells fill the cavity and extend beyond the glassy membrane and 
the level of the original amputation in an irregular fashion. Dermal sheath cells 
accumulate around the base of the follicle. 
Stage 2: the epithelial column evens out at its base and is enclosed within the extended 
glassy membrane along with dermal sheath cells that are accumulating below the 
epithelium. 
Stage 3: the demml cells enclosed by the extended glassy membrane indent the base of 
the epidermal column, this extends with time resulting in papilla formation. 
Stage 4: the new end bulb develops further as the dermal papilla increases in size, hair 
differentiation occurs and the glassy membrane disappears from beneath the end bulb. 
Adapted from Jahoda et al., 1992a. 
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3.3.2. Determining areas of cell proliferation 
PRE-STAGE I 
All follicles at pre-stage I had been biopsied 24 hours after the amputation of the 
end bulbs. The epithelial cells had not yet filled the space created by removal of the hair 
fibre and there was a significant quantity of disrupted tissue remnants, particularly 
within the proximal end of the follicle (Fig. 3.3 A,B,D). Cells were occasionally present 
within the most proximal area of the cavity and these included a minority of cells that 
had incorporated BrdU (Fig. 3.3 D) whilst the majority were labelled with Jol-4 
antibody (Fig. 3.3 B). Distal to this, the basal layer of the outer root sheath was 
adherent to the glassy membrane and this single cell layer was labelled with Jol-4 
antibody (Fig. 3.3 A), whilst a minority of cells had incorporated BrdU (Fig. 3.3 D). 
These proliferating cells were spaced along the basal layer at fairly regular intervals. 
The tissue became less disrupted towards the distal end of the follicle and the layers of 
ORS cells increased in number. As they did so it was evident that BrdU incorporation 
had occurred within the supra basal layers of this tissue as well as the basal layer (Fig. 
3.3 D). The vast majority of cells however were determined to be non-dividing by their 
immunoreactivity to the Jol-4 antibody (Fig, 3.3 A). 
BrdU had also been incorporated into the nucleus of epithelial cells at the neck of 
the follicle. In one follicle in particular there was a distinct line of labelled cells running 
from the skin epidermis into the follicle infundibulum and down to the level of the 
bulge (Fig. 3.3 C). Cells of the sebaceous gland had also incorporated BrdU. In other 
follicles there was not such a distinctive line, but individual cells within the basal 
epithelial layers at the neck of the follicle were positively marked. The nuclear staining 
here was distinctly different in appearance to that seen in the lower, regenerating part of 
the follicle. Staining in the cells at the neck revealed considerably larger nuclei than 
were seen in the BrdU labelled cells in the proximal portion of the follicle. 
I26 
Fngure 3.3. Cell proliferation and cycle activity in pre-stage 1 regenerating vibrissa 
follicles. 
Pre-stage 1 follicles immunostained with monoclonal Jol-4 antibody (A, B) or a 
monoclonal antibody against BrdU (C,D) (green fluorescence) and, with the exception 
of C, a polyclonal antibody against laminin (red fluorescence). 
(A) Jol-4 staining highlights the nuclear envelope of cells in the dermal sheath (small 
arrow) and basal and supra basal epithelial ( ep) cells in the distal half of the follicle. The 
dermal and epithelial compartments are separated by the glassy membrane (large arrow). 
The proximal part of the follicle still contains tissue remnants (tr) from the removal of 
the hair fibre. (B) Close to the site of amputation a small number of epithelial cells are 
stained with the Jol-4 antibody but Jol-4 staining in the dermal sheath is minimal. The 
glassy membrane is indicated by arrows. (C) BrdU is incorporated by epithelial cells in 
the upper follicle in the infundibulum, the sebaceous gland (sg) and in the cells at the 
point where folicular outer root sheath is continuous with epidennis (arrows). (D) In the 
proximal follicle proliferation is occurring in a sub-population ofbasal (thin anows) and 
suprabasal (wide arrows) epithelial cells. In the small cluster of epithelial cells at the site 
of amputation there are cells that have incorporated BrdU (arrowheads). 
Scale bar= A, B, D = 50J..un, C = lOOJ..tm. 
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Dermal sheath cells were stained with Jol-4 antibody, although the most proximal 
section of the follicle had noticably fewer labelled cells than the rest of the dermal 
sheath, indicating a subpopulation of cells from this tissue had entered the cell cycle 
(Fig. 3.3 A, B). Jol-4 staining was evident in cells within the collagen capsule and in the 
loose mesenchymal tissue of the follicle sinus complex. There was little or no evidence 
ofBrdU incorporation in the dermal tissue (Fig. 3.3 D). 
STAGE 1 
The epithelial cells formed a solid column filling the cavity that had been evident 
in pre-stage 1 follicles (Figure 3.4). At the base of the follicle, a deposition oflaminin 
delineated the border between the epithelial compartment and the surrounding dermal 
tissue. Within the basal layer of epithelial cells BrdU incoporation was evident at fairly 
regular intervals throughout the lower follicle. The column of epithelial cells displayed 
a high level of Jol-4 staining in all areas except the proximal part of the early stage 1 
follicle (Fig. 3.4 A). Dermal cells in close proximity to the laminin deposition were Jol-
4 immunoreactive (arrows, Fig. 3.4 B). The nuclei indicated these cells displayed 
polarity, orientated perpendicular to the long axis of the follicle. At the neck of the 
follicle Jol-4 staining highlighted cells in the suprabasallayers only (Fig. 3.4 C). 
The epithelial column extended beyond the level of the glassy membrane 
during stage 1 of regeneration and as it did so Jol-4 staining became evident in 
cells throughout this compartment (Fig. 3.4 D). During this stage a few cells were 
weakly labelled with BrdU in the proximal region of the epithelial compartment, 
and in the loose dem1al tissue at the base of the follicle (Fig. 3.4 E). Very 
occasionally a dermal sheath cell was labelled but overall the level of proliferation 
was very low. This was emphasised by the high level of Jol-4 staining in the 
dermal tissue, including the dermal sheath, as well as in the epithelial column. 
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Ffigmre 3A. Cell cycle activity and proliferation in stage 1 regenerating vibrissa 
follicles. 
Stage 1 follicles immunostained with Jol-4 (A- D) or a monoclonal antibody 
against BrdU (E) (green fluorescence), and a polyclonal anti-laminin antibody (red 
fluorescence). 
(A) Jol-4 staining highlights cell nuclei in the distal epithelial column ( ec) of early 
stage I follicles. Arrowheads mark the glassy membrane. (B) Dermal cells 
(arrows) in close proximity to the laminin deposit at the base of the epithelial 
column are labelled with Jol-4. (C) Jol-4 staining in the epidetmal cells ( ep) at the 
follicle neck highlights the stratified nature of the epidermis with non-dividing 
cells featuring in the uppermost layers only. (D) As the epithelial cells extend 
beyond the glassy membrane, Jol-4 staining is evident tlu·oughout the epithelial 
cell population, and Jol-4 stained detmal cells accumulate (cluster of cells is 
outlined) around the base ofthe epithelial column. 
(E) BrdU staining is weak but incorporation is evident in proximal epithelial cells 
(anowheads) and a few detmal cells (arrows) scattered at the base of the follicle. 
Scale bar: A, C-E = 501-J.m, B = 25~tm. 
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In particular Jol-4 staining showed a cluster of dermal cells at the base of the epithelial 
column that was reminiscent of the dermal aggregation seen in follicular development 
(Fig. 3.4 D). Cells within the surrounding mesenchymal tissue were also frequently 
labelled with the Jol-4 antibody. 
STAGE 2 
The base of the epithelial column had retreated to within the extended glassy 
membrane of stage 2 follicles. At the cut base of the follicle, a laminin-containing basal 
layer of extracellular matrix separated the dermal and epithelial compartments (Figure. 
3.5) as in stage I. The epithelial compartment contained a large number of Jol-4-
labelled non-dividing cells throughout, including along the length of the basal layer 
(Fig. 3.5 A,B). In one follicle however, a central column of cells exhibited a slightly 
different staining pattern that separated them from the surrounding suprabasal layers of 
epithelial cells (Fig. 3.5 B,C). The sections of this follicle were slightly oblique with 
that shown in Fig. 3.5 B being more midline than that in Fig. 3.5 C. It appears this 
follicle may be at a slightly later stage of regeneration than the follicle in Fig. 3.5 A. 
This is evident from the more organised arrangement of the cells. The shape of the 
nuclei, highlighted by Jol-4 staining, indicates that the cells are arranged radiating from 
a central column of cells aligned with the long axis ofthe follicle (Fig. 3.5 B,C). This is 
in contrast to the random arrangement of nuclei seen at a slightly earlier stage (Fig. 3.5 
A,D). 
BrdU incorporation was evident at regular intervals in the basal layer along 
the entire length of the follicle. In the most proximal part of the column, this was 
more pronounced and included all cell layers, so forming a plug of proliferating 
cells at the open base of the follicle (Fig. 3.5 E). Proliferation was also evident in a 
few dermal cells positioned centrally below the epithelial column and laterally 
132 
1Fngu11re 3.§. Jol-4 staining and BrdU incorporation in stage 2 regenerating follicles. 
Stage 2 follicles immunostained with Jol-4 (A-D) or a monoclonal anti-BrdU antibody 
(E) (green fluorescence) and a polyclonal anti-laminin antibody (red fluorescence). 
(A) Jol-4 immunoreactive cells occupied all areas ofthe epithelial column (ec) and were 
evident throughout the dermal sheath (arrow) and loose mesenchymal tissue (mt). Jol-4 
immunoreactive dermal cells were evident as a strip of cells (arrowheads) extending 
laterally from the dermal aggregation at the base of the epithelial column. 
Band C show slightly oblique sections (B is the closest to the midline) of one follicle in 
which the shape of the epithelial cell nuclei indicated cells were becoming organised, 
with a central column developing within the epithelial compartment. (D) Dermal cells 
stained with Jol-4 (long arrows) were very closely associated with the laminin that 
separated the epithelial and dermal compartments across the cut end of the glassy 
membrane (indicated by dashed lines). The shmt arrow indicates a Jol-4 stained dermal 
cell between the inner aspect of the glassy membrane and the epithelial column. (E) 
BrdU incorporation was evident in cells at the proximal end ofthe epithelial column (ec) 
and in the basal epithelial layer in the more distal part of the follicle. Dashed lines 
indicate the end of the glassy membrane. 
Scale bar: A= lOO~m, B, C, E = SO~m, D = 25~tm. 
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within the loose mesenchymal tissue. These cells were frequently associated with 
laminin expression and appeared to be within vasculature. The dermal sheath cells 
lateral to the glassy membrane were strongly stained by the Jol-4 antibody (Fig. 3.5 
A,B) as were dem1al cells within the confines of the glassy membrane below the 
epithelial column (Fig. 3.5 A,B,D). Jol-4 staining highlighted a strip of mesenchymal 
cells extending across the base of the follicle from one side of the severed capsule to the 
other (Fig. 3.5 A). This was more evident in some follicles than others. 
STAGE 3 
The proximal tip of the epithelial column was no longer flat. The basement 
membrane was indented upwards into the body of epithelial cells as the initial stages of 
dem1al papilla formation took place. BrdU staining revealled proliferating cells at 
regular intervals in the basal layer of the ORS along the length of the glassy membrane 
(Fig. 3.6 A). At the proximal end of the follicle the BrdU labelled epithelial cells were 
more numerous around the dermal indentation of the laminin-positive basement 
membrane (Fig. 3.6 A). 
The majority of dermal cells that surrounded the base of the epithelial column 
were mitotically quiescent. Only one cell in this area was observed to have incorporated 
BrdU, in two follicles. An occasional cell in the loose mesenchymal tissue lining the 
follicle capsule had incorporated BrdU (Fig. 3.6 A) as had cells within the vasculature 
at the very base between the ends of the regenerating capsule. 
Staining with the Jol-4 antibody highlighted the nuclei of the vast majority of 
epithelial cells in the regenerating follicle as well as the lower dermal sheath cells (Fig. 
3.6 B). Dermal cells within the confines of the extended glassy membrane and in the 
presumptive dermal papilla were also Jol-4 immunoreactive (Fig. 3.6 B). 
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Fftgun-e 3.6. Cell proliferation and dermal papilla f01mation during stages 3 and 4 of 
vibrissa follicle regeneration. 
Stage 3 (A, B) and stage 4 (C) follicles immunostained with a monoclonal antibody 
against BrdU (A) or Jol-4 (B, C) (green fluorescence), and a polyclonal anti-laminin 
antibody (red fluorescence). 
(A) BrdU incorporation was detected in the proximal epithelial cells and in the basal 
epithelial layer along the length of the follicle. Individual dermal cells were occasionally 
labelled with BrdU (anow). (B) At stage 3 Jol-4 staining highlighted the nuclei of cells 
throughout the epithelial compartment and dermal sheath cells, including those within 
the area enclosed by the extended glassy membrane (arrows). (C) Once an end bulb had 
formed J ol-4 labelling was lost from the epithelial cells in the new follicle matrix (em) 
around the dermal papilla ( dp). 
Scale bar= SOJ.lm. 
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STAGE 4 
BrdU incorporation was not performed on any follicles that had reached stage 4 in 
the regeneration process. However, Jol-4 staining exhibited a labelling pattern similar to 
that seen in a late stage developing follicle (see chapter 2, Fig. 2.11 C,D). The newly 
formed dermal papilla and dermal sheath were heavily labelled whilst staining was 
noticeably weaker in the developing epithelial matrix (Fig. 3.5 C). Distally, cells of the 
outer root sheath were labelled by Jol-4 antibody as they had been throughout 
regeneration. 
A summary ofthese results is shown in Figure 3.7 as a diagrammatic 
representation, highlighting regions in which proliferation was evident during the stages 
of follicle regeneration. 
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FigUlllre 3.7. Schematic diagram indicating areas ofJol-4 staining and BrdU incorporation 
during regeneration of the vibrissa follicle end bulb. 
The areas highlighted are the dermal sheath (extemal to the glassy membrane), the 
epithelial column and the dermal cell aggregation that develops at the base ofthe 
regenerating follicle. 
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3.3.3. a-smooth muscle actin expressiollll 
An extensive study of this protein's expression was not carried out but two 
follicles, one at stage 2 (Fig. 3.8 A-F) and one at stage 4 (Fig. 3.8 G, H), were 
immunostained with a monoclonal a-smooth muscle actin antibody. The stage 2 follicle 
was atypical in that it exhibited an unusual split in the centre of the epithelial column, 
that was delineated by the laminin antibody (see 3.3.4.1 ). Significant levels of a-
smooth muscle actin expression were observed in the loose mesenchymal tissue lining 
the inside of the collagen capsule at stage 2, along with strong expression in the dermal 
sheath, particularly in the proximal half of the follicle. However, expression was 
downregulated in the dermal sheath, alongside the most proximal section of extended 
glassy membrane, on the nerve side (Fig. 3.8 A-C). In contrast, those dermal cells 
within the compartment created by the extended glassy membrane displayed high levels 
of a-smooth muscle actin expression. This extended into the convolutions of the 
basement membrane between the dermal and epithelial cells (Fig. 3.8 A,D-
arrowheads). The a-smooth muscle actin staining highlighted dermal sheath cells 
extending processes into the glassy membrane itself (Fig. 3.8 C,F). Jahoda et al. 
(1992a) made similar observations by TEM of dermal sheath cells apparently passing 
through the disrupted lower glassy membrane in this stage of regeneration. 
A degree of asymmetry was seen in this follicle with much more a-smooth 
muscle actin expression being evident in the loose mesenchymal tissue on the 
nerve side of the follicle (Fig. 3.8 D). In the most proximal section of the detmal 
sheath the asymmetry was the opposite, with higher expression on the side of the 
follicle opposite that at which the nerve enters (Fig. 3.8 A-D). Obliquely cut 
sections revealed that the circular arrangement of actin fibres, typically seen within 
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JFngllllre 3.8. a-smooth muscle actin expression in vibiissa follicle regeneration. 
Stage 2 (A-F) and stage 4 (G-l-1) follicles immunostained with a monoclonal antibody 
against a-sma (green fluorescence) and a polyclonal antibody against laminin (red 
fluorescence). 
Stage 2: An unusual laminin deposition extends distally from the base of the epithelial 
column in a midline section of the stage 2 follicle (A). a-sma expression in the dermal 
sheath was strong in the lower third of the follicle (D) but diminished at the very base 
(between arrowheads in A & D), particularly on the side from which the deep vibrissa) 
nerve entered the follicle. Successive sections from the middle of the follicle (A) 
towards the edge (C) demonstrate the base of the glassy membrane (arrowheads in B) 
separates from the epithelial column ( ec) and a-sma-positive dermal cells often become 
sandwiched between the two structures (A-C). a-sma-positive cell projections also 
extend deep into the glassy membrane (small arrows, C, F). a-sma staining is also 
evident within the mesenchymal tissue lining the lower capsule (D). The characteiistic 
circular arrangement of a-sma-positive fibres in the lower dermal sheath is clearly 
shown in an off-centre section (E). a-sma-positive fibres are also evident running 
perpendicular to the circular fibres, between these and the glassy membrane (large 
arrow, A & F). 
Stage 4: Once the end bulb has reformed, a-sma expression is much the same as in a 
typical anagen vibiissa follicle with no expression in the dermal papilla ( dp) and the 
lower dermal sheath expression ceases level with the top of the dermal papilla (G, H). 
Scale bar: A-C = 20!-!m, D, G = 100!1-m, E, H = 50!-!m, F = 10!-!m. 
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the dermal sheath of vibrissa follicles, was also apparent in the regenerating follicle 
(Jahoda et al., 1991) (Fig. 3.8 E). However, in the dermal sheath cells immediately 
adjacent to the glassy membrane there were also a.-smooth muscle actin fibres aligned 
with the long axis of the follicle, perpendicular to the circular fibres (Fig. 3.8 A,F-
large arrows). Strong a.-smooth muscle actin expression also highlighted small blood 
vessels within the follicle. 
In a stage 4 regenerating follicle (Fig. 3.8 G,H), a.-smooth muscle actin 
expression was similar to that seen in the anagen vibrissa follicle with distinct staining 
of the dermal sheath in the proximal part of the follicle but not around the end bulb. As 
before, blood vessels were effectively highlighted by the a.-smooth muscle actin in the 
vessel walls. 
3.3.4. Extracellular matrix remodelling 
3.3.4.1. Laminin 
Laminin was used as an effective means of delineating the glassy membrane and 
to aid orientation when viewing sections by fluorescence microscopy. The glassy 
membrane was highlighted (Fig. 3.8 B-arrows), along with other basement 
membranes, including those of blood vessels. These observations were consistent with 
those previously made by Jahoda et al. (1992). A layer oflaminin was observed at the 
junction between the epithelial compartment and the dermal cells at the base of the 
regenerating follicle where the glassy membrane was 'open' (Figure 3.4). This was not 
an extension of the glassy membrane but a thin deposition oflaminin, evident from 
stage 1 of regeneration, delineating the two separate compartments. The only follicles in 
which this was absent were those designated as pre-stage 1 of regeneration. As 
regeneration progressed, more laminin accumulated and by stage 4 the layer was of 
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similar thickness around the newly-formed dermal papilla as the lower glassy 
membrane in the same follicle. 
One follicle in particular, believed to be in stage 2 of regeneration, showed an 
unusual laminin deposition which extended through the lower portion of the epithelial 
column. Initially, this was thought to be an extended indentation representing the early 
stage of dem1al papilla formation, but the length of projection into the epithelial column 
was excessive for this to be the case (Fig. 3.8 A,D). 
3.3.4.2. Versican 
PRE-STAGE 1 
V ersican immunoreactivity was seen as normal in areas associated with 
innervation (see chapter 2), that is in the mesenchymal tissue about halfway up the 
follicle and at the infundibulum (Fig. 3.9 A). In the lower third of the amputated 
follicle, versican was expressed within the glassy membrane on the nerve side of the 
follicle (Fig. 3.9 B). Occasional staining was seen in the glassy membrane on the 
opposing side but this was weak and inconsistent in comparison. This asymmetry was 
consistent in both follicles studied at this stage. The most striking staining however, 
was the strong labelling associated with the dermal sheath at the lowermost end of the 
open glassy membrane (Fig. 3.9 C). This was highly localised at this stage, limited to 
the dermal sheath within approximately 100~-tm of the cut end of the glassy membrane. 
Distal to this, versican expression in the dermal sheath was significantly reduced. 
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lFngmre 3.9. Versican expression in early regenerating vibrissa follicles. 
Pre-stage 1 (A-C) and stage 1 (D, E) follicles immunostained with a monoclonal 
antibody (12C5) against versican (green fluorescence) and a polyclonal antibody against 
laminin (red fluorescence). 
(A) Pre-stage 1 follicles (A-C) display versican immunoreactivity at the infundibulum as 
in nmmal adult vibrissa follicles. (B) Asymmetry is evident within the glassy membrane 
half-way up the follicle with significant expression in the membrane (anow) on the side 
of the follicle which is penetrated by the deep vibrissal nerve. (C) Versican is abundant 
within the dermal sheath at the open end of the glassy membrane. 
(D) Stage 1 follicles show strong versican immunoreactivity in the dermal tissue 
corresponding to the point of entry of the deep vibrissa! nerve (*). ec - epithelial column. 
(E) There is also dennal expression in the lower region of the follicle extending laterally 
from the lower dermal sheath. The immunoreactivity stops abruptly at the lower edge of 
the glassy membrane, indicated by a dashed line. 
Scale bar: A, D = 1 OOJlm, B, C, E = 50Jlm. 
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STAGE 1 
As in pre-stage 1 follicles, versican was abundant at the level of the deep vibrissa] 
nerve entering the capsule and this staining extended throughout the dermal tissue in 
this region (Fig. 3.9 D). In the proximal portion of the follicle, versican expression 
remained strong in the lower dermal sheath and extended laterally into the surrounding 
dermal tissue with no evident asymmetry (Fig. 3.9 E). However, asymmetry was seen 
within the glassy membrane itself as versican expression was detected in this 
extracellular matrix (although at lower levels than in pre-stage 1 follicles) on the nerve 
side of the follicle but not the other (Fig. 3.9 E). This was consistently observed in the 
early stages of follicle regeneration. The lateral spread ofversican from the dermal 
sheath, had a distinct border at the level of the proximal end of the glassy membrane. 
Dermal tissue below this lacked versican expression, in sharp contrast to the strong 
labelling evident in the dermal tissue alongside the glassy membrane, including the 
dermal sheath (Fig. 3.9 E). 
STAGE 2 
V ersican expression was maintained in the proximal dermal sheath during this 
stage as was the expression within the loose mesenchymal tissue around it. The border 
extending laterally from the end of the glassy membrane was also still evident, with 
tissue proximal to the point of amputation remaining free of versican immunoreactivity 
(Fig. 3.1 OA). 
STAGE 3 
Versican staining in the dermal sheath during stage 3 was weaker than that seen in 
previous stages. V ersican expression in the loose mesenchymal tissue of the proximal 
stage 3 follicle was now stronger than that of the dermal sheath (Fig. 3.10 B,C), in 
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contrast to previous stages. The loose dermal tissue, lateral and slightly distal to the 
base of the epithelial column, maintained a high level ofversican expression. At the 
very base of the regenerating follicle where the dermal tissue had formed an indentation 
in the base of the epithelial column, only low levels ofversican were evident, though 
some was present within the dermal tissue sunounded by the laminin-positive basement 
membrane (Fig.3 .1 0 B,C). 
STAGE4 
In the regenerated end bulb versican was abundant throughout the loose 
mesenchymal tissue, within the collagen capsule (Fig. 3.10 D). Strong expression was 
evident in the newly formed dermal papilla as in an anagen follicle. The glassy 
membrane and lower dermal sheath however, displayed a slightly weaker level of 
versican immunoreactivity than the rest of the mesenchymal tissue within the follicle. 
Double-labelling with a neurofilament antibody demonstrated that areas free ofversican 
expression were frequently associated with the presence of nerve fibres (Fig. 3.10 E). 
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Figllllre 3.10. Versican expression during stages 2-4 of vibrissa follicle regeneration. 
Stage 2 (A), stage 3 (B,C) and stage 4 (D, E) follicles immunostained with a monoclonal 
antibody (12C5) against versican (green fluorescence) and a polyclonal antibody against 
either laminin (A-C) or neurofilament (D, E) (red fluorescence). 
(A) Versican is expressed in the lower dermal sheath adjacent to the glassy membrane 
(mTOw) but stops abruptly at the point where the glassy membrane ends (arrowhead). (B) 
At stage 3 versican is expressed at relatively low levels in the dermal sheath (arrowhead) 
compared to the surrounding dennal tissue. In the early dermal stalk penetrating the 
epidem1is traces ofversican are evident (arrow). (C) A higher magnification of the 
section in B. (D) By stage 4 versican is abundant throughout all dermal tissue enclosed 
by the collagen capsule. (E) The new dermal papilla ( dp) is densely stained for versican. 
Double-labelling with neurofilament indicates breaks in the versican staining are 
commonly associated with the presence of nerve fibres (arrow). em- epithelial matrix. 
Scale bar: A-C, E = 50J.lm, D = lOO~tm 
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3.3.5. Sonic hedgehog (Shh) expression 
Pre-stage 1 follicles showed no evidence of Shh expression in any part of the 
follicle. At stage 1 the dermal tissue that enclosed the amputated end of the follicle as 
patt of the wound response, displayed a high level of staining that extended to the edge 
of the capsule. This tissue was well vascularised and staining was particularly strong in 
association with blood vessels. In one particular follicle, punctate staining lined the 
outer aspect of the glassy membrane, suggestive of Shh expression in lower dermal 
sheath cells (Fig. 3.11 A). Sense controls indicated that this staining of the dermal 
sheath and the irregular, patchy staining seen in the mesenchymal tissue around the 
proximal end of the follicle was specific (Fig. 3.11 B). There was no evidence of Shh 
expression in the epithelial cells of stage 1 follicles. The same was true of stage 2 
follicles with dermal tissue exhibiting patchy staining in the lower mesenchymal tissue 
and the proximal capsule, whilst epithelial cells displayed only background levels of 
staining in all areas of the epithelial column. 
During stage 3 the dermal cells formed an indentation in the proximal end of the 
epithelial column. During this process Shh expression was evident initially as a weak 
band of staining in the most central cells of the epithelial column (Fig. 3.11 C). 
Subsequently, as the cells within the indentation developed a more typical papilla 
formation, a cap of epithelial cells situated around the developing papilla showed 
significantly higher levels of Shh expression (Fig. 3.11 E). 
In all cases, hybridisation with a sense riboprobe acted as a negative control (Fig. 
3.11 B,D,F), whilst for positive controls, anagen vibrissa follicle sections were 
hybridised alongside the experimental sections (except for two experiments which had 
no positive control), again with anti-sense and sense probes (Fig. 3.11 G,H). Strong 
expression was detected in the epithelial matrix of anagen follicles as previously 
reported (St-Jacques et al., 1998; Karlsson et al., 1999; Sato et al., 1999). 
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Figure 3.1 ]. Expression patterns of Shh in vibrissa follicle regeneration and anagen, by 
in situ hybridisation. 
Stage 1 (A,B) and stage 3 (C-F) regenerating follicles and an anagen vibrissa follicle 
(G,H) hybridised with anti-sense (A, C, E, G) or sense (B, D, F, H) Shh riboprobes. 
Lines indicate the position of the glassy membrane in B, D & F. 
(A) During stage 1, Shh expression is only detected within the dermal tissue, particularly 
the lower dermal sheath (below the level indicated by arrows) and the mesenchymal 
tissue at the base of the follicle. (C) During stage 3, epidermal cells in the centre of the 
column (*) weakly express Shh and expression in the mesenchymal tissue is maintained. 
(E) A distinct cap of cells around the presumptive papilla (pp) express Shh. (G) The 
expression of Shh in anagen follicles was used as a positive control for the in situ 
hybridisation method. Cells of the epithelial matrix (em), but not the germinative 
epithelial (ge) cells, expressed Shh. dp - dermal papilla. (B, D, F & H) Sense controls 
demonstrate staining A, C, E & G represents specific hybridisation of riboprobes. 
Scale bar: A-D, G, H = lOOj.tm, E, F = 50j.tm. 
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3.4. DISCUSSION 
3.4.1. Summary 
Regeneration in the epithelial compartment resulted from extensive proliferation 
in the basal layer of outer root sheath cells. This proliferation extended along the length 
of the follicle and was also evident at the follicle neck and in the epidetmis continuous 
with the outer root sheath. This supports proposals that stem cells are continuously 
migrating through the outer root sheath during anagen (Oshima et al., 2001 ). The lack 
of dermal cell proliferation suggested the dermal structures of the regenerated end bulb 
were derived from mesenchymal cells that migrated into the follicle during 
regeneration. a-smooth muscle actin expression however, supported proposals that 
dermal sheath cells formed the dermal papilla and migrated through the glassy 
membrane. V ersican expression demonstrated that the dermal sheath responded to 
injury in a manner that differed from that of the other tissues within the follicle. In 
addition, the association of versican with innervation, described in chapter 2, was 
evident in follicle regeneration. Shh was expressed in epithelial cells associated with the 
regenerating dermal papilla, as it is expressed in association with the developing dermal 
papilla. 
3.4.2. Where are the regenerated tissues derived from? 
3.4.2.1. Cell proliferation 
BrdU is incorporated into the nucleus of cells during DNA replication and can 
subsequently be detected immunologically, thereby providing a means for detecting cell 
proliferation (Gratzner, 1982). The observation that proliferation occurs in the outer 
root sheath cells ofpre-stage 1 follicles, suggests that local cell division gives rise to the 
cells that subsequently fill the cavity created by removal of the hair fibre. Proliferation 
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is also evident in cells at the neck of the pre-stage 1 regenerating follicle, raising the 
possibility that cells originating from the surrounding epidem1is migrate into the follicle 
and contribute to the initial stages of regeneration. Outer root sheath cells have been 
demonstrated to contiibute to interfollicular epidennis in neonatal skin during tissue 
expansion and in adult skin during re-epithelialisation after wounding (Taylor et al., 
2000). There is no evidence that the interfollicular epidermis would not be capable of 
reciprocating, in follicle regeneration. 
The concentration of proliferative activity in the proximal end of the epithelial 
column, from stage 1 onwards, reflects the significant amount of remodelling occurring 
in this region of the follicle. The increase in cell numbers is likely to be a contributing 
factor in the initial projection of the epithelial column into the dermal tissue at the base 
of the follicle. The distribution of proliferating cells in stage 3 follicles is reminiscent of 
that seen in the end bulb of an anagen follicle (Gharzi et al., 1999; Rumio et al., 2000) 
indicating that these cells are forming the new epithelial matrix of the end bulb. 
Throughout the regenerative process, proliferating cells were identified at regular 
intervals along the inner aspect of the glassy membrane. This suggests epithelial stem 
cells are distributed throughout the follicle. 
Epithelial cell proliferation in the basal layer of outer root sheath along the length 
of the follicle supports the proposals by Oshima et al. (200 1) that stem cells migrate 
from the bulge through the outer root sheath during anagen. Under the "traffic light" 
hypothesis (Oshima et al., 2001) stem cell migration ceases in the lower outer root 
sheath at the onset of catagen. Migration from the bulge continues, resulting in the stem 
cells accumulating along the length of the outer root sheath during catagen right back to 
the bulge. Subsequently, cells stop migrating out of the bulge during telogen. Only 
when early anagen is initiated and the "queue" of cells moves downwards, do bulge 
cells begin to migrate again. Studying BrdU incorporation during the follicle cycle 
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would be a means of testing this hypothesis, whilst the observations described above on 
mid-anagen follicles support the proposal of stem cells migrating along the length of the 
outer root sheath at this stage. 
The "traffic light" hypothesis would also suggest that regeneration of the follicle 
would be successful at all stages of the cycle as there are consistently stem cells along 
the length of the follicle, the density of these being the only variable. Investigating the 
regeneration of follicles amputated at different stages of the follicle cycle would 
therefore reveal any changes in the regenerative capacity of the dermal sheath according 
to the cycle stage. 
In all stages of regeneration, the vast majority of epithelial cells displayed nuclear 
labelling with the monoclonal antibody, Jol-4. This antibody is specific to lamin A in 
the nuclear envelope of non-dividing cells (see chapter 2, Dyer et al., 1997) and 
therefore, identified the mitotically quiescent cell population within the follicles. The 
newly formed epithelial matrix of a stage 4 follicle was the only epithelial cell 
population in which Jol-4 staining was conspicuously absent, suggesting this follicle 
was in the early stages of fibre production. Whilst Jol-4 staining was intended to 
highlight non-dividing cells, the nature of the stain also revealed the shape of cell nuclei 
and in some instances this gave further insight into the changes occurring during 
regeneration. The nuclei of one stage 2 follicle in particular indicated that cells were 
becoming polarised within the epithelial column. Cell nuclei were aligned along the 
long axis of the follicle prior to indentation of the base of the epithelial column. This 
regular arrangement contrasted with the randomly arranged epithelial cells observed in 
follicles at earlier stages of regeneration. Such organisation indicates the epithelial cells 
are undergoing morphological changes during this stage of regeneration. 
Rober et al. (1989) found that during development the expression oflamin A/C 
was only upregulated when tissues were differentiating leading to proposals that lamin 
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AIC expression limits the plasticity of cells. Whilst this may be tme to a certain extent, 
the data presented here demonstrates that laminA expression, detected by Jol-4 
immunostaining, does not identify a cell as 'differentiated'. The fate of the cell may 
simply have been limited somewhat, for example, a dermal cell may have been 
designated as hair follicle-specific but still has the potential to contribute to papilla or 
sheath. Similarly a Jol-4 labelled epithelial cell can still potentially contribute to any of 
the seven follicular cell types. 
Very few dermal cells had successfully incorporated BrdU, suggesting there was 
no surge of dermal cell proliferation in the regenerative process. The most extensive 
dem1al staining was seen in a stage 1 follicle and this was restricted to less than 10 cells 
over a number of sections, only one of these cells being in the dermal sheath. The 
follicular mesenchyme and dermal sheath have been cited by previous authors as 
sources of additional dermal cells in regeneration of the dermal papilla (Oliver, 1966b; 
Jahoda & Oliver, 1984c; Jahoda et al., 1992a), but proliferation in these areas was not 
detected. Lack of cell proliferation implies that migration of dermal cells either from 
within the vibrissa follicle, or from the mesenchymal tissue at the site of amputation, is 
necessary to provide a considerable proportion of the dermal cell population for the new 
end bulb. However, there is also the possibility that the lack of BrdU incorporation in 
dermal cells may reflect a longer S phase than that of the epidermal cells. In the most 
proximal section of dermal sheath, in pre-stage 1 follicles, less Jol-4 immunoreactive 
cells were present than in the distal dermal sheath. The lack of BrdU incorporation in 
areas that were not stained by the Jol-4 antibody suggests these areas contained cells 
that were either just entering the cell cycle or had already completed the S phase by the 
time of BrdU treatment. Testing a range of BrdU incubation times, in combination with 
a detailed study of cell migration during the regenerative process, should provide more 
informed answers regarding the source of the dermal cells of the new end bulb. 
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3.4.2.2. a.-smooth muscle actin expression 
The inner cells of the lower dermal sheath display strong a-smooth muscle actin 
expression in vivo (J ahoda et al., 1991 ). Detection of this protein during regeneration 
therefore identifies the dermal sheath cell population, along with any cells in which this 
protein is upregulated as part of the regeneration process. The expression of a-smooth 
muscle actin was only studied in one follicle at stage 2 of regeneration and one follicle 
at stage 4, due to limited antibody stocks. This must therefore be borne in mind when 
considering the results. In the stage 2 regenerating follicle, expression of a-smooth 
muscle actin is evident in the dermal cells gathered below the epithelial column, prior to 
de1mal papilla formation. Previous authors have proposed these cells to be of dermal 
sheath origin and the expression of a-smooth muscle actin supports these proposals. 
Following wounding of the dermal papilla, Jahoda & Oliver (1984c) observed 
cells within the glassy membrane. This was followed by observations, at the 
ulh·astructurallevel, of cell projections within the dismpted glassy membrane that were 
described as dermal sheath cells moving through the membrane (Jahoda et al., 1992a). I 
observed filamentous a-smooth muscle actin within the lower glassy membrane, 
providing further evidence of dermal sheath cells passing through this thickened ECM. 
Cells within the glassy membrane itself and those situated on the inner aspect, where it 
had detached from the epithelial column, displayed the same high level of a-smooth 
muscle actin expression as seen in dermal sheath cells distal to the site of end bulb 
regeneration. 
The point at which dermal cells become dermal papilla cells in the regeneration 
process is unknown but, it appears the first interaction of dem1al sheath cells with the 
epithelial cells, and subsequent cell movement into the confines of the extended glassy 
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membrane, does not result in downregulation of a-smooth muscle actin. The expression 
of this protein in stage 4 of regeneration is much the same as that of an anagen vibrissa 
follicle suggesting the switch to dermal papilla occurs in dermal cells during stage 3, 
presumably as they form the indentation that will develop into a functional papilla. 
Expression of a-smooth muscle actin was not restricted to the tissue closely 
associated with the lower epithelial column. Expression extended into the loose 
mesenchymal tissue, particularly that immediately adjacent to the inner aspect of the 
collagen capsule. Jahoda et al. (1996) observed that regenerating human hair follicles, 
implanted beneath the skin of athymic mice, developed bulbous structures of similar 
appearance to the collagen capsules surrounding vibrissa follicles. It was proposed that 
these structures were formed from the outer layer of dermal sheath whilst the inner 
layer contributed to the new dermal papilla. The wider expression of a-smooth muscle 
actin in regenerating vibrissa follicles supports the proposal that dermal sheath cells 
may contribute to the regeneration of the collagen capsule as well as the dermal papilla. 
However, the distinction between the layers is unclear. The only indication from the 
results presented here is the orientation of a-smooth muscle actin filaments in the lower 
dermal sheath. The fibres lining the outer aspect of the glassy membrane lie along the 
long axis of the follicle whilst fibres external to these, appear to lie perpendicular to 
this, encircling the glassy membrane. The significance of these two layers is unclear in 
the regenerating vibrissa follicle and detailed analysis is needed to reveal if a similar 
arrangement is evident in the anagen vibrissa follicle. 
The expression of a-smooth muscle actin within the mesenchymal tissue was lost 
by stage 4 of regeneration suggesting the functional requirement is transient, possibly as 
part of the wound response. 
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3.4.2.3. Possible ways of deducing the origin of the new dermal papilla 
Previous studies proposed the dermal sheath gave rise to the regenerated dennal 
papilla. The expression of a-smooth muscle actin in dermal cells at the base of the stage 
2 follicle, as well as in cells passing through the glassy membrane, appears to support 
these assertions. However, while the dermal sheath seems the most likely origin of 
these cells, migration of cells into the wound site from the surrounding mesenchyme, or 
delivery of cells via the blood supply are still possibilities in the regeneration of the end 
bulb. Indeed, the possibility of a distant source of dermal cells is made all the more 
likely by the evident lack of dermal cell proliferation in the regenerating follicle. The 
exact origin of the regenerated dermal papilla is still to be defined. 
One means by which cells could be tracked during follicle regeneration would be 
to take advantage of transgenic mice in which all cells express marker genes, for 
example, Zin40 mice which express lacZ in all cells. Lengths of Zin40 mouse vibrissa 
follicle wall, consisting of dermal sheath and outer root sheath cells only (Oliver, 
1967a), could be implanted under the kidney capsule of nude mice, a site that has been 
successfully used for ectopic follicle regeneration by Kobayashi & Nishimura (1989). 
The lacZ gene, expressed by Zin40 cells, could then be detected by X-Gal staining, thus 
determining which tissues derived from Zin40 cells. Any contribution from the host 
tissue would be identifiable by the lack of blue staining. 
BrdU incorporation detected minimal dermal cell proliferation during 
regeneration. As mentioned previously the protocol for incorporation could be altered to 
address this issue but other techniques might also be employed to detect proliferating 
cells such as tritiated thymidine incorporation or using Ki67 antibodies which detect a 
nuclear protein only expressed by proliferating cells. 
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3.4.3. Do events in follicle regeneration reflect aspects of appendage development? 
During the adult hair cycle the morphological changes and remodelling processes 
that occur are often regarded as a recapitulation of the epithelial-mesenchymal 
interactions of follicle development. The regeneration that occurs in the vibrissa follicle 
is likely to involve similar epithelial-mesenchymal interactions, to achieve the 
successful production of a functional end bulb. 
3.4.3.1. Dermal papilla regeneration: aggregation 
The formation of a detmal papilla is the key factor in successful hair fibre 
production by regenerated follicles. Disruption of the dermal papilla has demonstrated 
that the integrity of this group of specialised cells is crucial for normal hair growth in an 
otherwise intact follicle (J ahoda & Oliver, 1984b, 1984c ). Dermal papilla cells possess 
innate aggregative properties both in vivo and in vitro (W essells & Roessner, 1965; 
Jahoda & Oliver, 1981, 1984a; Jahoda et al., 1993). The fact that high passage dermal 
papilla cells lose both their inductive capacity and aggregative behaviour, indicates the 
importance of aggregation to follicle formation (Home et al., 1986). The aggregation of 
dermal cells observed in hair follicle development would therefore be expected to occur 
in regeneration. 
The most prominent aggregation of dermal cells was highlighted by Jol-4 staining 
in stage 1 follicles. A cluster of Jol-4 immunoreactive cells was situated beneath the 
epithelial column that extended below the glassy membrane. This extension of the 
epithelial cells provides an opportunity for the epithelial and dermal cells to interact 
without obstruction by the glassy membrane. In follicle development, epithelial-
mesenchymal signals lead to dermal aggregation. Direct epithelial-me·senchymal 
interaction at this early stage of regeneration appears to result in a similar aggregation 
in the dennal tissue immediately proximal to the epithelial column. Dermal sheath cells 
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from the lower third of the follicle display aggregative behaviour in vitro whilst those 
from the upper follicle do not and it has been suggested this is related to the 
regenerative properties of the proximal third of the follicle (Home et al., 1986), these 
cells sharing some of the key characteristics of dermal papilla cells. 
The dermal cells that gather below the epithelial column are thought to act in a 
manner comparable to that of the dermal condensation observed in follicle 
development. Further study of the proteins expressed by these cells would enable the 
direct comparison of signalling mechanisms occurring in regeneration to those of 
development. In particular, determining the pattern ofNoggin and BMP expression 
would be interesting, as these two signalling molecules are understood to play 
important roles in follicular morphogenesis. BMP exerts an inhibitory influence in 
development, preventing follicle induction. The expression ofNoggin by the cells of the 
dem1al condensation antagonises BMP signalling so providing a permissive signal, 
enabling the initiation of follicle development (Botchkarev et al., 1999a). 
In the adult vibrissa follicle, Noggin is only expressed in the dermal papilla and 
would therefore be an interesting molecule to study during the process of regeneration. 
Establishing at what stage the cells of the new dermal papilla express Noggin, and the 
position of these cells when they do, may indicate the origin of these cells. For example, 
if the dermal papilla is shown to be a derivative of dermal sheath by the experiments 
described previously using Zin40 mice, the expression of Noggin might first be evident 
in the dermal sheath at the site of amputation, prior to cell aggregation. Alternatively, 
the cells may aggregate but not express Noggin until the dermal compartment creates an 
indentation in the base of the epithelial column. The pattern ofNoggin and BMP 
expression, when compared to that seen in development, would indicate how the 
regeneration process relates to follicle organogenesis, in addition to providing some 
important information regarding the transition from dermal sheath to dermal papilla. 
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3.4.3.2. Sonic hedgehog expression 
Sonic hedgehog (Shh) is expressed in the epithelial component of the developing 
follicle and the adult follicle, but has not been detected in follicular dermal tissue 
(Bitgood & McMahon, 1995; Iseki et al., 1996; Gat et al., 1998; Karlsson et al., 1999). 
In the regenerating follicle, however, transcripts of Shh were detected throughout the 
lower mesenchymal tissue at the wound site and in the lower dermal sheath. In a recent 
review, Callahan & Oro (2001) discussed the fact that Shh or its target genes were 
commonly expressed in association with multipotent progenitor cells at a time of 
proliferation and differentiation. The expression pattern observed in regenerating 
follicles correlates with this, as dermal sheath is the proposed source of dermal papilla 
cells and the mesenchymal tissue will ultimately contribute to the closure of the capsule 
below the newly formed end bulb. In the early stages of regeneration therefore, Shh 
expression does not reflect the pattern of expression seen in early stages of follicle 
development, but highlights areas in the process of extensive remodelling. 
This association with areas of remodelling is continued into the later stages of 
follicle regeneration when Shh is expressed in the epithelial cells, as well as the loose 
mesenchymal tissue. Expression in the lower dermal sheath was transient. The weak 
expression in the central epithelial cells suggests these cells are undergoing some 
morphological change, possibly in preparation for migration distally, to enable 
indentation at the proximal end of the epithelial column by dermal cells. (This is also 
suggested by the orientation of the cells in one particular stage 2 follicle in which Jol-4 
staining highlighted the nuclei of the central epithelial cells to be aligned with the long 
axis ofthe follicle (Fig. 3.5 C).) 
During early papilla formation in stage 3 of follicle regeneration, a collection of 
cells around the apex of the new papilla express Shh. At this later stage of regeneration 
the expression of Shh resembles that seen in stage 3 developing follicles when 
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expression is detected at the base of the epithelial downgrowth in association with the 
presumptive detmal papilla (lseki et al., 1996). Shh is not crucial to follicle induction 
but is essential for successful morphogenesis ofthe dermal papilla (Chiang et al., 1999). 
Shh expression in the epithelial cells associated with the dermal papilla suggest Shh is 
once again regulating the formation of this structure. Recently, Wnt5a has been 
identified as a target of Shh signalling in follicle morphogenesis (Reddy et al., 2001 ). 
Determining the expression of this and other target genes in follicle regeneration, would 
provide further evidence as to whether developmental processes were involved in 
regeneration of a functional end bulb. 
The close interaction between epithelial-mesenchymal cells is crucial for follicle 
organogenesis, as is the aggregation of follicular dem1al cells. As mentioned previously, 
the fact that epithelial cells extend into the dermal tissue at the same stage as dem1al 
cells were seen to form a cluster of cells beneath the epithelial column suggests the 
inductive interactions of follicle regeneration occur at this early stage. Previous 
suggestions were that wound healing characterised the initial tissue response and 
inductive interactions were second to this (Jahoda et al., 1992a). Whilst some wound 
healing characteristics are evident, the direct interaction of dermal and epithelial cells 
without the barrier of the glassy membrane provides an opportunity for inductive 
signals to be relayed between the two tissues at this early stage of regeneration. 
3.4.3.3. Lessons from other examples of regeneration 
Regeneration in mammals is decidedly limited in comparison to that ofurodele 
amphibians and teleost fish. These organisms are capable of regenerating amputated 
limbs or fins and the formation of a blastema is believed to be crucial for successful 
regeneration (Brockes, 1997). The blastema develops beneath the wound epidermis and 
is derived from the mesenchymal tissue at the site of amputation. The interactions 
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between the epidermis and the blastema have been shown to involve signalling 
molecules that participate in developmental epidermal-mesechymal interactions. As 
such some lessons may be learnt from studies on amphibian and fish models that are 
relevant to mammalian appendage regeneration. 
Mesenchymal expression of Shh is not a feature of hair follicle development but 
is evident in other sites of epithelial-mesenchymal interactions in development, 
including the developing limb bud. Polmised Shh expression in the posterior 
mesenchyme of the limb bud is integral to pattern formation (Niswander et al., 1994). 
Similar polarisation was demonstrated in the epithelial matrix of hair follicles by Gat et 
al. (1998) who observed aberrant expression coincided with random orientation of the 
follicle in relation to the skin. Whilst there was no asymmetry or polarisation of 
expression in the regenerating follicles of this study, it would be interesting to see if 
polarised Shh expression was evident in the later stages of follicle regeneration. 
Limb regeneration does not generally occur in mammals, but two examples have 
been demonstrated in particular circumstances. One displays regenerative properties in 
the presence of exogenous factors (Taylor et al., 1994), whilst the other is similar to the 
vibrissa follicle in that regeneration will occur provided the amputation is distal to a 
certain point (Borgens, 1982). In this second model, the distal tip of the murine toe was 
observed to regenerate provided the amputation was distal to the nail bed. The authors 
observed that there was no recognizable blastema formed but proliferation of fibroblasts 
and progenitors of osseous tissue was evident at the site of amputation (Borgens, 1982). 
The accumulation of a mass of mesenchymal tissue is therefore a feature common to all 
regenerative processes, including that of the vibrissa follicle. The precise nature of this 
tissue, with regard to cellular composition and origin is unclear and further 
investigations are required to establish the degree of multi potency contained within this 
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tissue. Extracting a sample of this tissue and establishing an explant culture in vitro 
could be a basic, but effective, means of determining the cells present within this tissue. 
The sites of regenerative potential in chick limb and murine toes both express msx 
genes. Amputation beyond the region of msx expression does not result in regeneration 
(Reginelli et al., 1995; Kostakopoulou et al., 1996), suggesting expression of these 
genes is crucial to the regenerative process (Poss et al., 2000). Msx genes are involved 
in the development of feathers, teeth and hair, and expression has also been reported in 
the inner root sheath of adult hair follicles (Noveen et al., 1995; Chen et al., 1996; 
Stelnicki et al., 1997). A more detailed analysis of msx distribution within the follicle 
might prove informative as to the cause of the difference in regenerative potential 
between the upper two thirds and the lower third of the follicle. 
The lack of regeneration in follicles from which more than the lower third has 
been amputated (Oliver, 1966b) has been attributed to a lack of inductive or 
regenerative properties in the upper follicle wall, comprising dermal sheath and outer 
root sheath (Oliver, 1967a). However, Matsuzaki et al. (1996) observed frequent 
generation of follicle bulb formation in the upper portion of folicles from which the 
lower half had been amputated. The fibres produced from these bulbs were pelage-like, 
reflecting the small size of the bulbs produced. Whilst bulbs were formed they were 
frequently embedded in the dem1al tissue at the upper end of the follicle, raising the 
question of how induction occurred, as at the site ofbulb formation dermal and 
epidermal components were separated by the glassy membrane. Further investigation is 
required to determine the nature of these follicle bulbs and the tissues from which they 
are derived. 
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3.4.4. The role of extracellular matrix in regeneration 
3.4.4.1. Versican 
The concentrated expression of versican, at the proximal end of the pre-stage 1 
follicle, suggests dermal sheath cells are expressing versican as part of their initial 
wound response, possibly in association with cell proliferation (Zimmermann et 
al.l994). This is a reaction specific to dermal sheath cells as versican is not expressed in 
any other tissue at the site of amputation. From stage 2 to 3 the expression in the dermal 
sheath diminishes, becoming weaker than that of the loose mesenchymal tissue in the 
lateral aspects of the follicle. However, at no stage is versican expressed in the dermal 
tissue enclosing the base of the follicle. This indicates that a) versican is not expressed 
as a component ofthe universal wound response, and b) versican plays no direct role in 
the epithelial-mesenchymal interactions occurring during follicle regeneration as at all 
times, areas ofversican expression remain separated from the epithelial cells by the 
glassy membrane. Indeed, the lack of versican in the aggregating dermal tissue is 
reminiscent of the expression pattern observed in development. 
From the data presented in the previous chapter (see 2.3) and the results obtained 
by double-labelling with neurofilament antibody in a stage 4 regenerating follicle, it 
appears that versican has two separate roles in the regenerating follicle. The early 
localised versican expression may be related to a specific wound response, whilst the 
later widespread expression is likely to be associated with the regeneration or 
stabilization of follicle innervation during this period of remodelling. The expression in 
the upper halfofthe follicle during the early stages remains associated with the deep 
vibrissa! nerve and the superficial nerves at the neck of the follicle. The expression 
throughout the mesenchyme of a stage 4 regenerating follicle and the presence of fine 
nerve fibres on the inner aspect of the collagen capsule, was reminiscent of the strong 
expression at the follicle neck in association with the delicate fibres of the superficial 
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vibrissa! nerves. I propose versican stabilises the innervation of the vibrissa follicle 
during the later remodelling stages of regeneration. 
It is well documented that the dermal components of the hair follicle produce a 
specialised ECM (Couchman & Gibson, 1985; Couchman, 1986; Messenger et al., 
1991; Couchman, 1993; Couchman & du Cros, 1995) and the contribution ofECM to 
healing is significant (reviewed by Tuan & Nichter, 1998). Given that versican appears 
to be specific to the wound response of dermal sheath cells it may be a key factor in the 
scar-free healing and regeneration of follicle tissue (Jahoda & Oliver, 1984c). Limited 
data is available on the contribution of versican to wound healing and the expression of 
versican varies between different models of healing (Boykiw et al., 1998; Geary et al., 
1998; Gutierrez et al., 1998; Plaas et al., 2000). Perhaps most intriguing though, is the 
observation that wound healing myofibroblasts, known to express a-smooth muscle 
actin and recently proposed to derive from dermal sheath (Jahoda & Reynolds, 2001), 
express versican at high levels (Hakkinen et al., 1996). There is no clear evidence of the 
role ofversican in the wound healing process. However, it is expressed in cells 
associated with skin wound healing, upregulation ofversican is rapid in the amputated 
dermal sheath, and hair follicles, which express versican throughout the dermal 
component (chapter 2; du Cros et al., 1995), are able to heal without scar tissue 
forming. All these facts provide a good basis for further investigation into the 
contribution ofversican in successful healing. 
3.4.4.2. Laminin 
Laminin is expressed in all basement membranes and as such provided a useful 
marker to identify both the glassy membrane and the extracellular matrix laid down in 
stage 1 of regeneration to separate the epithelial and dermal compartments. It also 
highlighted the vasculature within the regenerating follicles, which was mostly 
169 
associated with the lower dermal sheath and the plug of dermal tissue that covered the 
amputated end of the follicle by stage 2. This is further evidence that a wound-type 
response has occurred during follicle regeneration as a rich blood supply is one of the 
key requirements for any such process. 
3.4.5. Conclusions 
The regenerating vibrissa follicle remains an excellent model for studying 
various aspects of hair follicle biology. The differentiation of dem1al papilla cells 
from the existing cell population is an area that requires further study, but the 
dermal sheath remains the most likely source of these cells. 
Aspects of development are evident in follicle regeneration, including the 
physical aggregation of dermal cells at the base of the follicle. Shh expression is 
not evident in the initial stages of regeneration when epithelial and dermal cells 
first interact, but at the time of dermal papilla formation, Shh is expressed in the 
epithelial cells. The molecular induction of follicle regeneration is yet to be 
elucidated, but the morphogenetic Shh signal is evident in the later stages of 
regeneration, as it is in development. 
The capacity to heal scar-free is an intriguing one and many possibilities 
have yet to be explored in asking what factors result in this flawless healing. The 
specialised ECM of the follicular dermal tissue is a likely source and from the 
expression observed in the early stages of regeneration, versican is a possible 
factor. 
Regeneration models provide good opportunities to investigate both wound 
healing and developmental processes. The vibrissa follicle is an excellent example 
of such a model. 
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Chapter 4: Follicular dermal cells and embryonic 
stem cells: reciprocal interactions. 
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4.1. INTRODUCTION 
4.1.1. Embryonic stem cells 
Embryonic stem (ES) cells originate from the inner cell mass of early blastocysts 
and have two important properties. First, they are totipotent, that is when injected into a 
blastocyst they integrate into the developing embryo and contribute to all cell lineages 
including the germ line (Bradley et al., 1984; Saburi et al., 1997). Second, in an 
appropriate environment, they will proliferate in culture indefinitely without any change 
to their behaviour (Smith, 1990). Established lines of murine ES cells provide a very 
useful tool for investigating the differentiation process as, given the correct stimuli, in 
the form of additions to the culture medium and substrate, they can be induced to 
differentiate along a variety of cell lineages, including blood and neuronal cell types 
(Hole & Smith, 1994; Bain et al., 1995; Dani et al., 1997). 
The manipulation of the genetic material of ES cells in culture provides a 
powerful tool for investigating specific genes, either in differentiation processes in vitro 
or a functional role in vivo by the creation of chimaeric mice (Capecchi, 1989; Koller & 
Smithies, 1992; Bagutti et al., 1996; Dani et al., 1998; Rohwedel et al., 1998; Gimond 
et al., 2000). For example, the requirement of J31-integrin expression, for keratinocytes 
to assemble an ECM, was initially described after J31-integrin null ES cells showed 
atypical characteristics when induced to differentiate along the keratinocyte lineage 
(Bagutti et al., 1996). These findings have been supported by recent in vivo studies in 
which targeted deletion of the J31-integrin gene in keratinocytes resulted in severe 
abnormalities in hair follicles and interfollicular skin (Brakebusch et al., 2000). The 
studies onES cells therefore provided the basis for a more focused analysis in vivo. 
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When murine ES cells were first isolated they were cultured on a layer of feeder 
cells to maintain them in an undifferentiated, pluripotent state. These feeder cells were 
initially teratocarcinoma stem cells (Martin, 1981 ). Subsequently, buffalo rat liver cells 
were found to produce conditioned media which had the same effect (Smith & Hooper, 
1987). The molecule involved was purified from conditioned media ofthe feeder layer 
cells and found to be a polypeptide, which was subsequently named differentiation 
inhibitory activity (DIA) (Smith et al., 1988). Independently, Williams et al. (1988) 
demonstrated that the pluripotency of ES cells could be maintained by leukemia 
inhibitory factor (LIF), and the work of Gearing et al. (1987) and Moreau et al. (1988) 
established that DIA and LIF were actually one and the same molecule, as suggested by 
Smith et al. ( 1988). 
4.1.2. Interleukin-6 cytokine family 
LIF is a member of the interleukin-6 (IL-6) cytokine family which also includes 
ciliary neurotrophic factor (CNTF), oncostatin M (OSM) and cardiotrophin-1 (CT-1). 
CNTF, OSM and CT -1 have all been shown to maintain pluripotent ES cells in culture, 
in the same manner as LIF (Conover et al., 1993, Rose et al., 1994, Pennica et al., 
1995). These cytokines share a four helical bundle structure and exert their effects on 
the cell through receptor complexes that include the gp 130 subunit, first identified and 
cloned by Taga et al. (1989) and Hibi et al. (1990). 
The common signalling mechanisms of the IL-6 family result in these cytokines 
displaying equivalent function in a number of assays (Pennica et al., 1995; Piquet-
Pellorce et al., 1994). In contrast, there are circumstances where family members exert 
opposite effects on the same process. For example, there is evidence for IL-6, LIF, 
CNTF and OSM to have both anti-inflammatory and pro-inflammatory responses. In 
neural tissue, LIF plays a key role in response to injury and possible infection, and there 
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is evidence to suggest that LIF is chemotactic for inflammatory cells within the nervous 
system (Gadient & Patterson, 1999). 
As a family of cytokines, the effects of these molecules are very widespread, both 
in vitro and in vivo, affecting the nervous system (Yamamori et al., 1989; Li et al., 
1995), haematopoietic system (Moreau et al., 1988), adipogenesis (Aubert et al., 1999), 
hepatic development and maturation (Baumann & Wong, 1989; Kamiya et al., 1999; 
Miyajima et al., 2000), kidney development (Barasch et al., 1999), maintaining 
pluripotency within the early embryo (Nichols et al., 1996), and the maternal expression 
of LIF is crucial to implantation of the blastocyst (Stewart et al., 1992). The functions 
of these molecules are complex, changing with the tissue involved and also the 
circumstances (reviews- Gomez-Lechon, 1999; Miyajima et al., 2000). 
4.1.3. Cytokine receptor complexes and signalling pathways 
4.1.3.1. Signalling at the cell membrane 
The diversity of function within this family of cytokines is mediated to a degree 
by the various receptor components required to form functional complexes, the 
components and configurations of which are shown in Figure 4.1 (for reviews see 
Kishimoto et al., 1994; Bravo & Heath, 2000). When LIF binds with low affinity to the 
LIF receptor (LIFR) it induces this receptor to form a complex with gp 130 so 
generating high-affinity binding sites for LIF (Gearing et al 1992). CT -1, like LIF, 
interacts directly with the LIFR and then gp 130 is recruited (Pennica et al., 1995). OSM 
can bind directly to soluble gp 130, so acting as an IL-6 antagonist (Sporeno et al., 
1994 ), and interact with the LIFR/ gp 130 complex. There is also an OSM specific 
receptor which forms heterodimers with gp 130. OSM therefore has two positive 
signalling mechanisms, potentially with separate signal transduction pathways (Gomez-
Lechon, 1999), and an antagonistic mechanism, a good example of the diversity within 
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this family of cytokines. CNTF requires a third component, CNTFRa, to make a 
functional receptor complex (Conover et al., 1993). 
Figure 4.1. gp130 receptor complexes for which the IL-6 family cytokines are ligands. 
IL-6 and CNTF require a specific a-subunit for signal transduction, as well as the 
gp130 homo- and hetero-dimer respectively. LIF, CT-1 and OSM all signal through 
gp130/LIFR~ heterodimers, and OSM can also signal via an OSMR/gp130 heterodimer. 
gp130 
CNTFRa 
0 ll-6Ra 
LIFR~ 
OSMR 
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4.1.3.2. Intracellular signalling pathways 
The signal from receptor complexes involving gp 130 is transduced by two 
cascades independent of one another, the Ras/MAP kinase pathway, activated by the 
tyrosine kinase l-Ick (Emst et al., 1994; 1996), and the Jak-STAT (STAT- signal 
transducer and activator of transcription) pathway (Emst et al., 1996; 1999). The exact 
combination of events after gp 130 activation varies hugely, depending on the ligand 
and the cell type, but in ES cells the result is maintenance of a pluripotent cell 
population. In ES cells, activation of gp 130 by IL-6 bound to a soluble form of IL-6 
receptor, is sufficient to maintain ES cells (Yoshida et al., 1994). ES cells do not 
express the membrane-bound IL-6 receptor, hence the gp130 molecules cannot form 
heterodimers (Saito et al 1992). The successful formation of gp 130 homodimers 
initiated by the soluble IL-6 receptor, is a clear indication that gp 130 is the key 
membrane bound receptor to initiate the intracellular signalling cascade that will 
maintain ES cells in culture. 
Downstream of gp 130, tyrosine-phosphorylation of STAT3 (Figure 4.2) is 
necessary for the DNA-binding activity of this transcriptional regulator (reviewed by 
Williams, 2000). ES cells consistently express STAT3, but tyrosine-phosphorylation of 
STAT3 only occurs in the presence of LIP (Boeuf et al., 1997). Expression of a 
dominant -negative mutant ST A T3 protein in ES cells resulted in differentiation in the 
presence of LIP, providing the first evidence that tyrosine phosphorylation of ST A T3 is 
crucial to LIP-dependent maintenance ofES cell pluripotency (Boeuf et al., 1997). 
Further work demonstrated a critical amount of ST AT3 was not only essential, but its 
activation alone (at sufficient levels) is enough to maintain ES cells in an 
undifferentiated state (Raz et al., 1999; Matsuda et al., 1999; Emst et al. 1999). Genes 
whose transcription is regulated by ST A T3 are therefore potential candidates as effector 
molecules for self-renewal of ES cells. 
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Figure 4.2. The STAT signalling pathway. 
The signalling process is simplified and broken down into three main steps: 
(a) ligand binding to the receptor results in activation of JAK.s which tyrosine 
phosphorylate the receptor chains; (b) STAT monomers are recruited to these 
phosphorylated receptor chains and are subsequently tyrosine phosphorylated 
themselves by the JAK.s; (c) phosphorylated STATs dissociate from the receptor, 
form dimers and translocate to the nucleus where they bind regulatory DNA elements. 
Williams. 2000. 
(a) 
JAK 
(b) 
1 
STAT 
monomer 
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STAT 
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Nucleus 
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4.1.4. Plasticity in adult cell populations 
While the embryonic stem cell has the highest degree of plasticity, with the 
potential to differentiate along any lineage, it has been demonstrated that plasticity 
amongst adult somatic cells is more frequent than was previously thought (reviews -
Seale & Rudnicki, 2000; Clarke & Frisen, 2001 ). The ability to direct cells along an 
alternative lineage enables the processes of cell specification and differentiation to be 
investigated. The ultimate aim of such research is to understand the mechanisms by 
which a blastocyst develops into an embryo, and how embryonic tissues differentiate to 
form complex structures. 
The influence ofneighbouring cells can dramatically affect a cell's phenotype and 
this is evident during development in many instances, the development of skin 
appendages being just one example (Hardy, 1992; Thesleff et al., 1995). During 
developmental processes, cells are understood to be receptive to inductive signals 
directing them along particular lineages. In adulthood however, the lineage of a cell is 
believed to be restricted within a specific tissue. Stem cells or progenitors give rise to 
transit amplifying cells that undergo a few rounds of proliferation, resulting in a number 
of tissue-specific, terminally differentiated cells. This belief has been challenged 
recently by the demonstration that the transit-amplifying population of the corneal 
epithelium is capable of producing epidermal keratins, glandular epidermis and hair 
follicles (Ferraris et al., 2000). Induced by exposure to embryonic dermal tissue, the 
basal epithelial cells lose their corneal phenotype before taking on other characteristics, 
suggesting there is a deprogramming step that occurs before reprogramming of the 
cells. Not only does this demonstrate the previously unrecognised plasticity of a 
somatic cell population, but provides fm1her evidence of the inductive capabilities of 
embryonic dermal tissue. 
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4.1.5. Follicular dermal cell lineage 
The inductive capacity retained by adult follicular de1mal cells is one of a number 
of intriguing properties they possess. Whilst the lineage of the epithelial cells under 
their influence is relatively well understood, little attention has been paid to the 
development and differentiation of dermal papilla and dermal sheath cells. The detmis 
is derived from the mesodetm and experiments have shown that different regions of 
dermis derive from different mesodermal structures. The dorsal dermis, for example 
arises, from somites whilst the dermis of the head is a derivative of neural crest cells 
(Couly & Le Douarin, 1988; Oliver-Martinez et al., 2000). However, prior to somite 
fmmation, the unsegmented mesoderm has the ability to determine appendage 
patteming, indicating that cells are already fated to appendage lineages (Manger & 
Sengel, 1970). 
Patteming signals determine the site of formation of the dermal condensation, a 
crucial step in early follicle morphogenesis. The aggregative properties displayed by 
dermal papilla cells in vitro, and when implanted ectopically in vivo, have led to 
suggestions that cells of the dermal condensation retain their embryonic status through 
into adulthood (Jahoda & Oliver, 1984a). Further evidence to support this idea comes 
from the fact that a specialised ECM distinguishes these cells from other skin 
fibroblasts in development and adulthood, both in vivo and in vitro (chapter 2; 
Couchman & Gibson, 1985; Couchman, 1986; Messenger et al., 1991; Couchman, 
1993; Couchman & du Cros, 1995). Indeed, many of the properties of dermal papilla 
and dermal sheath cells that have been demonstrated experimentally, can be explained 
by the cells being in a relatively undifferentiated state. Follicular dermal cells have the 
capacity to regenerate the end bulb of an amputated follicle (Oliver, 1966b; Jahoda et 
al., 1992a). They are also capable of inducing follicle formation when combined with 
an epithelium in vivo (Jahoda et al., 1993; Reynolds & Jahoda, 1992; Reynolds et al., 
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1995). The type of follicle formed is determined by the dermal implant, a fact 
demonstrated by implanting vibrissa} dermal tissue beneath ear epidermis for example, 
resulting in a thick vibrissa-type fibre being produced (Jahoda et al., 1993). At the neck 
of the follicle, the outer root sheath is continuous with the interfollicular epidermis, 
whilst the follicular dermal sheath is continuous with the dermal papillary layer of the 
skin (Jahoda & Reynolds, 2001). This has led to the proposal that dermal sheath cells 
play a role in wound healing, with follicular cells contributing to the interfollicular 
dermis, as outer root sheath cells contribute to interfollicular epidermis (Taylor et al., 
2000; Jahoda & Reynolds, 2001). In a dermal sheath transplant it has been shown that 
the dermal papilla of the induced follicle was derived from the originally transplanted 
cells, showing that the cells are capable of changing phenotype (Reynolds et al., 1999). 
All these findings demonstrate that the follicular dermal cells possess stem cell-like 
qualities, and are able to instruct other "stem cells" to differentiate along a certain 
lineage. 
4.1.6. Aims 
The inductive and regenerative properties of the hair follicle dermal cells imply 
that they instruct cells in their immediate environment to undergo changes. ES cells are 
defined by their flexible, pluripotent nature and therefore provide an excellent tool to 
investigate inductive processes. I cocultured follicular dermal cells with ES cells, based 
on the hypothesis that the stem cells would be directed along an epithelial lineage. Early 
experiments demonstrated this was not the case so further investigation focussed on the 
nature ofthe reciprocal interactions between the cell populations, the level of 
differentiation that had occurred in the ES cell population, and the influence that the ES 
cells had on the dermal cells. 
180 
4.2. MATERIALS & METHODS 
To investigate the interactions betweeen hair follicle dermal cells and embryonic 
stem cells, the two cell types were grown in culture together. Pilot experiments 
(desctibed in Appendix II) were performed to determine culture conditions and to refine 
methodology. Figure 4.3 shows the progression from the pilot experiments to the more 
detailed analysis of cell interactions, characteristics and gene expression. 
4.2.1. Cell culture 
4.2.1.1. Vibrissa follicle dermal cells 
Dermal cells were obtained from the vibrissa follicles of adult PVG rats or Zin40 
mice, aged between 2 and 6 months, by the dissection method previously described 
(2.2.1 ). After exposure of the follicles and removal of surrounding connective tissue the 
follicle end bulbs were cut off with curved scissors and placed in MEM (Gibco) 
containing 50f!g/ml gentamicin. (At this stage the follicles were sometimes kept at 4°C 
overnight before continuing with the next step.) Each individual follicle bulb was then 
placed in a drop of MEM on the lid of a petri dish and microdissected using 
watchmakers forceps under a Zeiss Sterni SV11 microscope. The bulb was inverted to 
expose the dermal papilla (DP) and dermal sheath (DS) which remained attached to the 
collagen capsule. The DP and DS were cleaned of epithelial cells as much as possible 
before separating them from the capsule. The DP was then separated from the DS and 
the components collected in two 35mm culture dishes containing 2m1 MEM with 20% 
foetal bovine serum (FBS). The dermal tissue was then tom with forceps and pressed to 
the bottom of the dish to aid attachment and encourage cell growth. The cultures were 
incubated at 37°C in 95%0z/5%COz and left undisturbed for at least eight days. They 
were subsequently maintained in MEM with 20% FBS. 
181 
Figure 4.3. Flow diagram outlining the progression of experiments and the methods 
involved at each stage of the investigation. 
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4.2.1.1.1. Passaging dermal cells 
Explant cultures of dermal cells were passaged to 25cm2 flasks once cells were 
growing well, usually between 2 and 4 weeks after the initial explant was plated out. 
Flasks of cells were passaged when confluency was reached and prior to aggregation in 
the case of DP cells. 
Dermal cells were washed twice with warmed PBS/EDT A before addition of 
trypsin (0.25% in PBS/EDTA). The cells were incubated in trypsin for 2-3 minutes, 
until cells had begun to detach. The flask was tapped gently to detach the cells and 1 m! 
MEM + FBS was added to inactivate the trypsin. The cell suspension was transferred to 
a sterile tube, the cells spun down at 1800rpm for 3 minutes, the supematant discarded 
and the cell pellet resuspended in lml MEM + FBS. The cell suspension was then 
transferred to flasks or dishes and volume made up with MEM + FBS. 
4.2.1.2. Skin fibroblasts 
Ear skin or footpad skin was used as the source of "skin" dermal fibroblasts. Ear 
skin was first shaved with a scalpel blade to remove as much hair as possible. The skin 
was scored with a scalpel to the depth of the connective tissue beneath and the layer of 
skin carefully removed with as little connective tissue associated with it as possible. 
Two to three pieces of skin were collected by this method and placed in MEM. In a dry 
35mm culture dish the skin was then minced with fine scissors to give pieces no bigger 
than 1mm2. These were spread over the surface of the dish and left to adhere for 1 
minute before adding 2ml MEM with 20% FBS. The culture was then left to grow at 
3 7°C in 95%02/5%C02. Skin fibroblasts were passaged as described in 4.2.1.1.1. 
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4.2.1.3. RDP-B cells 
A spontaneously transformed cell line of rat dermal papilla cells, RDP-B 
(Reynolds et al., 1991), was maintained in MEM with 10% FBS. These cells were 
passaged as described in 4.2.1.1.1. 
4.2.1.4. Embryonic stem cells 
The established murine embryonic stem cell line, CGR8 (Mountford et al., 1994) 
was used for all investigations. Cells were grown on 0.1% gelatin-coated tissue culture 
plastic and maintained in CGR8 medium (Glasgow MEM containing non-essential 
amino acids, 0.25% NaHC03, 2mM L-glutamine, 1mM pyruvate, 100jJM 2-
mercaptoethanol and 10% FBS; Gibco BRL) supplemented with LIF as described by 
Smith (1991 ). At all times, unless specifically stated, the culture medium contained 
5,000U/ml Penicillin and 5,000~-tg/ml Streptomycin (Gibco). CGR8 medium 
supplemented with LIF will be referred to as complete CGR8 medium. ES cells were 
passaged by washing with PBS, incubating with trypsin-versene-PBS (TVP) at 37°C for 
5 minutes and stopping the reaction with CGR8 medium. The cell suspension was then 
transferred to a sterile tube, centrifuged at 1 OOOrpm for 5 minutes and the cell pellet 
resuspended in CGR8 medium. The cell suspension was then transferred to gelatin-
coated flasks for routine maintenance, or the cells were counted using a 
haemocytometer for setting up eo-cultures. 
For some studies green fluorescent protein (GFP) labelled ES cells were used to 
distinguish those ofES cell migin from dermal cells. To obtain labelled cells, CGR8 
cells were transfected with a CMV-GFP vector (gift from John Mason, Edinburgh) by 
electroporation. Stable colonies were selected using 2~-tg/ml puromycin and expanded. 
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These cells are referred to throughout the text as CMV -GFP ES cells. This cell line was 
developed and provided by Majlinda Lako (Durham University). 
4.2.1.5. E§/dermal cell eo-cultures 
Pilot studies demonstrated no difference in cell behaviour between two methods 
of setting up eo-culture. To achieve a degree of consistency in dermal cell confluency 
and ES cell numbers the following method was used in all subsequent eo-culture 
experiments. 
4.2.1.5.1. Simple eo-culture 
Dermal cells of passage number 2 to 7 (see Table 4.1 for numbers) were grown in 
35mm dishes to form a monolayer of 60-80% confluency. ES cells grown in culture 
flasks, as described above, were trypsinised using TVP, spun down, resuspended in 
CGR8 medium to give a single cell suspension and 3.1 x 105 cells added per dish in a 
minimal volume. The total volume of media was made up to 2ml per dish with CGR8 
medium (no exogenous LIF). 
4.2.1.5.2. Exposure of dermal cells to eo-culture media through porous 
membrane 
Co-cultures were grown on porous membrane inserts (0.45).lm pore size, Falcon) 
over 6-well plates containing dermal cells for up to 6 days. Z40 DS and DP, and PVG 
DP cells (all passage number 3) were used for these experiments, once for each cell 
type and each was done in duplicate with two positive controls cultured alone in CGR8 
medium. The PVG DP cultures were exposed to eo-culture medium for 5 days before 
comparing the a-smooth muscle actin expression in the cells grown in the well beneath 
by immunocytochemistry (see 4.2.2.2. for method). One of the control cultures was 
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used as a negative control (no primary antibody) for the a-smooth muscle actin 
immunostaining. 
Table 4.1. Number of sets of ES cell eo-cultures with each dermal cell type. 
Co-cultures were set up with dermal papilla cells (DP), dermal sheath cells (DS), and 
ear or footpad (FP) skin fibroblasts (SF) that had been passaged between 2 and 7 times. 
For each set of eo-cultures the number of replicate dishes ranged from 2 to 9. The RDP-
B cells are a transformed cell line so passage number is not applicable but was > 10 at 
the time of use. 
PVG Zin40 
Passage DP DS SF RDP-B DP DS SF 
number Ear FP Ear FP 
2 1 I I NIA 2 2 2 
3 I 4 NIA I 2 
4 4 3 NIA 3 3 
5 2 2 NIA I 
6 I NIA 
7 I NIA 
Total 8 IO 3 4 6 7 3 
4.2.2. Initial Analysis 
4.2.2.1. Electron Microscopy 
Cells were fixed in 50:50 Kamovsky's fixative:sodium cacodylate buffer for 1 
hour at 4°C (Kamovsky, I965). The fixative was then removed and 0.5% osmium 
tetroxide in sodium cacodylate buffer was added and the cells were left at 4°C for 50 
minutes. Dehydration was then cani.ed out through a series of alcohols starting with 
70%, then 95% and finally 100%. Three 5 minute washes of each (I 0 minutes in 100%) 
were done before progressing onto the next alcohol. 
During the dehydration period the embedding medium (IOml araldite CY2I2, 
10ml DDSA, Iml dibutyl pthalate and 0.4ml BDMA) was prepared with araldite, 
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dodecenylsuccinic aldehyde (DDSA) and n-Benzyldimethylamine (BDMA) pre-
warmed to 40°C. The reagents were all mixed thoroughly to ensure even 
polymerization. 
The final 100% ethanol wash was aspirated, replaced with a 1: 1 mix of 100% 
ethanol and araldite mix and the dishes left open in a fume hood for 30 minutes to allow 
the ethanol to evaporate. The ethanol/araldite was then removed and approximately 
0.5ml embedding medium added to fom1 a very thin layer covering the cells which was 
incubated at room temperature for 1-2 hours. This was then replaced with fresh 
embedding medium and incubated at 60°C for 24 hours. At the end of this incubation 
the embedded cells were left in the dish for re-embedding at a later date. 
The layer of embedded cells was removed from the plastic dish and cut into small 
strips (2mm wide) using a scalpel. These were washed in 70% ethanol and dried at 
3 7°C. Each individual strip was then immersed in a labelled mould containing fresh 
embedding medium, before being incubated at 60°C for 24 hours. 
Semi-thin (lflm) sections were cut on a C. Reichert (Austria) Om U3 
ultramicrotome, mounted on slides and allowed to dry before staining with toluidine 
blue. Ultra-thin sections (60-90nm) were cut on an ultramicrotome (as for semi-thins) 
and mounted on a copper grid. The sections on the grid were then coated as follows in 
preparation for analysis by transmission electron microscopy (TEM). The grid was 
placed face down in 1% uranyl acetate in 70% ethanol for 10 minutes then washed 
thoroughly by dipping twice in dH20. The grid was then placed face down in Reynolds 
lead citrate (Reynolds, 1963) for 10 minutes before washing thoroughly as before. 
Analysis of the semi-thin sections was carried out on a Zeiss Axiovert 135 
microscope, whilst the ultra-thin sections were viewed by TEM (Philips EM 400T/ST 
Analytical TEM/STEM system). 
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4.2.2.2. Immunocytochemistry 
Cultured cells, on plastic or glass coverslips, were washed twice with PBS. They 
were then fixed in either methanol (2 min., -20°C) or, for CMV- GFP ES cell eo-
cultures, 4% paraf01maldehyde (20 min., room temperature). After two washes with 
PBS, primary antibody (Table 4.2) diluted in PBS sterilised by passage through a 0.2um 
filter, was applied to the cells and incubated at room temperature for 1 hour. Unbound 
antibody was removed with four 5 minute PBS washes before adding the secondary 
antibody (Table 4.2) diluted in filter-sterilised PBS. The slides were incubated at room 
temperature for 45 minutes in the dark then the unbound antibody was removed by PBS 
washes as before. The stained cells were mounted under glass coverslips in mowiol, a 
glycerol-based mountant containing an anti-fade reagent (recipe in Appendix I). Initial 
observations were done on a Zeiss Axiovert 135 microscope. Subsequent analysis was 
carried out on a confocallaser-scanning microscope (MicroRadiance scanning system, 
BioRad). All images were processed using Adobe Photoshop 3.0 software. 
Table 4.2. Source and dilution factors of antibodies for immunocytochemistry 
Antibody Dilution Source 
anti-a-smooth muscle actin (monoclonal) 1:10 Prof. G. Gabbiani, University of 
Geneva 
anti-albumin (polyclonal) 1:100 DAKO 
anti-alpha-1-fetoprotein (polyclonal) I :50 DAKO 
NF200 (polyclonal) 1:100 Si gm a 
AlexaFluor 546 anti-mouse I :lOO Molecular Probes 
AlexaFluor 546 anti-rabbit 1:100 Molecular Probes 
FITC anti-mouse 1:80 DAKO 
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4.2.3. Differentiation assays 
4.2.3.1. ESC plucking 
This process is summarised by Figure 4.4. From each eo-culture, at each 
timepoint, three lots ofES cells were plucked and plated out. Two of the three samples 
were then used for the differentiation assays (the third sample was in reserve and 
discarded once the differentiation assays were established). 
To isolate ES cells from eo-cultures the medium was removed and the cells 
washed twice with warmed PBS. 30J.!l TVP (see Appendix I) was taken up in a yellow 
pipette tip and repeatedly expelled and aspirated over a small area of the eo-culture until 
small gaps could be seen in the cell layer. The contents of the pipette tip were then 
expelled into a 0.1% gelatin-coated 35mm tissue culture dish and the cells grown up in 
complete CGR8 medium until cell numbers had reached approximately 3.5x106. At this 
stage the cells were trypsinised and started on the differentiation assays. 
The methods for these differentiation assays are detailed below and summarised 
in Figure 4.5. 
4.2.3.2. Blood Assay 
2x106 cells were suspended in 10ml complete CGR8 medium, transferred to a 
25cm2 culture flask (uncoated) and incubated for 2 days at 37°C. On day 2 the 
embryoid bodies (EB) (Martin & Evans, 1975) were collected by repeatedly pipetting 
medium over the layer of cells and this was then aspirated and centrifuged for 3 minutes 
at lOOOrpm. The supematant was discarded and the collected EBs were resuspended in 
10ml fresh CGR8 medium (no exogenous LIF). They were then transferred to a 
bacteriological Petti dish for 2 days incubation. On day 4 the EBs were collected, spun 
down and resuspended in fresh CGR8 medium before incubation in a bacteriological 
Petri dish for a further two days. On day 6 the CFU-A assay was set up. 
189 
....... 
\0 
0 
Figure 4.4. Method for isolating ES cells, from cocultures, for subsequent differentiation assays. 
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Figure 4.5. Schematic representation ofprotocols for differentiation assays. 
Cells were counted and resuspended in CGR8 medium (+LIF for blood assay) in the vessel indicated on day 0. Changes in culture conditions are 
indicated. Medium was changed every 2 days between the steps shown, except day 10 of the neuron assay when cytosine arabinoside (AraC) was 
added to the medium present. PD- Petri dish, TC- gelatin-coated tissue culture, AFP- alpha-feta-l-protein, RA- all-trans retinoic acid, NF-
neurofilament, LJF- leukemia inhibitory factor. 
Day 0 1 2 3 4 5 6 7 8 
I I I I I I I 
Endoderm I I 
~ 35mm TC dish D 
Blood I 
2 x10
6 ~-~IF I Cfu-A 
flask+LIF PO assay 
I Neurons~ 
0.5x1 0 
PO 
~ 60mm 
TC dish ~ 
Adipocytes I I 
~~ ~~ 
I 
~ 35mm TC dish +T3 
+insulin 
9 10 11 12 13 14 
I 
I , 
I+Ara~C~ 
I 
NF200 
stain 
1516 17 18 19 20 21 22 23 24 
I I 
I 
albumin 
+ AFP stain 
~ t 
I 
Oil 
red 0 
stain 
, 
4.2.3.2.1. CFU-A assay 
The assay is based on the method described by Pragnell et al. (1994). The assay 
was carried out in 35mm Petri dishes and consisted of a sandwich of Noble agar, the 
bottom layer at 0.6% with added cytokines, and the top layer, containing EBs, at 0.3%. 
Agar was melted at 60°C then cooled to 37°C. The mix for the bottom layer of the 
dishes consisted of 1.2% Noble agar in CFU-A media (see Appendix I) with L929 
conditioned media and AF19 conditioned media (these provide CSF-1 and GM-CSF 
respectively) (Pragnell et al., 1994). 1ml of this mix was added to each ofthree dishes 
and allowed to set before making the mix for the top layer which consisted of 
approximately 150 Ebs in 0.3% Noble agar in CFU-A media. lml of this top layer mix 
was added to each dish to get an even distlibution of EBs between dishes. The plates 
were left to set before being incubated in 10% C02 at 3 7°C. Dishes were left for 11 
days and the results analysed by inspecting the dishes using low power microscopy. 
4.2.3.3. Neuron Assay 
This method is modified from Bain et al. (1995). 0.5x 106 cells were transferred to 
a bacteriological Petri dish and the volume made up to 10ml CGR8 medium. They were 
then incubated for 2 days at 37°C. On day 2 the EBs were collected by centrifugation 
(3min. 800rpm) and resuspended in 1 Oml fresh CGR8 medium. The EBs were 
incubated as before for a further 2 days. On day 4 the medium was changed as before 
and all trans-retinoic acid (Sigma) was added to a final concentration of 10"7M (10-5M 
stock made up in 100% ethanol and stored at -20°C). This was repeated on day 6. By 
day 8, the EBs were at the stage designated by Bain et al (1995) as 
4-/4+. Approximately 50 EBs were transferred to gelatin-coated 60mm dishes (three 
plates were set up for each assay). These were then incubated with 5ml CGR8 medium -
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2ME (2-mercaptoethanol prohibits differentiation so is left out of the medium from this 
stage) for 2 days. After this the majority of the EBs had attached and cells, including 
some neuron-like cells, were growing out of them. Cytosine arabinoside (Ara-C) was 
added to a final concentration of 18J..!M on day 10 and the dishes were incubated for a 
fmiher 2 days to optimize neuron-like cell numbers. 
Immunocytochemistry was carried out on day 12 on differentiated cells from a 6d 
PVG DP/ES cell eo-culture (n = 1). The method was as described in 4.2.2.2., using 
NF200, a primary antibody specific to neurofilament. 
4.2.3.4. Adipocyte Assay 
This method was carried out according to Dani et al. (1997). 0.5x106 cells were 
transferred to a bacteriological Petri dish and the volume made up to 10ml with CGR8 
medium. They were then incubated for 2 days at 3 7°C. On day 2 the EBs were collected 
by centrifugation (3min. 800rpm) and resuspended in 1 Oml fresh CGR8 medium with 
10"7M all-trans retinoic acid (Sigma). This was repeated on days 3 and 4 giving the EBs 
three days exposure to retinoic acid. This was withdrawn on day 5 and the cells were 
resuspended in CGR8 medium. On day 7 the EBs were collected as described 
previously and approximately 40 EBs were plated out on each of three gelatin-coated 
35mm dishes and incubated in 2ml CGR8 medium with 2nM triiodothyronine (T3) 
(Sigma) and 85nM insulin (Sigma). The cells were maintained in this medium which 
was changed every two days until day 24 when they were stained with Oil red 0 to 
detect lipid (Green & Kehinde, 1974). 
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4.2.3.4.1. Oil red 0 staining 
Cells were washed twice in PBS then fixed in calcium formol ( 4% formaldehyde, 
1% CaCh) for I hour. They were then incubated in 60% isopropanol for I5 minutes 
before being stained in filtered Oil red 0 stain (3 pm1s saturated solution of oil red 0 in 
99% isopropanol, 2 parts distilled water) for 15 minutes. This was washed off with a 
brief (15 seconds) rinse of 60% isopropanol followed by washes with distilled water. 
The cells were then counterstained with haematoxylin (3 minutes), washed well in tap 
water and given a final rinse in distilled water before being mounted in aquamount 
(BDH). 
4.2.3.5. Endoderm Assay 
0.5x106 cells were transferred to a bacteriological Petri dish and the volume made 
up to IOml CGR8 medium. They were then incubated for 2 days at 37°C. On day 2 the 
EBs were collected by centrifugation (3min., 800rpm) and resuspended in I Oml fresh 
CGR8 medium. The EBs were incubated as before and on day 4 the medium was 
changed as on day 2 before incubation at 37°C for a further 2 days. On day 6 the EBs 
were plated out on 35mm 0.1% gelatin-coated dishes and maintained in CGR8 medium. 
On day I8 the cells were stained with antibodies against albumin and alpha-I-
fetoprotein (DAKO) according to the method in 4.2.2.2. 
4.2.4. Conditioned Medium 
In the routine maintenance of cultures, medium was removed from dermal cell 
cultures and dermal/ES cell eo-cultures after 48 hours, centrifuged (30 min. at 
3,300rpm) to remove cell debris, and the supematant stored at -20°C for future use. 
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4.2.5. Microscopy 
Live and oil red 0 stained cultures were viewed by phase contrast microscopy on 
a Zeiss Axiovert 135 microscope. Images were taken with a Contax 167MT camera on 
35mm film, or a Spot RT digital camera and RT software (Diagnostic Instruments Inc.). 
Fluorescent immunostaining was analysed by confocallaser scanning microscopy 
(Microradiance scanning system, LaserSharp 2000, BioRad). 
4.2.6. Molecular Analysis 
4.2.6.1. RNA extraction from cultured cells 
The RNA was extracted from cultured cells by the following method using 
Stratagene's microRNA kit according to the manufacturers protocol. RNA was 
extracted from either an entire dish of cells or a plucked "colony" of cells from the eo-
cultures. The cells were first washed twice with PBS/EDT A then colonies were plucked 
in 20j.!l trypsin (0.25%) and transferred to an eppendorf containing 0.5mllysis buffer. 
For whole dishes 0.5mllysis buffer was added to the dish to lyse the cells and the lysed 
cell solution transferred to a clean microcentrifuge tube. (In some instances 1 mllysis 
buffer was added to dishes with large numbers of cells and the lysed cells split between 
two microcentrifuge tubes.) 50j.!l2M sodium acetate (pH4.0) was added to each tube 
followed by 0.5ml phenol (equilibrated to pH5.3-5.7 with succinic acid) and 200j.!l 
chlorof01m:isoamyl alcohol. The lid was then closed and the tube vortexed vigorously 
until a unif01m white suspension was seen, followed by centrifugation for 5 minutes at 
14,000rpm. The aqueous phase was then transferred to a clean microcentrifuge tube 
containing 0.5ml isopropanol(+ 5j.!g glycogen carrier for RNA extracted from single 
colonies). The tube contents were mixed by inversion and incubated at -20°C for 
several hours (ideally overnight). 
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After the required time the RNA was pelleted by centrifugation at 14,000rpm for 
30 minutes at 4°C. The supematant was removed and the pellet washed with 75% 
ethanol/25% DEPC-treated H20 before being left to air dry. The RNA pellet was 
resuspended in DEPC-treated H20, then aliquoted and stored at -80°C. 
RNA was extracted from 6d eo-cultures, Zin40 dermal cell cultures, ES cells 
maintained by frequent passaging and addition ofLIF, and ES cells that were cultured 
in the presence (+LIF) or absence ofLIF (-LIF) for 6 days (no passaging). 
4.2.6.2. RNA extraction from mouse vibrissa follicles 
Initially RNA was extracted from vibrissa follicles that had not been sorted 
according to their cycle stage. Subsequently extractions were done from mid-anagen 
vibrissa follicles. The follicles were dissected out and placed in MEM. Once all the 
follicles were collected they were trisected with a scalpel into end-bulb, mid-follicle 
and upper follicle (Figure 4.6) and the pieces put into the appropriate glass 
homogenizers which were on ice and contained 330J.1llysis buffer. The tissue was then 
homogenized over ice for 5 minutes, the homogenate transfened to a microcentrifuge 
tube and the RNA extraction carried out as described in 4.2.6.1. 
4.2.6.3. DNase treatment of RNA 
Ambion's DNase-free kit was used to remove any contaminating genomic DNA 
from the extracted RNA by the following method. 5Jll 10xDNase I buffer and 3U 
DNase I were added to 50Jll RNA in a microcentrifuge tube and incubated at 37°C for 
25 minutes. 5Jll DNase inactivation reagent was then added, mixed with the tube 
contents by flicking and incubated at room temperature for 2 minutes. This was then 
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pelleted by centrifugation (1 minute, 14,000rpm) and the supematant containing the 
DNA-free RNA transferred to a clean microcentrifuge tube. 
4.2.6.4. c])NA Synthesis 
1J..!g random hexamers (Promega) was added to RNA in DEPC-treated dH20 to a 
final volume of 15J..!l and incubated at 70°C for 5 minutes. The samples were then 
chilled on ice and the tubes briefly centrifuged. 5J..!l 5x RT buffer+ 5J..!l2.5mM dNTPs 
were then added followed by 200U M-MLV reverse transcriptrase (RNase H Minus, 
Point mutant) enzyme (Promega). For each RNA sample negative controls (no RT 
enzyme) were also performed. The reactions were then incubated at 3 7°C for 1 hour 
before being heated to 74°C for 15 minutes and finally chilled on ice. 
4.2.6.5. Polymerase Chain Reaction (PCR) 
Each PCR consisted of a sample of cON A in PCR buffer with 0.2mM dNTPs, 1-
2mM MgCh (see Table 4.3), 0.5J..!M of each primer and 1 U Taq polymerase in a final 
volume of 15J..!l. cDNA negative controls were tested with GAPDH primers to ensure 
the RNA was free of contamination. All PCR reagents were from Gibco except the 
primers which were from Cruachem Ltd (Genosys for CNTFRa and STAT3 primers). 
The samples were treated as follows: 
Step 1: 94°C (2 min) 
Step 2: 30 cycles of94°C (20s), annealing temp. (Table 4.3) (30s), 72°C (40s) 
Step 3: 72°C (10 min) 
After the reaction the samples were cooled on ice then aliquots were 
electrophoresed on a 1.2- 1.5% TAE/agarose gel depending on the size of the 
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expected PCR product. Images of agarose gels were recorded on B ioRad' s Gel-
Doe System and the images processed using Adobe Photoshop 3.0. 
Figure 4.6. Diagram indicating levels at which vibrissa follicles were cut to 
separate end bulb, mid-follicle and upper follicle sections for RNA extraction. The 
upper cut was made level with the ringwulst whilst the low~r cut was made above 
the end bulb below the point of entry of the deep vibrissal nerve. 
Upper 
follicle 
Mid-follicle 
End bulb 
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Table 4.3. Primers and PCR conditions 
All primers were designed against published murine sequences except GAPDHl and 
GAPDH2 which were designed against rat sequence but can be applied to mouse cDNA 
for RT-PCR. 
Primer pair Oligo (5'-3') [MgCI 2] annealing Product 
mM temp. (0 C) size 
LIF for A TT GTG CCC TT A CTG CTG CT 1.5 61 583bp 
LIF rev GCC TGG ACC ACC ACA CTT AT 
CT-1 for GAG GAA TAC GTG CAG CAA CA 2.0 57 389bp 
CT-1 rev AGC ACC TTG GCT GAG AAG AT 
CNTF for CTT TCG CAG AGC AA T CAC CT 1.5 61 579bp 
CNTF rev CCC CAT AAT GGC TCT CAT GT 
CNTFRa for CTG TTT CCA CCG TGA CTC CT 2.0 59 802bp 
CNTFRarev TGG GAC ACT GGT CAA GAA GA 
OSM for CAC GGC TTC TAA GAA CAC TGC 2.0 59 547bp 
OSM rev CGA TGG TAT CCC CAG AGA AA 
GAPDH1 GCC AAA AGG GTC ATC ATC TC 1.5 61 379bp 
GAPDH2 ACG GAT ACA TTG GGG GTA GG 
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4.3. RESULTS 
4.3.1. Observations from cell cultures 
4.3.1.1. Dermal cell culture 
PVG rat detmal papilla (DP) and dermal sheath (DS) cell cultures displayed 
typical morphology and behaviour in initial explant cultures and subsequent passages. 
In particular, characteristic aggregations were seen in post-confluent DP cultures 
(Jahoda & Oliver, 1984a). It was also observed that DP cells had a slower rate of 
growth than DS cells. 
Zin40 mouse DP and DS cells cultured in the same conditions had a noticeably 
faster rate of growth than the corresponding PVG cells although the growth rate of DP 
was still slower than that ofDS. The mouse cells were also more compact in culture 
than their PVG rat counterparts and the DP cell aggregation behaviour was less 
prominent. An example of each cultured cell type is shown in Figure 4.7. 
4.3.1.2. Embryonic stem cell culture 
ES cells, cultured on gelatin-coated tissue culture plastic, grew in colonies and 
displayed typical morphology as small, compact cells with distinct nucleoli and a high 
nuclear:cytoplasmic volume ratio (Fig 4.7 E). LIF withdrawal resulted in these cells 
beginning to change characteristics and show evidence of differentiation in a very short 
period of time. As shown in Figure 4.7 F, within 6 days ofLIF withdrawal considerable 
changes occurred as nucleoli became less pronounced, some cell death occurred, many 
cells were in suspension and multiple morphologies were evident in a single culture. 
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!Fngmre ~.7. Typical morphology of cell types. 
Detmal papilla (A & C) and dermal sheath (B & D) cells have fibroblast-like 
morphology with Zin40 cells (C & D) appearing more compact than the comparable 
PVG cells (A & B). ES cells maintained with LIF are small and compact with distinct 
nucleoli (E) compared to ES cells after 6 days without exogenous LIF when they show 
more varied morphology and nucleoli are less obvious (F). 
Scale bar: A - D = 1 OOJ.!m, E & F = 50jlm. 
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4.3.L3. Co-cultures 
The pilot experiments carried out to establish suitable culture conditions in which 
to conduct these experiments are described in Appendix 11. From these preliminary 
studies several key observations were made: A) dermal cells were capable of supporting 
ES cell growth in othetwise unsuitable culture medium; B) medium conditioned by 
dermal cells was not sufficient to maintain viable ES cells; C) a characteristic 
morphology developed in ES/dermal cell eo-cultures whether they were plated out as a 
mixed cell population, orES cells added to an established dermal cell monolayer. All 
subsequent eo-cultures were prepared by establishing a dermal cell monolayer prior to 
addition of ES cells in the fmm of a single-cell suspension, and experiments were 
carried out in CGR8 (ES cell) medium. 
4.3.1.3.1. Morphology of eo-cultures 
When ES cells were eo-cultured with follicle dermal cells the differences in 
morphology were such that the two cell types were easily identifiable, with ES cells 
settling in discrete colonies on top of the dermal cell monolayer (Fig. 4.8 A-D). This 
was a very quick process as when ES cells were added to dermal cells and washed off 
instantly with medium, a good number of cells remained attached to the dermal cell 
layer. Distinguishing the two cell types was also straightforward when the cells were 
plated as a mix, rather than adding ES cells to an established monolayer of dermal cells. 
The ES cells remained small and compact within the colonies, whilst the dermal cells 
retained their fibroblast-like morphology. 
The development of ES cell colonies was observed in eo-cultures with DP and 
DS cells originating from both PVG rats and Z40 mice. To establish if this effect on ES 
cells was a feature common to all dermal cells, eo-cultures were set up with PVG 
dermal skin fibroblasts from two body sites, footpad and ear. With both of these, whilst 
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IFD.gmre .:a.s. Dennal cell!ES cell coculture morphology after ld (A, C, E, G), 8d (B, D, F) 
and 4d (H). 
ES cells fom1 visible colonies (arrows) after ld on PVG DP (A) and DS (C) cells. 
Colonies are maintained for at least 8d (B, D). On SF and RDP-B cells patches ofES 
cells (arrows) are evident after ld (E, G). On SF the ES cell patches grow in colonies 
but these are not as compact or as distinct from the fibroblast layer as on follicular 
dermal cells (F compared to B & D). On RDP-B cells, the ES cells (arrows) blend into 
the rapidly proliferating fibroblast layer so after 4d ES cells can only be identified by 
high power microscopy (H). 
Scale bar = 1 OO~m 
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ES cells again grew in clusters these did not remain as separate from the dermal cell 
layer. In DP and DS eo-cultures the developing ES colonies stood proud of the dermal 
cells. The ES cell colonies in skin fibroblast cultures tended to be flatter and less 
distinct in appearance (Fig. 4.8 E,F). The difference was most evident in the first round 
of eo-cultures. Subsequently, a considerable amount of variation was seen in ES cell 
behaviour in skin fibroblast eo-cultures, with some colonies having almost identical 
morphology to that seen in follicular cell eo-cultures. A transformed rat dermal papilla 
cell line, RDP-B, was also used for eo-cultures and in these the ES cells, although 
distinguishable by their small compact morphology, tended to grow within the dermal 
cell layer (Fig. 4.8 G,H). This behaviour was consistent from one eo-culture to the next 
(n = 4) and RDP-B cells were therefore used as a control rather than the inherently 
variable skin fibroblasts. 
4.3.1.3.2. EM of eo-cultures 
Transmission electron microscopy (TEM) was used as an initial means of 
establishing if the colonised cells were maintaining their undifferentiated ES cell 
characteristics. Conventional microscopy of semi-thin sections stained with 
toluidine blue gave an overall perspective of the composition ofthe rounded 
colonies in eo-culture (Fig. 4.9 A). Each colony was composed of tightly packed 
round cells, whilst thin, elongated fibroblast-like cells grew in a single cell layer 
over the colony. TEM through the colonies showed that the rounded cells within 
them had a very large nuclear:cytoplasmic volume ratio and few organelles were 
present in the cytoplasm (Fig. 4.9 B). The cells were also fairly tightly packed with 
minimal extracellular matrix. In contrast, the thin, flattened cells growing over the 
colony had many organelles in the cytoplasm and the cell nucleus was not always 
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FftgUllre 4.9. Dermal cell/ES cell coculture processed for electron microscopy. 
Toluidine blue staining of a semi-thin section shows a typical colony of closely packed, 
small, rounded cells with a layer of thin, elongated cells growing over the top in a single 
layer (A). Transmission electron microscopy reveals the difference in the cell types with 
a complex cytoplasm in the thin, fibroblastic cells, whilst the simple cytoplasm and high 
nuclear:cytoplasmic ratio of the colonised cells suggests they are maintaining stem cell 
characteristics (B). In places the contact between fibroblast-like cell (f) and the 
colonised round cell (c) was very close making it difficult to discern a clear border 
between the two (arrows - C, D). 
Scale bars: A= 25!-lm, B = l11m, C & D = 0.5~tm. 
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evident, indicating a much smaller nuclear:cytoplasmic ratio in these cells (Fig. 4.9 B). 
In some sections the contact between the colonised, round cells and fibroblast-like cells 
was very close, with the border between the two cells being difficult to determine in 
places (Fig. 4.9 C, D). These observations supported an initial idea, not obvious from 
conventional phase microscopy, that the colonies consisted of ES cells whilst the 
detmal cells grew around them. 
4.3.1.3.3. Green Fluorescent Protein (GFP) as a tool to identify cells of ES 
cell origin 
The microscopical evidence suggested dermal cells were growing around colonies 
of ES cells, but the possibility that the cells on the outside of the colony were 
differentiated ES cells could not be ruled out. To investigate this possiblity and to 
distinguish betweeen ES and dermal cells in subsequent experiments, a CMV-GFP 
stably transfected line of ES cells was used, enabling cells of ES cell origin to be 
identified using fluorescence microscopy. This showed that the small compact 
colonised cells were indeed ofES cell origin whilst the larger bipolar cells were GFP-
negative and therefore dermal cells (Figure 4.1 0). 
4.3.1.3.4. Changes in eo-culture morphology over time 
For the first 2-3 days of eo-culture there was no significant change in dermal cell 
morphology but subsequently these cells became more compact and bipolar (Fig. 4.8 B, 
D). As eo-cultures matured the colonies ofES cells became larger, growing as mounds 
above the base layer of dermal cells. The dermal cells between colonies became more 
polarised whilst those at the edge of colonies started to grow over them. In all colonies, 
cells that maintained ES cell morphology were distinguishable. At the edge of colonies, 
particularly in more mature eo-cultures, fluorescence microscopy revealed that a 
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minority ofES cells showed signs of differentiation (Figure 4. 10). In one particular 
culture, a large dividing cell was visible by phase contrast microscopy between two 
colonies ofES cells. Fluorescence microscopy revealed that this individual cell was 
expressing GFP, showing that a subpopulation of ES cells was moving out of the 
colonies, dividing and changing morphology (Fig. 4.10 A, B). Cells that originated 
from the ES cell population spread from the edge of the colonies at the base of the 
cultures. They displayed various morphologies ranging from very large, flattened cells, 
that appeared to be forming a layer on the dish under the rest of the cells, to small 
compact cells that appeared to be budding off the edge of colonies (Fig. 4.10 C, D). 
However, the vast majority of ES cells retained their undifferentiated morphology 
within the colonies. 
Another feature of eo-cultures after a few days was the large number of rounded 
up cells seen floating in the media. It was confirmed in one culture that these were 
indeed viable cells by spinning down the supematant and plating out the pellet in a 
flask. Dermal and ES cell morphology was evident in this culture and eo-culture 
morphology developed in some areas (Fig, 4.10 E,F). These cells went on to produce 
more floating cells growing in clumps. The ES cells in this culture were of the CMV-
GFP line and as a result it was possible to estimate that approximately 30% of the 
fibroblast-type cells in this culture were derived from the ES cell line. 
In a small number of eo-cultures of two weeks or more, the massed cell layers 
began to peel away from the dish and in some cases came away altogether. When this 
occurred a few cells were observed still attached to the dish and these were maintained. 
Proliferation of these cells produced a mostly dermal cell population but a few ES cells 
were also present resulting in ES cell colony formation, in a manner typical of eo-
cultures. 
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lFigame 4.li0. Identification of cells of CMV -GFP ES cell origin by fluorescence 
m1croscopy. 
A 2d Z40 DS/ES cell coculture contains a large dividing cell (A) which by fluorescence 
microscopy is identified as being of ES cell origin (B) demonstrating that whilst the 
majority ofGFP positive cells are within colonies there are a minority which undergo 
differentiation. An 8d PVG DP/ES cell coculture has many distinct colonies but some 
cells appear to be differentiating (C) and again the GFP enables identification of these 
rounded up cells, as well as the colonised cells, as ES cells (D). Cells spun out of the 
media removed from an 8d PVG DS/ES cell coculture grew in a characteristic coculture 
morphology (E & F) 24hr and 6d after plating respectively. 
Scale bar: A & B = SO~tm, C - F = 1 OOJ.lm. 
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4.3.2. ][nfluence of follicle dermal cells on ES cells 
To establish whether colonised ES cells had retained their plmipotency during a 
period of eo-culture, it was necessary to isolate them from the dermal cells before 
assessing this characteristic. Ideally the whole eo-culture would have been 
enzymatically dissociated and the cells separated to isolate as many ES cells as 
possible. Unfmtunately we did not have access to a F ACS machine that maintained the 
cells in a viable state after counting. In the absence of this, I therefore used a method by 
which a few colonies of ES cells were removed and these cells were then expanded in 
the presence ofLIF (non-differentiating conditions). The cells were then exposed to 
conditions designed to induce differentiation along a number of lineages. 
4.3.2.1. Plucked cells 
Cells were plucked from eo-cultures at successive time points, the earliest being 6 
days, and the latest being 20 days, after ES cells were added to dermal cells. When ES 
cells were plucked from small areas of the eo-cultures, some dermal cells were also 
usually removed resulting in a mixed culture. In cases where the dermal cells were 
closely associated with the plucked colonies the resulting culture developed as a eo-
culture once more and the dermal cells multiplied at a faster rate than the ES cells (Fig. 
4.11 A,B). To prevent the ES cells being swamped by dermal cells the colonies were re-
plucked. Plucking a colony clean from surrounding cells was much easier to achieve the 
second time around as these isolated colonies were clearly visible to the naked eye, so 
facilitating their easy removal with a micropipette tip. 
During the time in which the plucked cells were proliferating to provide sufficient 
numbers for the pluripotency assays, a number of cells underwent significant changes, 
resulting in a range of cell morphologies within these cultures (Fig. 4.11 C,D). 
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JFngure 4.H. Plucked cells. 
Plucked colonies were often accompanied by dem1al cells which grew rapidly forming 
new 'cocultures' (A,B). Cells underwent differentiation to a degree whilst the majority 
remained in colonies (C, D) or grew in adherent patches (E). 
Cells plucked from 6d PVG DS/ES (A,B), 20d Z40 DP/ES (C,D), 6d Z40 DS/ES (E). 
Scale bar: A-D= 100~-tm, E = SO~tm. 
214 
215 
Despite this, the vast majority of cells ofES cell origin (determined by GFP) 
maintained the typical ES cell morphology whether in colonies or in patches of cells 
adhering to the culture substratum (Fig. 4.11 E). 
When sufficient cells were available the cells were trypsinised and used to initiate 
the various differentiation assays. In the cultures where a few dermal cells remained, 
they were lost at this stage during the formation of embryoid bodies (EBs), the initial 
step for all assays, as cells of ES cell origin formed these aggregates whilst dermal cells 
adhered to the substratum. 
4.3.2.2. Initial pluripotency assays 
In the first set of assays, neuron-like cells were derived from all groups of ES 
cells on which the assay was performed (after 6, 10 and 14d eo-culture with PVG DP; 
after 8d eo-culture with Z40 OS; after 6, 10, 14 & 20d eo-culture with Z40 DP). In all 
instances, except for 20d Z40 DP, experiments were performed in duplicate. A positive 
control was run for each differentiation assay using ES cells maintained with LIF. 
CFU-A assays for haematopoietic activity were also carried out but were less 
successful. A very low percentage ofEBs produced colonies (an indication of 
haematopoietic differentiation), but this was also the case with positive controls using 
ES cells maintained with LIF. The low result was therefore attributed to a failure of the 
assay rather than the potential of the cells. In support of the early indications that these 
cells were pluripotent, cardiomyocytes, clearly distinguishable by spontaneous rhythmic 
contractions, were observed in cultures of differentiating ES cells derived from all types 
of eo-culture. 
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4.3.2.3. lEndodermal, mesodermal and ectodermal pluripotency assays 
To further test whether pluripotency ofES cells was maintained in eo-culture, 
another round of eo-cultures was set up and the cells plucked at 6 and 10 days. This 
round of assays was more extensive. Differentiation was directed along cell lineages 
representative of the three primordial tissues, the time points were more consistent, 
replicates were done for each culture at each time point, and there was less of a problem 
with contamination. All these improvements allowed a comprehensive set of data to be 
obtained. Four differentiation assays were carried out from each sample of plucked 
cells: neuron, adipocyte, endoderm and blood. Observations of cardiomyocytes were 
also noted. 
Figure 4.12 shows cells derived from a 6 day Z40 DS eo-culture at key time 
points in the three successful differentiation assays. This is a representation of the 
process and ES cells plucked from PVG DP and DS, and Z40 DP eo-cultures underwent 
similar changes giving the same positive results. Once again the positive control for the 
CFU-A assay was unsuccessful, so the failure of the plucked cells to demonstrate 
evidence of haematopoietic differentiation is likely to be as a result of technical 
problems and does not reflect a limitation in pluripotency. 
4.3.2.3.1. Neuron assay 
Networks of neuron-like cells were visible by day 12 of the neuron assay (Fig. 
4.13 A). Axon-like projections extended in networks from EBs, in association with 
other cell types of more varied morphology which adhered to the culture substrate (Fig. 
4.13 B,C). The number ofEBs that had neuron-like cells associated with them were 
counted on day 12 as by day 14 a large proportion ofEBs had floated away and there 
was considerable cell death. 
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lFigmre <t.12. An example of the key steps in the differentiation assays. 
Cells originating from a 6d Z40 DS/ES cell coculture formed embryoid bodies (EBs) (A, 
A') which were treated in the manner specific to each differentiation assay (B-D, B '-D') 
before being plated out on gelatin-coated tissue culture dishes. Cells grew out from the 
EBs and differentiated along a number of lineages (E, F) and the success of the assays 
were determined by either morphology (in the neuron assay- G) or by the relevant 
staining method (for adipocytes and endoderm- H, 1). Images A'-D' are fluorescence 
micrographs which confirm the EBs seen by phase microscopy (A-D) originate from ES 
cells within the coculture. Similarly the green fluorescence in I is GFP whilst the red 
fluorescence is albumin showing the ES cells have differentiated into endodermal cells. 
Scale bars: A- F = 20011m, G- H = 100!-lm, I= 50~tm. 
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Figmre 4.13. Neuronal assay results. 
Networks of neurons extend from EBs derived from ES cells after 6d coculture with 
PVG OS cells (A - C). CMV -GFP ES cells after 6d coculture with PVG DP cells 
produce neuron-like cells, the projections of which are visible by fluorescence 
microscopy (D). Immunostaining with NF200 demonstrates expression ofneurofilament 
protein in this culture (E) and the colocalization with the GFP expression identifies the 
ES cell origin of these neuron-like cells (F). 
Scale bar: A = 200J.lm, B - F = 50J.lm. 
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Cells originating from eo-cultures with PVG and Z40, DP and DS cells gave 
positive results in this assay, with a minimum of 65% of EBs producing networks of 
neuron-like cells. The greatest numbers of neuronal outgrowths was observed in cells 
originating from 6d Z40 DS eo-cultures where 90% ofEBs had neuron-like cells 
associated with them (Table 4.4). 
To characterise the cells further, immunocytochemistry was carried out, using an 
antibody specific to neurofilament, on a sample of differentiated cells (assay day 12) 
originating from a 6d PVG DP/ES cell eo-culture. The GFP was expressed in axon-like 
processes (Fig. 4.13 D) which were then revealed to be immunoreactive for 
neurofilament (Fig. 4.13 E). When the two images were merged it was confirmed that 
the neurofilament was present in GFP-positive cell projections (Fig. 4.13 F). 
4.3.2.3.2. Adipocyte assay 
ES cells plucked from PVG and Z40, DP and DS eo-cultures gave consistently 
positive results in this assay. This was in stark contrast to undifferentiated CGR8 cells 
that had tiny lipid droplets scattered around with no evidence of lipid-filled cells at all 
(Fig. 4.14 A,B). Throughout experimental cultures, oil red 0 staining showed small 
lipid droplets and large lipid-filled cells in patches ranging from a collection of just a 
few cells to up to 50 cells closely packed together (Fig. 4.14 C-H). One EB in particular 
was observed to be producing copious amounts oflipid (Fig. 4.14 F). Approximately 
30% of each culture exhibited high levels of lipid deposition. 
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lFigmre 41.141. Adipocyte assay results detennined by oil red 0 staining. 
ES cells maintained with LIF have very little lipid present (A, B). ES cells plucked from 
lOd Z40 DS/ES cell coculture (C, D), 6d Z40 DP/ES cell coculture (E, F) and 6d PVG 
DS/ES cell coculture (G, H) all produced high levels of lipid (stained red) having been 
subjected to the adipocyte differentiation assay demonstrating their ability to 
differentiate along the adipocyte lineage. 
Scale bar: A, C, E, G = 200J.lm, B, D, F, H = 50J.lm. 
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4.3.2.3.3. Endoderm assay 
At the time when these assays were done there was no published method for 
inducing ES cell differentiation along an endodermal cell lineage and, as a result of 
spontaneous differentiation, less than 1% of cells were expected to express endodermal 
markers (personal communication Elizabeth Jones, Newcastle, U.K.). Cells originating 
from all eo-cultures gave positive results in this assay. Small clusters of cells were 
immunoreactive for albumin and less for alpha-feta-l-protein (AFP) (Figure 4.15). As 
expected these comprised no more than 1% of the total cell population. The CMV -GFP 
ES cells confirmed that the cells expressing these proteins were ofES cell origin. As 
well as cellular expression of these proteins a significant amount of extracellular matrix 
staining was evident, particularly with the albumin antibody (Fig. 4.15 E,F). 
The method adopted for this assay was based on allowing the EBs to differentiate 
without any exogenous factors and although many studies have identified stages at 
which the AFP and albumin genes are expressed in developing EBs, there is less data 
available on the detection of these proteins (Abe et al., 1996; ltskovitz-Eldor et al., 
2000; Xu & Lim, 2000). Therefore for some of the samples tested, EBs that were in 
excess of the requirements for the CFU-A assays were maintained in CGR8 medium for 
a further 6 days before plating out (day 12 of the assay). The resulting cultures of cells 
were stained for AFP and albumin 6 days later. Although a detailed analysis was not 
carried out to compare these two methods, the results showed no apparent difference 
between the cultures with AFP and albumin expression detected in both. 
In some cases the spontaneous differentiation of EBs resulted in intriguing 
developments, as yolk sac-like structures formed. Within a number of these there were 
morphologically distinct cell types and complex structures formed in the shape of 
strands of tissue spanning the cavity, or two separate chambers developing. Others were 
simple bubble-like structures with no distinguishing features. 
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lFigllllre 4.15. Results of endodermal differentiation assay. 
Endodermal cells are present in cells plucked from 6d cocultures ofGFP CMV-ES cells 
with Z40 DP (A), Z40 DS (B, D) and PVG DP (C, E, F). Green fluorescence identifies 
the cells as ofES cell origin whilst red fluorescence shows immunoreactivity for AFP 
(A, B) and albumin (C - F). 
During the differentiation process some EBs developed highly complex structures with 
rhythmically contracting cavities (G) and 3D structures within multilayered cell cultures 
(H). 
Scale bar: A, B, D = 25!-tm; C, E- F = 50!-im; G = 2001-1m; H = 1001-1m. 
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One however was pm1icularly noticeable as contractile muscle tissue was evidently 
present in three or four places in the wall of the "bubble" and also in a strand across the 
cavity (Fig. 4.15 G). This resulted in the whole structure contracting in a manner that 
was visible under a low power, dissecting microscope. Similar three dimensional bodies 
were evident in some of the developing adherent cultures (Fig. 4.15 H). 
Even when such structures were absent, the potential of these cells to differentiate 
along many lineages was shown by the many different morphologies present in the 
outgrowth from EBs. Figure 4.16 shows examples of differentiated cells which 
originated from ES cells plucked off a 6d Z40 DP/ES eo-culture. 
4.3.2.3.4. Cardiornyocytes 
During the period of outgrowth of differentiating cells from EBs many cultures 
contained groups of cells that were observed to spontaneously and rhythmically 
contract, a characteristic of cardiomyocytes. These groups were estimated to range from 
less than ten (Fig. 4.16 F) to over two hundred cells and were often organised as 
interconnected patches contracting as a synchronised network. Contractile 
cardiomyocytes were evident in cells derived from all eo-cultures after both 6 and 10 
days, with the exception of 10d PVG DP eo-cultures (see below). 
In summary, ES cells plucked from Zin40 and PVG, DP and DS eo-cultures gave 
1ise to cells of mesodermal, endodermal and neuroectodermal lineage (Table 4.4). The 
cells plucked from 10d PVG DP/ES eo-culture became contaminated during the 
outgrowth period but within these cultures neuron-like cells and cells ofpreadipocyte 
morphology were observed suggesting these cells would also have resulted in multiple 
lineages. 
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JFngun~ 4l.ll6. Multiple cell types in one endoderm differentiation assay. 
Cells derived from 6d PVG DP/ESC cocultures had differentiated into many 
morphologies by day 18 ofthe endoderm assay (A- E). On day 10 contracting muscle 
cells (arrow) were seen (F). 
Sclae bar: A- E = lOO~tm, F = 50~m. 
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Table 4.4. Summary of neuroectodermal, mesodermal and endodermal assay 
results. 
Neuronal assay results are expressed as percentage ofEBs that were associated with 
axons. Adipocytes were abundant in all completed assays and some cells with 
preadipocyte morphology were seen in cultures from 1 Od PVG DP eo-cultures. AFP 
and albumin expression was detected in a small proportion of the total cell population. 
The number of cardiomyocytes observed was varied but they were evident in all 
completed assays. 
Dermal cell Z40DS Z40DP PVGDS PVGDP 
type 
6d 10d 6d 10d 6d 10d 6d 10d 
Neurons 73% 65% 88% 75% 82% 82% 73% + 
90% 65% 84% 80% 87% 70% 72% 
Adipocytes ++ ++ ++ ++ ++ ++ ++ + 
AFP + + + + + + + NIA 
Endoderm 
+ + + + + + + NIA 
Albumin 
Cardiomyocytes + ++ + ++ + + ++ -
4.3.2.4. The influence of conditioned medium on ES cells 
Having established that the pluripotency ofES cells was maintained by follicular 
dermal cells in culture, some basic conditioned medium experiments were carried out to 
assess the contribution to this process by soluble factors. ES cells were grown in RDP-
B conditioned MEM + FBS (conditioned over 24hrs and diluted 1: 1 with CGR8 
medium) for 6 days. Over this period these cells underwent considerable differentiation, 
although there was less cell death than occurred in a flask of ES cells in CGR8 medium 
with no added LIF (data not shown). The degree of differentiation suggested there was 
no soluble factor present, with LIF-like properties. 
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To determine if follicular dermal cells shown to maintain ES cells in eo-culture, 
had the same capacity via factors secreted into the media, ES cells were cultured for 10 
days in conditioned medium (CM) diluted 1: 1 with CGR8 medium. The morphology of 
these cells was then compared to that of ES cells cultured for the same period in CGR8 
medium with or without LIF (Figure 4.17). The cultures from which the CM was taken 
were as follows: 6d Z40 DP/ES cell eo-culture, 8d Z40 DSIES cell eo-culture, DP and 
OS (for the first four days Z40 conditioned MEM/FBS, then switched to PVG 
conditioned CGR8 medium). 
As found previously there was a marked contrast between the cells maintained in 
complete CGR8 medium and those cultured in CGR8 medium with no added LIF. The 
vast majority of cells maintained with LIF grew in dense colonies and just a few cells 
exhibited morphological changes at the edge of these colonies (Fig. 4.17 A). In contrast, 
many cells underwent morphological changes in the culture without LIF (Fig. 4.17 B). 
In all CM cultures, a larger proportion of the ES cells maintained a typical ES cell 
morphology than in the CGR8 medium (no LIF) culture, suggesting that there is a 
certain amount of soluble factor secreted by the dermal cells (both in the presence and 
absence of ES cells) that prevents differentiation of ES cells. The medium conditioned 
by eo-cultures appeared to be more effective than CM from pure dermal cultures, and 
DP/ES eo-culture CM (Fig. 4.17 C) more so than DS/ES CM (Fig. 4.17 D). Similarly 
the DP CM cultures contained more ES-like cells (Fig. 4.17 E) than the DS CM cultures 
(Fig. 4.17 F). My observations were independently validated by another individual who 
was unaware of the previous work. 
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!Fngu11re 4!.17. ES cells cultured in conditioned media (CM). 
Cultures were maintained in the relevant media for 10 days: complete CGR8 medium 
(A); CGR8 medium (no LIF) (B); DP/ES CM (C); DS/ES CM (D); DP CM (E); DS CM 
(F). 
Coculture CM (DP/ES more so than DS/ES) appeared to maintain ES cells in a state 
closest to that seen in complete CGR8 medium, whilst DS cells were the least effective, 
although these cultures still retained more cells of ES morphology than CGR8 medium 
(no LIF). 
Scale bar= lOOj.tm. 
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4.3.2.5. Cytokine expression in cultured cells 
Having established that soluble factors within the culture medium had the 
capacity to inhibit ES cell differentiation, RT-PCR was used to detect transcripts of four 
cytokines (LIF, CNTF, OSM and CT-1) known to maintain ES cells in vitro. 
Results are shown in Figure 4.18 A. LIF, CNTF and OSM results are n = 2, CT -1 
results are n = 1. The small sample numbers must be taken into account when 
interpreting this data. Dermal cells (DP, DS and RDP-B) all expressed LIF and CNTF. 
OSM expression was clearly detected in RDP-B cells but DP and DS cells had barely 
detectable levels of expression. Of the faint bands the full transcript was most evident in 
DP and the shorter transcript more highly expressed in DS. CT-1 was detected in DP 
and DS cultures but not in RDP-B cells. ES cells maintained in complete CGR8 media 
with frequent passaging ("ES+LIF") expressed LIF, OSM and CNTF but not CT -1. ES 
cells cultured for 6 days in complete CGR8 media without passaging became confluent 
and a degree of differentiation occurred despite the presence of exogenous LIF ("ES + 
LIF diff' d"). Transcripts of all four cytokines were detected in these cells as was the 
case with ES cells cultured in CGR8 media with no exogenous LIF over a period of 6 
days ("ES diff'd"), although OSM expression appeared to be weaker in these cultures. 
When ES cells were eo-cultured with dermal cells the transcripts of all four cytokines 
were detected in the eo-cultures. 
In summary, the DP, DS and RDP-B cells express the four cytokines we 
investigated at varying levels, as did undifferentiated ES cells. Co-cultures expressed all 
four cytokines as did differentiating ES cells, both in the presence and absence of 
exogenous LIF. These results raised the question of whether these cytokines were 
expressed by follicular cells in vivo and if so, where within the follicle? 
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lFftgmre 41.13. RT-PCR results. 
Cytokine transcripts for LIF, CT -1 OSM and CNTF were detected in A) cultured cells 
and B) segments ofmid-anagen vibrissa follicles. 
A) cDNA was synthesised from RNA extracted from dermal cell cultures (DP, DS, 
RDP-B), undifferentiated ES cells (ES+LIF), 6d cocultures (DP/ES, DS/ES, RDP-B/ES), 
and differentiating ES cells after 6 days in the presence or absence of exogenous LIF 
(ES+LIF difrd, ES-LIF diff'd). LIF and CNTF were detected in all cell cultures, whilst 
CT-1 was not detected in undifferentiated (ES+LIF) cells or RDP-B cells, and OSM was 
barely detectable in DP or DS cells. 
B) Mid-anagen Zin40 vibrissa follicles were trisected and RNA extracted from the end-
bulbs (EB), mid-follicle sections (MF) and upper follicle sections (UF). LIF, CT-1 and 
CNTF transcripts were detected in all sections of the follicle whilst OSM was 
undetected. The a component of the CNTF receptor (CNTFRa) was also expressed 
throughout the follicle. 
236 
A 
I 
"C 
rE Cl) 
"C 
"C w 
-Cl) Cl) I.L I.L fE m m w w :J :J I I 
- -
+ + "C D.. D.. C1) D.. Cl) D.. Cl) tn tn tn c c > c c c c L&.l L&.l L&.l £t: £t: + 
·- ~· ---- . - . 
~-- .,- -
~1!!0 •..• 
.. _ - - - -- .. - - - -
-
B 
EB MF UF +ve -ve 
- ' - .. GAP OH 
LIF 
- --
CT-1 
I 
I -
OSM 
CNTF 
- - -·- -
CNTFRa 
237 
LIF 
CT-1 
OSM 
CNTF 
4.3.2.6. Cytokine expression in vibrissa follicles 
Vibrissa follicles were dissected from three Zin40 mice (n=1) and follicles 
identified as being in mid-anagen ofthe growth cycle were used as a source of RNA. 
The results (n = 2) are shown in Figure 4.18 B and demonstrate that of the four 
cytokines under investigation, CNTF, LIF and CT-1 were expressed in upper follicle, 
mid-follicle and end bulb sections ofmid-anagen follicles, whilst OSM was not 
expressed at comparable levels in any part of the follicle. Very weak OSM expression 
was however, evident in the end bulb, such expression being consistent with the weak 
expression of this cytokine in DP and DS cells in vitro. The receptor component 
CNTFRa was also expressed in all three sections of the mid-anagen vibrissa follicle. 
The in vivo data shows transcripts ofthree ofthese cytokines, LIF, CNTF and CT-1, are 
present in multiple regions of the mid-anagen vibrissa follicle. 
4.3.3. Influence of ES cells on dermal cells 
4.3.3.1. a-smooth muscle actin expression 
The expression of a-smooth muscle actin (a-sma) by DP and DS cells in vitro is a 
characteristic which distinguishes them from the non-follicular dermal (skin) fibroblasts 
(Jahoda et al., 1991). eo-cultures were immunostained with a monoclonal antibody for 
a-sma and two key observations were made (Figure 4.19). First, within the eo-cultures 
only a minority of cells were positively labelled. Those that were stained were usually 
in groups and exhibited a distinctly different staining pattern to the typical stress fibre 
appearance seen in cultures of pure DP or DS cells (Fig. 4.19 A, B). The a-sma was 
located around the edge of these cells and only faintly expressed in the central pat1 of 
the cell, suggesting cell junctions had developed between adjacent cells in a manner not 
notmally associated with follicular dermal cells in vitro. 
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lFiglllnre 4\.19. a-smooth muscle actin expression in cocultures. 
a-smooth muscle actin is expressed in a typical stress fibre pattern by DP cells in vitro 
(A). In DP/ES cell cocultures significant changes to the DP cells occur. DP cells closely 
associated with ES cells change cytoskeletal structure as shown by the a-smooth muscle 
actin expression pattern (B). DP cells between the ES cell colonies change morphology 
becoming bipolar (C) and these cells also lose their a-smooth muscle actin expression, 
as shown in D which is the identical frame of C but viewed by fluorescence microscopy. 
GFP-CMV ES cell cocultures combined with red immunofluorescence demonstrate that 
a-smooth muscle actin expression is only associated with DP cells in close contact with 
ES cells (E - F). These are two different planes of focus of the same area of culture. 
Scale bar: A, B = 1 OO)lm, C - F = 50)lm. 
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The cells expressing a-sma in this manner appeared to be flat, squamous cells, 
collectively forming a pavement-type layer of cells which was generally associated with 
a colony of ES cells. The dem1al origin of these cells was confirmed in CMV -GFP ES 
cell eo-cultures as a-sma staining was not colocalised with GFP expression and was 
therefore not exhibited byES cells. Confocal microscopy revealed this a-sma-positive 
layer of dermal cells wrapped around ES cell colonies (Fig. 4.19 E,F). 
The second observation was the distinct lack of a-sma expression in many of the 
dermal cells. As mentioned previously dermal cells which were not associated with ES 
cell colonies changed morphology developing a characteristic bipolar appearance (Fig. 
4.19 C). These cells had significantly reduced a-sma expression, in some cases losing it 
altogether (Fig. 4.19 D). The location of these cells between the ES cell colonies 
generally meant they were in the lower part of the eo-culture but in longer-term eo-
cultures which had developed multiple layers of detmal cells, the bipolar morphology 
was evident in lower and upper layers of dermal cells, as was the lack of a-sma 
expression. These effects were seen consistently in ES cell eo-cultures with PVG (n = 
3) and Zin40 (n = 1) DP and DS cells. 
To eliminate the possibility that the changes described were caused by culturing 
dennal cells in different media, a-sma expression was compared in dermal cells grown 
in CGR8 medium and cells grown in MEM + FBS. There was no significant difference 
in the level of a-sma expression (Fig. 4.20 A,B). The same was true when cells were 
cultured in complete CGR8 media. 
4.3.3.2. The influence of conditioned media on dermal cells 
The above results suggested that ES cells were influencing dermal cells in two 
different ways. The change in morphology and downregulation of a-sma expression in 
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the dermal cells between the ES cell colonies, was either due to soluble factors or 
extracellular matrix produced within the eo-culture. However, the redistribution of a-
sma within the cells associated with ES cell colonies suggested a direct influence from 
ES cells. To investigate the influence of soluble factors an initial experiment was 
carried out using conditioned medium taken from a IOd Z40 DP/ES cell eo-culture. 
After 4 days exposure to this medium, Z40 DP and DS cells showed no significant 
change in the level or pattern of a-sma expression (data not shown). (It should be noted 
that this medium had been stored at -20°C for 6 months so factors may have degraded 
in this time.) The most direct way to test the hypothesis that soluble factors resulted in a 
reduced a-sma expression was to expose dermal cells to the medium in which a eo-
culture was growing without allowing any contact. This was achieved by culturing 
dermal cells in the base of a culture well in which a eo-culture was growing on a 
suspended porous membrane. 
DP and DS cells of low passage number (P3) were plated out in wells which then 
had membrane inserts added and dermal cells were plated on the membrane. ES cells 
were subsequently added to form a eo-culture on the membrane. By this method dermal 
cells on the base of the well (Fig. 4.20 C) were cultured in the same medium as the eo-
culture (Fig. 4.20 D), so were exposed to exactly the same soluble factors as if grown in 
eo-culture but with no chance of direct contact with the ES cells. This was done with 
Z40 DS and DP cells, and PVG DP cells and in all cases over the 5 - 6 days exposure to 
eo-culture medium, the dermal cells at the base changed from the normal morphology 
(Fig. 4.20 C) to the bipolar, spindly phenotype seen previously in eo-cultures (n = I for 
each dermal cell type, two membranes for each) (Figure 4.20 F). When Z40 DP cells at 
the base of the well were fixed and stained for a-smooth muscle actin the expression 
level appeared weaker than controls (Fig. 4.20 G,H compared to E). 
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Figure 41.20. Influence of soluble factors on a-smooth muscle actin expression. 
PVG OS cells cultured in MEM+FBS (A) or CGR8 media (B) for 8 days exhibit the 
same a-smooth muscle actin (a-sma) expression. 
Zin40 DP cells cultured in wells separated from cocultures by a porous membrane 
demonstrated that soluble factors influence a-sma expression. A control culture ofDP 
cells (C) stained positively for a-sma (E). The same cells cultured beneath a coculture 
(D) for 4d had changed morphology with many cells adopting a bipolar appearance (F) 
and these cells had considerably reduced a-sma expression (G) whilst a few maintained 
their fibroblast-like appearance and these tended to have slightly higher a-sma 
expression but this was still weaker than controls (H). 
Scale bar: A, B = 50f1m, C, D, F = lOOf.Lm, E, G, H = 25flm. 
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4.4. DISCUSSION 
4.4.1. Summary 
The work presented in this chapter shows that reciprocal interactions occur 
between de1mal cells of the rodent vibrissa follicle and embryonic stem (ES) cells in 
vitro. Pilot experiments indicated dermal cells could support ES cell growth in media in 
which they would not normally survive. This early indication that dermal cells 
influenced ES cells, was confirmed by the finding that ES cells, maintained in eo-
culture with dermal cells, retained their pluripotency over a considerable length of time. 
Cytokines that are known to maintain ES cell pluripotency were found to be expressed 
at the mRNA level by follicle dermal cells in vitro and also in mid-anagen vibrissa 
follicles in vivo. 
The influence of the ES cells on the dermal cells was observed using 
immunostaining for a-smooth muscle actin, combined with the use of GFP expressing 
ES cells. This demonstrated two major changes in the dermal cell characteristics. 
Dermal cells closely associated with ES cells were found to express the cytoskeletal 
protein, but the pattem of expression had changed considerably from the usual stress 
fibre pattem. In contrast, demml cells in the lower part of the culture, in between ES 
cell colonies, had significantly reduced levels of a-smooth muscle actin expression and 
were frequently undetectable by fluorescence microscopy. 
The interactions described are summmised in Figure 4.21 including both short 
and long range effects. Together these results indicate a complex relationship in 
dermal/ES cell eo-cultures. The results have implications for dermal cell influences on 
other cell types within the hair follicle, and stem cell research in general with regards to 
how ES cells can influence more differentiated cells. 
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Figure 4.21. Interactions between follicular dermal cells and ES cells in eo-cultures. 
(A) Close contact interactions. 
(B) Interactions mediated by soluble factors. 
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4.4.2 The influence of derman cells on ES cells 
4.4.2.1. eo-culture morphology 
The morphology of the follicular dermal ceii/ES cell eo-cultures indicated ES 
cells were multiplying in such a way as to minimise contact with the dermal cells and 
so maintain their own characteristics. The colonies formed resembled those seen in 
cultures ofES cells maintained by LIF or by a feeder layer (Smith et al., 1988; Smith et 
al., 1992). TEM gave the first evidence that colonies comprised ES cells and this was 
confirmed when eo-cultures were set up with ES cells expressing GFP. Some 
differentiation of CMV -GFP ES cells was evident for a small percentage of cells within 
the eo-cultures but this is a normal feature of ES cell culture (Smith et al., 1992). 
Electron microscopy of sections through eo-cultures revealed a distinct similarity 
with another eo-culture system that has used follicular dermal cells, that of dermal 
papilla and germinative epithelial (GE) cells. In such eo-cultures, GE cells form 
organotypic structures surrounded by dermal papilla cells (Reynolds & Jahoda, 1991; 
Reynolds et al., 1993). A distinct basement membrane is laid down, separating the two 
cell populations, which is not evident in dermal/ES cell eo-cultures but the general 
arrangement is very similar. 
In some eo-cultures with skin fibroblasts the ES cells appeared less distinct than 
in the follicular dennal cell eo-cultures, resulting in a different overall morphology. 
Other skin fibroblast/ES cell eo-cultures displayed a morphology quite similar to 
follicular dermal cell eo-cultures. The identity of cells within skin fibroblast cultures is 
variable particularly with respect to numbers of cells expressing a-smooth muscle actin 
(Reynolds et al., 1993). An explanation for this is that cultures of dermal fibroblasts 
from rodent skin explants will almost inevitably include a contaminating population of 
follicular or glandular fibroblasts. Due to this the RDP-B cell line was used as a more 
consistent option for comparison to primary dermal cell cultures. This transformed cell 
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line does not express a-smooth muscle actin, does not display aggregative behaviour 
and has lost the inductive properties of primary dermal papilla cells. It therefore 
represents a dermal fibroblast population with none of the characteristics specific to 
follicular dermal cells. 
4.4.2.2. Isolation and proliferation of cells 
For the results of the pluripotency assays to be valid the cells committed to these 
assays needed to be as pure a population as possible. Cells plucked from eo-cultures 
were therefore cultured in non-differentiating conditions for a period before starting the 
differentiation assays. This served two purposes: first, there were insufficient numbers 
of cells to start the differentiation assays and therefore a period of proliferation was 
required; and second, it is advisable to passage ES cells at least once if they have been 
maintained on feeder cells (that is essentially what the dermal cells are acting as in the 
eo-cultures). This is to avoid any incorporation of the dermal cells into the embryoid 
bodies (EBs) (Hole & Smith, 1994 ), a possibility that I monitored by the use of CMV-
GFP ES cells. Whilst GFP-positive EBs are not guaranteed to be purely ES cell-derived 
structures, the odd contaminating dermal cell being undetectable, at later stages in the 
differentiation assays the expression of GFP by cells of multiple morphologies, 
including the target cell populations, demonstrated these cells were derived from ES 
cells. 
During the proliferation period, GFP was an invaluable tool for tracing the origin 
of cells. In some cases the morphology was straightforward and GFP expression simply 
confirmed what was already evident. However, for cells of a fibroblast morphology, 
fluorescence microscopy enabled differentiating CMV -GFP ES cells to be distinguished 
from contaminating dermal cells. The expression of GFP was observed in cells that had 
differentiated along a variety of lineages, as would be expected from the findings of 
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Hadjantonakis et al. (1998), who used the same vector to establish GFP-expressing ES 
cells and subsequently produced chimaeric mice which exhibited GFP expression in all 
cell lineages. GFP expression was therefore regarded as a means of identifying cells of 
ES cell origin, in all stages of differentiation. 
Differentiation inevitably did occur to some extent in virtually all the cultures and 
more so in some than others, but there was no pattern as to the resulting cell lineage. In 
ES cell cultures there is always a background level of differentiation that is not 
inhibited by increasing the concentration of LIF (Smith et al., 1992). All indications 
during this proliferation stage were that the cells isolated from eo-cultures were 
behaving in a manner typical of pluripotent ES cells. 
4.4.2.3. Pluripotency assays 
The fact that ES cells are pluripotent has been clearly demonstrated by their 
contribution to every cell lineage in chimaeric mice (Bradley et al., 1984, Saburi et al., 
1997). Spontaneous differentiation upon LIF withdrawal in vitro results in 
differentiated EBs which frequently contain cardiac muscle, neuronal, chondrocytic and 
haematopoietic cells (Martin, 1981; Zhuang et al., 1992; reviews - Bradley, 1990; 
Rathjen & Rathjen, 2001). However, methods have only been established for inducing 
differentiation along a limited number of cell lineages including neuronal cells, 
adipocytes and chondrocytes (Dani et al., 1997; Bain et al., 1995; Kramer et al., 2000). 
Recently, growth factors have been identified which induce endodermal cells to 
differentiate further than occurs in spontaneous differentiation, resulting in mature 
hepatocytes (Hamazaki et al., 2001). All these differentiation procedures result in a 
mixed cell population with a relatively high percentage of the target cell lineage. 
However, it would be advantageous to achieve pure cell populations if these cells are to 
be used for investigations beyond the initial differentiation process. An endothelial cell 
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differentiation method has been described by Balconi et al. (2000) that utilises the 
Polyoma middle T virus in a selective immortalisation procedure, resulting in a pure 
endothelial cell population. Further methods to achieve pure differentiated cell 
populations will no doubt develop as the field of stem cell research is explored and 
more investigators make use of ES cells as a research tool. 
The differentiation assays used in this study were chosen to produce a cell lineage 
derived from each of the three different layers of the trilaminar germ disc. Neurons are 
derived from the ectoderm (more specifically neuroectoderm), adipocytes are of 
mesodermal origin, whilst alpha-feta-l-protein (AFP) and albumin are markers of 
endodennal cells. The fact that ES cells plucked from eo-cultures were capable of 
differentiating into all of these lineages is a strong indication that they retained the key 
characteristic of the embryonic stem cell, pluripotency. 
The neuronal assay was based on the method described by Bain et al. (1995) to 
produce cells of a neuronal phenotype. In their article the authors referred to these cells 
as neuron-like cells, despite having detected tubulin and neurofilament proteins, 
expression of neuron-specific genes, and electrophysiological properties, including the 
capacity to generate action potentials and expression of a variety of ion channels. The 
authors declare caution on the basis that specialized functions such as the formation of 
synapses has not yet been demonstrated by these cells. On this basis the results of our 
work have also produced neuron-like cells, but as more and more evidence ofES cells 
resulting in differentiated, well-characterized cells comes forward, so the confidence 
that these cells are fully functional neurons increases. ES cell derived glial cells have 
certainly proved their functional capacity in vivo by myelinating host axons after 
transplantation into myelin-deficient or chemically demyelinated rat spinal cord 
(Brustle et al., 1999; Liu et al., 2000). There is a strong possibility that the adherent, 
fibroblastic cells seen associated with the neuron-like cells in this assay were glial cells, 
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as neuronal cell culture is rarely successful in the absence of glia. It would be 
interesting to establish the nature of these cells by immunostaining with a panel of glial 
cell markers. 
Dani et al. ( 1997) describe the use of retinoic acid and adipogenic hormones, 
insulin and triiodothyronine (T3) to induce differentiation resulting in large numbers of 
adipocytes. Retinoic acid (RA) is also crucial to neuronal differentiation, but at a later 
stage (4-8d) than in the adipocyte assay (2-5d), an example ofhow temporal expression 
patterns are as important as spatial expression patterns in developmental biology. 
Indeed, Dani et al. (1997) found treatment with RA before 2d to be cytotoxic whilst 
later treatment did not result in adipogenesis, revealing a strict window of time 
permissive for commitment to the adipocyte lineage. In a protocol which employed 
BMP-2 in induction of chondrocyte differentiation, also a mesenchymal lineage, the 2-
5d period was also critical (Kramer et al., 2000). Kramer et al. (2000) conclude that 
their results, when combined with similar findings involving different mesenchymal 
lineages (Dani et al., 1997; Johansson & Wiles, 1995; Rohwedel et al., 1998), indicate 
that this early stage of differentiation is the time when mesenchymal cells have their 
fate determined along a particular lineage. 
As expected only a small proportion of cells were stained positively for albumin 
and less cells stained for AFP. This difference between the two endodermal marker 
proteins could reflect the different temporal expression patterns seen in EB 
development. Whilst AFP mRNA is expressed in day 5 EBs albumin is not expressed 
until much later (day 13). Subsequently, AFP expression is downregulated as cells 
mature whilst albumin is strongly expressed at day 18 and in vivo is maintained in 
adulthood (Abe et al., 1996; Hamazaki et al., 2001). Differentiating cultures may 
contain endodern1al cells that express albumin but have reached the stage at which AFP 
is downregulated and these cells are, therefore, undetected by immunostaining for AFP. 
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The presence of cardiomyocytes within many of the differentiated cultures, particularly 
those of the endodem1al assay, provides further evidence of the pluripotency of these 
cells. 
The CFU-A assay has been utilised as a standard assay for haematopoietic 
potential with a number of cell types (Pragnell et al., 1994). In my experiments 
however, the positive controls proved unreliable. Hence, the lack of cell bursts (positive 
indication of haematopoietic potential) in the experimental assays does not indicate that 
the cells from eo-culture lack haematopoietic potential, simply that this assay was not 
working sufficiently well to deem whether the cells had haematopoietic potential or not. 
The most rigorous test ofpluripotency is to inject cells into a blastocyst, reimplant 
this into a surrogate mother and produce a chimaeric mouse. If the cells can be shown 
to have contributed to the germline cells, as well as somatic cells, then there is no 
question of their pluripotency. For our purposes however the resulting chimaeras would 
not have served any purpose beyond confitming pluripotency. In the light of the fact 
that the dermal cells expressed cytokines already proven to maintain ES cell 
pluripotency, the use of animals was deemed unnecessary. 
4.4.2.4. Controls for pluripotency assays 
Positive controls were carried out with LIP-maintained ES cells to ensure the 
differentiation assay methods were successful. The original papers for the 
differentiation assays detailed the proportion of cells expected to differentiate along the 
target lineage. Such high proportions are not seen in cultures of pluripotent ES cells 
undergoing spontaneous differentiation upon withdrawal ofLIF (Bain et al., 1995; Dani 
et al. 1997). Therefore the data presented demonstrates the differentiation of the 
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majority of cells along a particular lineage was due to the protocol these cells were 
subjected to rather than a predetermined fate. 
Dermal cells exposed to retinoic acid (to simulate the neuronal assay) or to 
retinoic acid followed by T3 and insulin (to imitate the adipocyte assay) showed no 
significant change, indicating that neuronal and adipocyte differentiation had resulted 
from ES cells. This was confirmed by the detection of GFP expression within the 
differentiating cultures. 
4.4.2.5. Long term maintenance 
The pluripotency of cells was detem1ined after 6, 10, 14 and 20 days of eo-
culture. The 6 day time point was significant as after this length of time without any 
external influence ES cells would have begun differentiation. This is clear both from 
our own observations (controls for the conditioned media experiments) and published 
work (Smith & Hooper, 1987; Smith et al., 1988; Duval et al., 2000). Cells were also 
plucked after 10, 14 and 20 days from eo-cultures and all that were subjected to the 
differentiation assays gave consistently positive results. The longest eo-culture tested 
was a 20d PVG DP/ES eo-culture from which neuron-like cells were derived. This 
indicates that follicular dermal cells were effective at maintaining ES cells for a 
significant length of time, despite the changes that the dermal cells themselves 
underwent in relatively early stages of eo-culture. 
4.4.2.6. Initial hypothesis 
The inductive capacity of dermal papilla cells has been well-documented (see 
3.1.3 and Jahoda et al., 1984; Home et al., 1986; Reynolds & Jahoda, 1992; Jahoda & 
Reynolds, 1993). Non-follicular epithelium will form follicles when associated with DP 
cells, demonstrating the ability of DP cells to direct the differentiation of cells in close 
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proximity, as is believed to be their physiological role in the adult hair follicle (Hardy, 
1992; Jahoda & Reynolds, 1996). The initial hypothesis for my work was therefore that 
DP cells, when eo-cultured with pluripotent ES cells, would induce differentiation 
along the lineage of follicular epithelial cells. The dermal cells did exert an influence on 
the behaviour of the ES cells, but not what was expected. In contrast to the working 
hypothesis, the dermal cells maintained the ES cells in an undifferentiated state, an 
effect usually achieved by exogenous LIP or embryonic stem cell renewal factor 
(ESRF) (Smith, 1991; Dani et al., 1998). 
4.4.2.7. By what means do dermal cells maintain ES cells? 
The maintenance of ES cells by LIF can be mediated by two means. LIF is 
produced in a soluble form and a matrix-associated form (Rathjen et al., 1990a). The 
morphology ofES cells exposed to dermal cell or eo-culture conditioned media 
indicated that a soluble factor with the capacity to inhibit differentiation was present in 
the media. Whilst the experimental conditions were not ideal (batches of conditioned 
media had to be changed in some cultures due to limited stocks), media conditioned by 
eo-cultures proved to be the most effective. Differentiating ES cells express LIF 
enabling the self-renewing population to be maintained (Rathjen et al., 1990b). 
Therefore, a proportion of the inhibitory factor in the eo-culture conditioned media may 
be LIF from a small number of differentiating ES cells. However, given that pure 
dermal cell conditioned media has the same effect, albeit to a lesser extent, and ES cells 
are maintained in eo-cultures, it appears that eo-culture of these two cell types 
upregulates cytokine expression in either dennal orES cells. As there appears to be 
more changes occurring in the dem1al cells than ES cells in eo-culture, I propose any 
upregulation is likely to be in the dermal cell population. 
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The media for these experiments was conditioned by non-aggregated, confluent 
DP cells. The aggregative phenomenon of DP cells has important physiological 
relevance to the development and cycling of the hair follicle and is likely to be 
associated with significant changes in the biochemistry of the cells (Jahoda & Oliver, 
1984a). As such the prope1ty of maintaining ES cell pluripotency may be more evident 
in cultures at a particular state of aggregation than another, a possibility that could be 
investigated with media conditioned by DP cells in various states of aggregation. 
4.4.2.8. Potential candidates 
Four members of the IL-6 family of cytokines (LIF, CNTF, CT-1 and OSM) have 
the capacity to maintain ES cells in their undifferentiated state in vitro (Smith et al., 
1988; Williams et al., 1988; Conover et al., 1993; Rose et al., 1994; Pennica et al., 
1995) and transcripts of all four of these cytokines were detected in eo-cultures. When 
considering my results it must be noted that the sample numbers were very small so 
whilst they may give an indication of cytokine expression, further work would be 
required to confirm this expression profile. 
Another potential member of this cytokine family is an as yet unidentified ligand 
for the gp130/LIFRJ3 receptor complex known only as sweat gland-derived 
differentiation activity. Whilst functional assays have determined that this factor acts 
through the same pathway as LIF, CNTF, CT-1 and OSM, its identity remains unknown 
(Habecker et al., 1997). Another potential candidate is ES cell renewal factor (ESRF), a 
soluble macromolecule, whose ES cell maintaining-activity is trypsin-sensitive and 
independent of the LIFR/gp130/STAT3 pathway (Dani et al., 1998). The expression of 
ESRF was not investigated due to the lack of available sequence for primer design. 
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Cytokine PCR products were of the expected size, with one additional smaller 
product from the OSM primers. This is likely to be the mOSM 13 alternate transcript 
which results from alternate splicing ofexons 1 and 3, giving a product 130bp less than 
the full OSM transcript (Voyle & Rathjen, 2000). The two splice variants of OSM 
appear to be differentially expressed in DP and DS cultures, although both are at 
extremely low levels. DP cells express the full length transcript whilst DS cells display 
a higher level of the shorter transcript. This splice variant has been proposed to encode 
an intracellular OSM protein, the significance of this is not yet known. Further work 
would be required to confirm ifthe differential expression ofOSM splice variants, and 
the expression ofCNTF, CT-1 and LIF, detected in DP and DS cells is reflected in the 
individual tissues in vivo. 
By comparison with expression in single cell-type cultures the expression of each 
cytokine in DP/ES and DS/ES cell eo-cultures can probably be attributed to the dermal 
cells (CT-1), the undifferentiated nature of the ES cells (OSM) or both (LIF and 
CNTF). In the case ofRDP-B eo-cultures LIF, CNTF and OSM are expressed in both 
RDP-B cell cultures and undifferentiated ES cell cultures. However, neither of these 
express CT-1 at the level detected in the RDP-B eo-cultures. This suggests that either 
the ES cells are differentiating in RDP-B/ES eo-cultures, or the interaction between the 
two cell types has resulted in upregulation of CT -1 expression in a sub-population of 
cells. Given the morphology ofRDP-B eo-cultures, in which ES cells are difficult to 
identify by phase microscopy after a few days of eo-culture, the first scenario seems 
likely whilst the second may also be true. 
It would be interesting to know if the interaction between the cell types results in 
altered expression levels in eo-cultures, as appears to be the case for CT-1 in RDP-B/ES 
eo-cultures, but due to the nature of the material it would be extremely difficult to 
assess this in a truly quantitative fashion. Whilst the RT-PCR could be carried out semi-
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quantitatively, an equal amount of RNA from one eo-culture may have different 
proportions of dermal and ES cell RNA to another similar eo-culture. Once again the 
ability to separate the two cell populations and then analyse them would prove far more 
useful. For our purposes however, determining the presence or absence of cytokine 
transcripts was sufficient. 
A more intriguing case of upregulation appears to occur with OSM. Not only does 
it appear to be upregulated in cocultures with DP and DS cells, but in ES cells alone the 
expression level is altered dependent on the conditions in which the cells were cultured. 
These three samples were processed simultaneously and the GAPDH levels were 
comparable so the difference in expression levels are significant. Undifferentiated ES 
cells (ES+LIF) display a similar level of OSM expression to those which have 
differentiated upon withdrawal ofLIF (ES-LIF diff'd). However, those that 
differentiated in the presence of LIF (ES+LIF diff'd) have significantly higher levels of 
OSM. This would suggest that differentiation in the presence of LIF is not 
indiscriminate, but preferential towards one or more cell lineages which 
characteristically express OSM. 
4.4.2.9. Maintenance of stem cell populations within the hair follicle 
The expression of these cytokines in vitro clearly has a relevance in experimental 
work, but the important question is whether they play a functional role in vivo? The 
expression ofLIF, CNTF and CT-1 in all three segments ofmid-anagen vibrissa 
follicles suggests they are physiologically relevant. The distribution within the follicle 
was assessed in an attempt to determine the function of these cytokines. Previous 
studies have cited them as promoters and inhibitors of both cell differentiation and cell 
proliferation (Gearing et al., 1987; Williams et al., 1988; Smith et al., 1988; Malik et 
al., 1989; Conover et al., 1993; Rose et al., 1994; Pennica et al., 1995; Aubert et al., 
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1999), processes which occur predominantly in the follicle end bulb and are key to the 
cyclic nature of the hair follicle. The end bulb is also the location of the primitive 
germinative epithelial cells which are maintained in an undifferentiated state, as are 
cells within the bulge of the outer root sheath. An expression pattern restricted to the 
end bulb, or the end bulb and the upper follilcle segment containing the bulge, would 
have supported the idea that the cytokines function to maintain the epithelial stem cells. 
OSM expression, although at barely detectable levels, was exclusive to the end bulb, 
reflecting the weak expression detected in DP and DS cells in vitro. The expression of 
LIF, CNTF and CT-1 in all segments ofthe mid-anagen follicle however, indicates a 
widespread function within vibrissa follicles. 
Whilst cytokine expression may act to maintain the stem cell population, other 
molecules have been identified which are believed to regulate exit from the stem cell 
compartment. In those epithelia in which stem cells are in clusters, the release of cells 
into the TA compartment is likely to require changes in cell adhesion. Delta-Notch 
signalling appears to be involved in this process with stem cells expressing high levels 
of the ligand, Delta, whilst the highest levels of its receptor, Notch, are detected in the 
suprabasallayers (Lowell et al., 2000). The authors postulate that Delta-Notch 
signalling at the border of stem cell clusters stimulates cells to enter the TA 
compartment, whilst within the cluster, cell cohesiveness is enhanced by Delta 
expressiOn. 
Notch expression within the hair follicle exhibits a similar pattern. It is absent 
from the putative stem cells of the bulge and end bulb, but is highly expressed in the 
adjacent cell populations of supra basal outer root sheath cells and epithelial matrix 
cells, particularly precursors of the cortex, cuticle and inner root sheath (Kopan & 
Weintraub, 1993; Favier et al., 2000). Kopan & Weintraub (I 993) proposed that Notch 
regulates cell fate decisions, a suggestion that is supported by the expression pattern 
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through the adult growth cycle. During catagen, notch expression extends into the basal 
layer of ORS and in early anagen, is evident in the epithelial matrix and throughout the 
epithelial column (Favier et al., 2000). Delta is not expressed in follicular epithelial 
cells, but the expression of other Notch ligands, those of the Serrate/Jagged family, 
supports proposals that within the hair follicle, Notch participates in determining the 
fate of epithelial stem cells (Powell et al., 1998; Favier et al., 2000). 
Another molecule proposed to stimulate exit from the epidermal stem cell 
compartment is c-Myc. Ectopic expression of c-Myc, under the control of the K14 
promoter, impaired wound healing in mice and, over time, depleted the epidermal stem 
cell population. Intriguingly, sebaceous differentiation occurred at the expense of hair 
differentiation in the pilosebaceous unit, suggesting cells were stimulated to become TA 
cells of a sebaceous lineage rather than epidermal or hair lineages (Amold & Watt, 
2001; Waikel et al., 2001). This supports a model by which the step from stem cell to 
TA cell is not purely for amplification purposes, but also narrows the range of a cell's 
multipotency. Further evidence of the role of c-Myc in cell differentiation comes from 
recent studies describing three discrete rings of c-Myc expression in the anagen hair 
follicle. Each ring of expression corresponds to a layer of the inner root sheath at the 
level where cells within that layer undergo terminal differentiation (Rumio et al., 2000; 
Barajon et al., 2001). The transfer from stem cell to TA cell, and TA cell to terminally 
differentiated cell, is an area of research with important clinical relevance as it is likely 
to be reflected in the control of tumour growth. 
Identifying the location of the stem cell and TA cell populations within the hair 
follicle has been the subject of many studies but there seems to be no single 'niche' in 
which they reside. The follicular bulge and end bulb have been proposed as putative 
stem cell sites (Cotsarelis et al., 1990; Reynolds & Jahoda, 1991; Gharzi et al., 1999) 
but more recently there has been evidence to suggest stem cells are more widespread 
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throughout the follicle. Oshima et al. (200 1) proposed that whilst the upper follicle 
contains the vast majority of cells with clonogenic potential, these cells migrate down 
the outer root sheath during anagen, and become germinative epithelial cells prior to 
differentiation into one of the epithelial lineages that contributes to the growing hair 
fibre. The presence of cytokines in all segments of the follicle could therefore be 
explained as a means for maintaining the primitive state of the cells during this 
migration. 
The presence of stem cells throughout the follicle is also proposed by Ghazizadeh 
& Taichman (200 1) though in a somewhat different manner. They describe the 
pilosebaceous unit as separated into discrete sections (IRS, ORS, sebaceous gland, 
infundibulum), each containing a stem cell population, and propose hair follicle stem 
cells may be organised in a manner similar to epidermal stem cells. Distinct 
proliferative units produce the cells of the sections described and only under certain 
circumstances (such as a wound response) do adjacent proliferative units compensate 
for each other. By such a means the stem cells of the infundibulum contribute to the 
interfollicular epidermis, as described by Taylor et al. (2000). In normal circumstances 
however, the hair follicle proliferative units remain separate from those of the 
interfollicular epidermis. The location of stem cells within the hair follicle remains a 
matter of some debate but with the expression of the cytokines LIF, CNTF and CT -1 in 
the upper, middle and end bulb sections of the vibrissa follicle, the potential for 
harbouring stem cells appears to exist throughout this organ. 
Whilst epithelial stem cells within the hair follicle have been the subject of 
intense investigation, the dem1al components of the hair follicle have not really been 
investigated as a source of stem cells. However, as the outer root sheath contributes to 
the epidermis in a wound-healing scenario, the dermal sheath has been proposed to 
contribute to regenerating skin (Jahoda & Reynolds, 2001). Further multipotency has 
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been demonstrated in both DP and DS cells using the CFU-A assay described in 
4.2.3.2.1. Microdissected tissue fragments of dermal papilla and dermal sheath, and 
cultured DP and DS cells, gave positive results in this assay indicating the presence of 
cells with haematopoietic potential (M. Lako, personal communication). LIF and 
similar cytokines may be functioning within the follicle to maintain a suitable niche for 
dermal stem cells as well as epithelial stem cells. 
4.4.2.10. Cytokine signal transduction in the hair follicle 
Having established that the cytokines are widely expressed in the hair follicle 
there is the possibility that their signalling is restricted by extracellular modulation or 
the distribution of receptors. LIF is produced in both extracellular matrix -associated and 
diffusible forn1s by alternative splicing at the exonllexon2 boundary. The two forms 
appear to be transcribed from different promoters and hence, could be differentially 
regulated (Rathjen et. al., 1990a). Expression of the immobilised extracellular matrix 
form will be spatially regulated and exert a more selective influence on the adjacent 
cells, whilst the diffusible form will influence any cells in the environment which 
express the appropriate receptors. Determining the expression of these alternate 
transcripts within the follicle may provide some clues as to the cells that are targeted by 
cytokine signalling. 
Similarly, determining the expression of cytokine receptors might highlight the 
target cells. LIF, CT -1 and OSM operate through the gp 130/LIFRI3 complex whilst 
CNTF requires a third component named CNTFRa to make a functional CNTF 
receptor complex (reviewed by Kishimoto et al., 1994; Bravo & Heath, 2000). We 
found CNTFRa to be expressed in the vibrissa follicle which suggests hair follicles 
may be the location of the transcripts detected at low levels in skin by Ip et al. (1993). 
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The expression of CNTFRa in the follicle is a novel observation. When this receptor 
subunit was first identified and its expression investigated, it was thought to be 
restricted to the central nervous system and hence the biological function of CNTF 
restricted in the same manner (Davis et al., 1991 ). Since then its expression pattern has 
been found to be more widespread (Conover et al., 1993; Ip et al., 1993; Yang et al., 
2001) and sites of expression can now include the vibrissa follicle where it may be 
associated with the follicle's complex peripheral innervation. However, it may be 
involved in the maintenance of a stem cell population within the follicle. 
Although these cytokines were investigated due to their known role in vitro, (and 
in vivo in the case of LIF) in maintaining a stem cell population, the numerous roles that 
these cytokines play in a wide range of tissues must not be ignored. Further evidence of 
their function in relation to follicular stem cells is required and altering expression by 
using transgenes under the K14 promoter could prove very useful in achieving this 
objective. 
4.4.2.11. Involvement of STAT3 in the hair growth cycle 
A component of the intracellular signalling pathway downstream of LIF, CNTF 
and CT -1 signalling has already been identified as functionally important in the hair 
growth cycle. Targeted disruption of the Stat3 gene in keratinocytes resulted in a failure 
to initiate second anagen (Sano et al., 1999). This was attributed to cells being unable to 
migrate from the bulge after telogen, as Stat3 -1- keratinocytes displayed inhibited 
migration in an in vitro assay (Sano et al., 1999). Subsequently, it was demonstrated 
that anagen could be initiated in these mice by mechanical or chemical means via a 
STAT3-independent signalling pathway that promoted keratinocyte migration (Sano et 
al., 2000). The authors proposed HGF and EGF as candidates in regulating follicular 
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keratinocyte migration via a ST A T3-dependent pathway, but LIF, CNTF and CT -1 
signalling via STA T3-phosphorylation might also influence cell migration. 
Another migration-related study found DP cell conditioned media contains 
chemoattractants for outer root sheath cells in vitro (Fujie et al., 2001 ). The presence of 
soluble factors with inhibitory properties on ES cell differentiation was detected in 
conditioned media experiments. The soluble factors present are likely to include one or 
more ofthe cytokines LIF, CNTF and CT-1, all ofwhich transduce their signal via a 
gp 130 receptor complex and intracellular phosphorylation of STA T3, a key step in the 
maintenance ofES cells (Matsuda et al., 1999; Raz et al., 1999). It is possible therefore, 
that these cytokines may be effective both in maintaining the multipotency of a stem 
cell population within the hair follicle, and influencing its migration. Further 
investigation will be required to elucidate the contribution of these cytokines to various 
aspects of hair follicle biology. 
4.4.2.12. Other potential roles for cytokines within the hair follicle 
Cytokines are known to play a role in inflammation. Whether they are pro-
inflammatory or anti-inflammatory depends on the cell type and the cytokine but the 
IL-6 cytokines are no exception (reviewed in Gadient & Patterson, 1999). In such a 
response cytokines are extremely fast acting and there is always a possibility when 
working with cultured cells, or tissue that has been mechanically manipulated, that such 
an inflammatory response has been initiated and cytokine expression is upregulated. 
Although there is no reason to believe this is the sole reason for cytokine expression 
within follicular cells or tissue it must be considered as a possibility. 
The IL-6 family of cytokines play a wide variety of roles which are often opposite 
on two different cell types, for example LIF inhibits differentiation of ES cells whilst 
inducing differentiation of myeloid cells, the role by which it was discovered (Gearing 
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et al., 1987). So whilst the focus has so far been on their potential role as 'protecting' 
the stem cell population of the hair follicle, it is also possible that these factors may be 
present to promote differentiation of hair follicle stem cells. Slack (2000) expressed the 
opinion that whilst epithelial stem cells may act as unipotent cells the majority of the 
time, when tissue regeneration was required as a result of damage or insult, the same 
cells were multipotent and signals would be expressed which would activate this 
dormant multipotency. Potentially the IL-6 cytokines are ideal candidates for such a 
role given their rapid upregulation as part of the inflammatory response and their 
diverse roles in regulation of cell proliferation and differentiation. 
Of all the possible roles discussed it should be remembered that there may be 
multiple roles for these cytokines within the hair follicle that may be elucidated via 
different intracellular pathways. A review on FGF signalling highlighted two distinct 
pathways that were independently responsible for influencing cell migration and 
proliferation (Boilly et al., 2000). It may be a similar case for the LIF family cytokines 
as two intracellular pathways activated by gp 130 dimers have been identified (Emst et 
al., 1994; Emst et al., 1996; Emst et al., 1999). 
A wide array of molecules have been detected within the hair follicle but for most 
the functional significance of their presence is unknown (Stenn et al., 1994; Stenn & 
Paus, 2001 ). The hair growth cycle is a complex, dynamic process and has several 
secondary processes associated with it, such as remodelling of the vasculature and 
innervation, as well as melanogenesis. The detection ofLIF, CNTF, OSM and CT-1 in 
cultured dermal cells is a novel observation and from the data presented here, and the 
body of literature on the diverse actions of these cytokines, a functional relevance is 
apparent. Further investigation is required to determine the mechanisms to which these 
cytokines are relevant within the hair follicle, whether they are directly related to the 
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regulation of the hair growth cycle, or as appears to be the case for versican (discussed 
in 2.4), are involved in systems associated with the vibrissa follicle. 
Detem1ining the expression pattern of the cytokines and the components of the 
receptor complexes would indicate the tissues that are targets of cytokine signalling and 
from this further studies could be developed. If, for example, the outer root sheath 
appears to be a tissue involved in cytokine signalling, altering expression of LIF or one 
of the other cytokines under the regulation of the K14 promoter may demonstrate an 
effect on the proposed stem cell population. Interfollicular wounds in such a model 
would demonstrate the effect of a cytokine on the outer root sheath cells that are known 
to migrate into the epidermis during epidermal wound healing (Taylor et al., 2000; 
Arnold & Watt, 2001), thus indicating the influence LIF, CNTF, OSM or CT-1 has on 
the stem cells in the upper follicle. The function of cytokines within the hair follicle 
could also be investigated by blocking the signal with antibodies, either in follicle organ 
culture, or by subcutaneous injection. 
4.4.3. ES cells influence dermal a.-smooth muscle actin expression 
The initial hypothesis was proved wrong regarding the influence of follicular 
dem1al cells on ES cells, and whilst the ES cells maintained their own characteristics 
they appeared to influence the dermal cells within eo-cultures. This was initially evident 
from the altered morphology observed in dermal cells in areas between colonies. 
Bipolar morphology was observed in these cells by phase microscopy. Immunostaining 
with an antibody against a-smooth muscle actin revealed changes in expression in all 
dermal cells. The exact nature of the change was apparently dependent on the 
relationship of the dermal cell with ES cells. 
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4.4.3.1. Two methods of influence: contact and soluble/ECM factor 
The bipolar cells situated betweeen ES cell colonies had dramatically 
downregulated expression of a-smooth muscle actin, most cells being undetectable by 
fluorescence microscopy. In contrast, the follicular dermal cells that were situated on 
the surface of ES cell colonies expressed a-smooth muscle actin, but the pattern of 
expression at the intracellular level had changed. a-smooth muscle actin expression was 
altered from a stress fibre pattern, typically observed in cultured follicular dermal cells, 
to expression localised to the edge of the cell and points of contact with adjacent cells. 
This expression was reminiscent of that seen in ES cell-derived endothelial cells 
(Balconi et al., 2000). The lack of a similar intracellular a-smooth muscle actin 
expression pattern in dermal cells exposed to conditioned media, indicates that contact, 
or at least close association (possibly via the extracellular matrix), with ES cells is 
necessary for cells to retain their a-sma expression in ES cell eo-cultures and switch to 
the squamous morphology observed. 
In cells at the base of the eo-cultures, away from the ES cells, a-smooth muscle 
actin expression was down-regulated whilst the cells underwent a visible change in 
morphology, becoming bipolar. The effector molecule resulting in this change was a 
soluble factor secreted into the media either by the ES cells, or by the dermal cells 
under direct influence of the ES cells by contact. Evidence for this comes from 
experiments in which eo-cultures were grown on membranes above dermal cell 
cultures. Morphological changes occurred within 2-3 days and when the dermal cells 
were stained after 5 days, downregulation of a-smooth muscle actin was evident 
compared to controls. The fact that these changes occur in synchrony suggests the cells 
may have become more motile as the bipolar morphology was one of a less adherent 
cell, and a-smooth muscle actin has been connected with a retardation in cell motility 
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through organization of focal contacts (Ronnov-Jessen & Petersen, 1996). Why the 
cells should become motile is unclear. It is possible that the ES cells were producing a 
chemoattractant, resulting in dermal cells engaging with the ES cell colonies and 
changing morphology to the squamous cells. If this was the case it would be intriguing 
to be able to follow individual cells over a time course of these eo-cultures, observing 
both morphology and a-smooth muscle actin expression. 
The two changes in a-smooth muscle actin expression indicate there were two 
different influences exerted on the dermal cells, dependent on their relationship with the 
ES cells. Over a distance, soluble factors downregulated expression of this cytoskeletal 
protein. Close contact on the other hand, resulted in altered cytoarchitecture and 
accordingly, the distribution of a-smooth muscle actin was changed. 
4.4.3.2. Reprogamming somatic cells 
The changes observed in dem1al cells indicate that the ES cells were effectively 
reprogamming the follicular dermal cells. Reprogramming a cell involves changes to 
the nucleus to direct expression of genes that were not previously expressed and 
suppression of some of those that were. The most direct reprogramming of nuclei has 
been achieved by somatic nuclear transfer. That is the injection of a somatic cell 
nucleus into an enucleated oocyte. The cytoplasm of the oocyte will reprogram the 
nucleus so the cell becomes totipotent as demonstrated by cloning experiments resulting 
in healthy mammals (Wilmut et al., 1997; Wakayama et al., 1998). These experiments 
have demonstrated the ability of cytoplasm to reprogram nuclei when direct contact has 
been established. Other experiments have suggested reprogramming can occur without 
such drastic interjection. 
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Non-follicular epidermis has been shown to transdifferentiate upon the induction 
of follicle formation by cultured dermal papilla cells (Reynolds & Jahoda, 1992). 
However, this is transdifferentiation as opposed to reprogramming, as the production of 
follicular epidermal cells could be attributed to the resident population of epidermal 
stem cells. The first clear evidence that transient amplifying cells can be reprogrammed 
came from Ferraris et al (2000) who combined central corneal epithelium, isolated from 
the corneal stem cell population which is restricted to the periphery of the tissue, with 
detmis from a variety oflocations. Under the influence of embryonic dermis, corneal 
epithelium gave rise to hair follicles or sweat glands. The results suggested that the 
corneal epithelium first reverted to a stem cell-like condition before differentiating into 
the more complex epidermis. The down-regulation of a.-smooth muscle actin in 
follicular dem1al cells in ES cell eo-cultures may well be a process of dedifferentiation 
prior to differentiation along another cell lineage, possibly that seen in dem1al cells in 
contact with the ES cell colonies. 
In culture, myotubes have been shown to be reprogrammed by a number of means 
(reviewed by Hughes, 2001). Induction of the transcription factor Msxl resulted in a 
significant proportion of myotubes cleaving, to become mono-nucleated cells which 
were then capable of expressing markers of a number of lineages other than muscle 
(Odelberg et al., 2000). To investigate further the potential of dermal cells for 
reprogramming other cell types, it would be interesting to eo-culture follicular dermal 
cells with these myotubes. Fenaris et al (2000) suggested corneal epithelia was 
dedifferentiated prior to production of hair follicle and glandular cells and the 
combination of follicular dermal cells with myotubes provides the opportunity to 
investigate if this property extends beyond epithelial tissues. 
Mesenchyn1al tissue has been demonstrated to reprogram epithelial tissue, but 
there are also instances in which the reverse is true. Barasch et al. (1999) demonstrated 
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that LIF induces mesenchymal cells of the kidney to convert to epithelial cells and go 
on to form nephrons. The adjacent cells of the ureteric bud are the source ofLIF whilst 
the kidney mesenchyme expresses the receptors gp 130 and LIFR. Interestingly the 
authors found that the ureteric bud expresses CNTF, OSM and CT-1 as well as LIF. It 
seems a common theme that these cytokines are rarely expressed in isolation of each 
other, suggesting that the different cytokines can compensate for each other, or that a 
delicate balance between them is required to regulate processes in which they are 
influential. 
Recent work by Jahoda & Dhouailly has indicated that ES cells have an inhibitory 
effect on appendage morphogenesis in vivo (C. A. B. Jahoda, personal communication). 
Where follicle formation would nmmally occur, the presence of ES cells appears to 
prevent this process. Combined with my results this would suggest that ES cells have a 
propensity to inhibit or reprogram dermal papilla cells in some way. 
4.4.3.3. Interactions between cells at different stages of differentiation 
From these studies it appears that the less differentiated cell type exerts a greater 
influence on more differentiated cells than vice versa. This is also the case in somatic 
nuclear transfer with the simple cytoplasm of the oocyte directing the somatic cell 
nucleus, resulting in the development of an embryo with the genotype of the donated 
nucleus (Wilmut et al., 1997; Wakayama et al., 1998). Embryonic dermis affects adult 
epithelia and embryonic stem cells affect adult dermal cells. If this is a general 
phenomenon, it would be interesting to investigate the potential of ES cells for 
reprogramming other cell types besides follicular dermal cells. By eo-culturing ES cells 
with a selection of cell types which are well characterised and have good lineage 
markers the degree of de-differentiation or reprogramming could be established. For 
example, ifES cells were found to change expression ofMyoD in muscle cells or 
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neurofilament expression in a neuronal culture, this would be an extremely interesting 
result demonstrating a significant level of reprogramming. 
4.4.4. Conclusions 
I have shown that follicular dennal cells are capable of maintaining pluripotent 
ES cells in vitro. The detection ofLIF, CNTF and CT-1 expression in cultured 
follicular dermal cells, as well as intact vibrissa follicles, is a novel observation. I have 
demonstrated that ES cells exert strong influences, by soluble factors and close contact, 
on follicular dermal cells. This capacity of ES cells to influence other cell populations is 
an aspect ofES cell biology that has not previously been observed and merits further 
investigation. Under the influence of ES cells, the dermal cells display a degree of 
plasticity that results in significant changes in their phenotype, suggesting a level of 
multipotency that was previously unrecognised. The multipotent cell population within 
the dermal component of the follicle has the potential to contribute to tissues beyond the 
confines of the hair follicle, thus providing an accessible source of stem cells that could 
be exploited for therapeutic applications. 
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In this thesis I describe work using the vibrissa follicle as a model for studying 
vatious aspects of hair follicle development, innervation, and regeneration in vivo, in 
addition to investigating the relationship between follicular dermal cells and embryonic 
stem (ES) cells in vitro. Central to the study is the character and properties of hair 
follicle dennal cells. Thus, in my first experimental chapter, amongst other things, I 
investigated the appearance of dermal condensations, the precursors of both detmal 
papilla and dermal sheath cells. One of the questions examined in the following chapter 
was the transition of dermal sheath to papilla phenotype during the process of follicle 
regeneration. I then set out to detetmine whether the well established inductive powers 
of follicle papilla and sheath cells could act in the context of ES cell differentiation. 
In considering the results, one important point that emerged from the work 
concerns the complexity of molecular expression in the follicle, and an understanding 
that an individual molecule may play different functional roles in conjunction with 
different follicular activities. Another was that the role played by groups of molecules 
may be subject to multiple interpretation so the context in which molecular expression 
is examined in relation to the follicle is very important. Although the combination of 
follicular dermal cells with ES cells in vitro produced results that were totally 
unexpected, in terms of novelty and interest these data were intriguing, and may 
produce real insights into questions of cell lineage and reprogramming. 
Versican was observed to have a relationship with follicle innervation throughout 
development, during the growth cycle and the regeneration of the adult follicle. Strong 
expression in the amputated dermal sheath indicated a role for versican in the early 
wound response of this tissue. Whilst versican may have dual or multiple roles in the 
hair follicle, I propose that a significant function of this proteoglycan is to regulate the 
complex follicular innervation. 
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My work highlights the point that differential expression of molecules within the 
hair follicle, should be interpreted on the basis that the follicle is comprised of more 
than just a hair growth mechanism. Innervation, vascularisation and melanogenesis are 
all systems that change with the follicle cycle and should be considered when 
attributing function on the basis of distribution. 
Follicular dermal cells were eo-cultured with ES cells, the hypothesis being that 
the ES cells would be induced to differentiate along a follicular epithelial cell lineage. 
These novel experiments proved the original hypothesis wrong, as differentiation was 
not induced. In fact, the ES cells remained pluripotent whilst exerting strong influences 
on the dermal cells. The maintenance of the ES cells in eo-culture can be attributed to 
the production of cytokines previously demonstrated to maintain ES cells in vitro. I 
made the original observation that LIF, CNTF, CT-1 and OSM were expressed in 
follicular dermal cell cultures and the vibrissa follicle. In isolation, the expression of 
these cytokines within the follicle might have been viewed as an indication that they 
were involved in the follicle growth cycle. However, having observed the maintenance 
ofES cells in eo-culture, I propose that these cytokines regulate the stem cell 
population within the follicle. 
Follicular epithelial stem cells have been the subject of intense study for a number 
of years and there is an increasing body of literature that suggests they are not restricted 
to a single location within the follicle. Recently, Shimazaki et al. (200 1) demonstrated 
that signalling via the CNTFR/LIFR/gp130 receptor complex supports the self-renewal 
of a neural stem cell population in vivo. Thus, the differentiation inhibitory activity of 
these cytokines is not restricted to ES cells. The expression of LIF and other IL-6 
family cytokines throughout the length of the vibrissa follicle therefore, provides 
evidence that the follicular environment is suitable for widespread distribution of stem 
cells. This is suppmted by my observations of epithelial cell proliferation at regular 
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intervals along the regenerating follicle. I propose that IL-6 family cytokines act to 
provide an environment in which stem cells can migrate through the follicle in an 
undifferentiated state. 
The maintenance of ES cells by dermal cells was reciprocated by the ES cells 
altering the phenotype of the dermal cells, demonstrating that follicular dermal cells 
have a greater degree of plasticity than was previously recognised. Follicular dem1al 
cells possess a degree of multipotency, demonstrated in vivo during the induction of 
follicle formation and regeneration. In addition to this, recent evidence of 
haematopoietic potential within these tissues (M. Lako, personal communication), 
suggests the multipotency of follicular dermal cells extends to lineages beyond those of 
the follicle. Whilst the epithelial stem cells of the follicle have been the focus of many 
studies, the dermal cell population appears to have considerable potential as a source of 
multipotent stem cells. The extent of this multi potency is not evident in vivo, but in 
vitro experiments, such as the eo-cultures with ES cells, provide an excellent 
opportunity to investigate the full potential of these cells. 
My results could have a profound impact on stem cell research, raising new 
questions about the inductive capacity of ES cells. This characteristic has not previously 
been recognised in ES cells, as the focus of stem cell research has been to determine the 
mechanisms that induce ES cells to differentiate, rather than to investigate their 
influence on other cell populations. Having demonstrated that expression of a follicular 
dermal cell marker is altered byES cells, the fundamental question of whether ES cells 
affect other somatic cell populations in a similar way, could be answered with eo-
cultures of other differentiated cell types, for example, muscle or glial cell cultures. The 
analysis of lineage markers in such eo-cultures would demonstrate whether ES cells 
have an innate ability to reprogram somatic cells. A new perspective on ES cell biology 
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has been highlighted by my novel approach of eo-culturing these cells with somatic 
cells. 
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APPENDIX I 
Preparation of Materials 
CELL CULTURE REAGENTS AND MEDIA 
TVP: 250mg trypsin 
3 72mg EDT A, disodium salt 
1 Oml chicken serum 
llitre PBS (Oxoid tablets) 
filter-sterilize and store in aliquots at -20°C 
Alpha medium stock: One 10 litre alpha medium powder pack + 200mg gentamycin 
sulphate + 1 OOml MEM 1 OOx vitamins made up to 3 litres with dH20 and filter 
sterilized. 
2x CfuA medium: 
42ml alpha medium stock 
50ml donor horse serum 
2ml glutamine 
6ml NaHC03 (7.5%) 
ELECTRON MICROSCOPY 
0.2M Sodium cacodylate buffer: 
COS cell medium: 
50% HAMS F-12 medium 
50% Glasgow MEM 
1%FBS 
glutamine (lx) 
4.28g Na(CH3)2As02.3H20 in ddH20 made up to lOOm! 
pH adjusted with HCl to 7.3 
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Karnovsky's fixative: 40% solution A and 60% solution B 
Solution A = 2g paraformaldehyde dissolved in 40ml ddH20 
Solution B = 10ml25% gluteraldehyde 
50ml 0.2M sodium cacodylate buffer (pH7.3) 
NB/ Solutions A and Bare kept separate at 4°C until just before use 
IMMUNOSTAINING AND IN SITU HYBRIDISATION 
Mowiol: 
2.4g mowiol 488 (Calbiochem) and 6g glycerol were added to 6ml dH20 then 
mixed thoroughly and incubated at 37°C overnight. 12ml 0.2M TrisHCl (pH8.5) was 
added and the mix agitated at 50°C until everything had dissolved. The solution was 
then clarified by centrifugation at 5000xg for 15 minutes before adding 1 ,4-
diazobocyclo-[2.2.2]-octane (DABCO) antifade agent (Sigma) to 2.5%. When this was 
thoroughly dissolved the mowiol solution was aliquoted and stored at -20°C. 
Follicle powder 
Vibrissa follicles were dissected from 3 adult PVG rats and put in MEM. The 
follicles were ground to a powder in liquid nitrogen using a pestle and mortar before 
adding ice-cold acetone. The suspension was poured into a 50ml plastic tube and kept 
on ice for 30 minutes. The powder was then pelleted by centrifugation (1 minute at 
1700rpm) and the acetone poured off. 1ml ice-cold acetone was added, the pellet 
resuspended and centrifuged again (2 minutes at 2000rpm) before the supematant was 
removed by pipetting and the pellet spread out on a clean surface to air dry. The dry 
powder was then stored at 4°C in a microcentrifuge tube. 
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APPENDIXII 
Pilot experiments 
ES cells are routinely cultured in CGR8 media whilst follicular dermal cells are 
maintained in MEM with FBS. When dermal cells were first cultured in CGR8 media it 
was observed that the cells remained healthy although the growth rate was slightly 
slower than in MEM with FBS. In contrast, when ES cells were cultured in MEM, with 
or without FBS (20% ), the cells died. Cocultures were set up in both types of media and 
all cells appeared to be viable. This suggested that the dermal cells supported the ES 
cells in coculture in MEM + FBS. In an attempt to determine whether this was by 
contact or by secretion of factors into the culture media conditioned MEM + FBS was 
removed from a flask of PVG DS cells and diluted in CGR8 media as well as fresh 
MEM. ES cells were then cultured in the two dilution series of DS cell conditioned 
media and it was found that the cells died in all cases except those containing CGR8 
media. 
Summary of experiments to determine media requirements of cultured cells 
Cell type CGR8 Media MEM+FBS DS cond. MEM 
DP + + NA 
DS + + NA 
ES cells + - -
DP/ES + + NA 
DS/ES + + NA 
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The conclusions from these preliminary experiments were: 1) dermal cells can be 
maintained in CGR8 media; 2) ES cells can not be cultured in MEM + FBS; 3) viable 
dermal cells can support the growth ofES cells in MEM + FBS; 4) factors secreted into 
the culture media are not sufficient alone to maintain ES cells in MEM. 
On the basis of these experiments further investigations were carried out with all 
cocultures maintained in CGR8 media. 
Dermal cells were cocultured with ES cells either as a mixed culture or a 
monolayer with ES cells added. For the mixed cultures, the two cell types were 
trypsinised, spun down and resuspended. Equal volumes of the cell suspensions were 
then mixed, the cells spun down again, resuspended in the appropriate growth medium 
and plated out in 35mm dishes. For the monolayer cultures, dermal cells were grown in 
35mm dishes to form a monolayer. ES cells grown in 0.1% gelatin-coated culture flasks 
were trypsinised with TVP, spun down, resuspended and a volume of cell suspension 
added to each dish of dermal cells. 
The two types of coculture did not appear to be any different morphologically. 
Colonies of cells developed in both mixed and monolayer cocultures. After this inital 
comparison subsequent cocultures were all set up using an initial monolayer of dermal 
cells and adding ES cells to this. 
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